Role of seminal fluid in sexual transmission of HIV-1 by Kim, Louise U.
Open Research Online
The Open University’s repository of research publications
and other research outputs
Role of seminal fluid in sexual transmission of HIV-1
Thesis
How to cite:
Kim, Louise U. (2001). Role of seminal fluid in sexual transmission of HIV-1. PhD thesis. The Open University.
For guidance on citations see FAQs.
c© 2001 Louise U. Kim
Version: Version of Record
Copyright and Moral Rights for the articles on this site are retained by the individual authors and/or other copyright
owners. For more information on Open Research Online’s data policy on reuse of materials please consult the policies
page.
oro.open.ac.uk
La r>J/^ ^STieJ crr^J)
R ô le  o f  S e m in a l F lu id  in  
S e x u a l T ra n sm issio n  o f  HIV-1
L o u ise  U. Kim, B Sc, M Sc 
J u n e , 2001
Tm S THESIS IS SUBMITTED AS PARTIAL FULFILLMENT OF THE REQUIREMENTS OF
THE Op e n  U n iv e r sit y  fo r  the D eg ree  o f D octo r  o f  P h ilo so ph y
Institute o f Molecular Medicine, Oxford, in collaboration with 
Department o f Immunology, Chelsea and Westminster Hospital, London
ProQuest Number: 27532767
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 27532767
Published by ProQuest LLO (2019). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLO.
ProQuest LLO.
789 East Eisenhower Parkway 
P.Q. Box 1346 
Ann Arbor, Ml 48106- 1346
Index
Abstract 6
Acknowledgements 8
Abbreviations 9
List of Tables 13
List of Figures 14
Presentations and Publications arising from this thesis 18
Chapter 1 : Intro duction
1.1. Introduction to the thesis 20
1.2. Epidemiology of HIV 21
1.3. m v  structure and Rephcation 23
1.3.1. The structure of HIV 23
1.3.2. The viral life cycle 24
1.4. Cellular Tropism of HIV-1 29
1.4.1. Chemokine receptor usage by HIV-1 and their natural ligands 30
1.4.2. Mutations in the chemokine receptor genes and the effect on
m V -l entry into CD4^ cells and disease progression 34
1.5. Transmission of m v  37
1.5.1. Vertical transmission 37
1.5.2. Transmission via contact with HIV-infected blood 39
1.5.3. Sexual transmission 40
1.6. The biology of Dendritic cells 45
1.6.1. Dendritic cells and their potential role in HIV-1 transmission 53
1.7. Semen 56
1.7.1. Composition of seminal fluid 56
1.7.2. Immunological functions of seminal plasma 58
1.7.3. mV-1 in semen 60
1.7.4. ‘Sperm-washing’ 65
1.7. Aim of thesis 67
Chapter 2: Materials and Methods
n .l. Subjects 68
n.2 Sample preparation and cell cultures
n.2.1. Peripheral blood mononuclear cell separation 69
H.2.2. Semen separation 69
H.2.3. Freezing and thawing cells 71
n.2.4. Separation of CD 14  ^cells using MicroBeads 72
n.2.5. Generation of dendritic cells from CD14^ monocytes 72
II.2.6. Pulsing of dendritic cells with seminal plasma, PGE2, or
19-OHPGE2 and/or TNF-a 73
n.2.7. Allogeneic mixed lymphocyte reaction 75
n.2.8. Recovery of allogeneic T cell proliferation 76
n.3. Flow cytometry
n.3.1. Surface marker staining 76
n.3.2. Intracellular cytokine staining 77
n.4. Nucleic acid extraction
n.4.1. Tri Reagent 78
n.4.1.1. RNA isolation 78
n.4.1.2. DNA isolation 79
n.4.2. RNAzol B 80
n.4.3. NucliSens Lysis Buffer 81
n.4.4. Spectrophotometer 82
n.5. Molecular analysis of the cells
n.5.1. Reverse transcription-polymerase chain reaction for CD4 83
n.5.2. Polymerase chain reaction for viral (HIV-1 ) DNA detection 83
n.5.3. Quantitation of HIV-1 RNA load using NucliSens
n.5.3.1. Amplification 86
n.5.3.2. Detection 86
n.5.4. Gel electrophoresis 87
JÏ.6. In viTro-infection of dendritic cells with HIV-1
n.6.1. Propagation of virus 88
n.6.2. p24 Enzyme linked immunosorbent assay (ELISA) 89
n.6.3. In v/7ro-infection of dendritic cells with HIV-1 91
n.7. Statistical analysis 91
n.8. Reagents and suppliers 93
Chapter 3: Evaluation of sperm-washing as a potential method of reducing 
HIV transmission in HIV-discordant couples wishing to have 
children
m. 1. Introduction 97
m.2. Results
ni.2 .1. HTV-1 RNA load in seminal fractions and blood plasma 99
in.2.2. Proviral DNA detection in seminal cells
andPBMCs 101
ni.2.3. Expression of CD4 and HTV-1 co-receptors on seminal cells 102
m.2.4. Reverse transcription-polymerase chain reaction for CD4 104
m.2.5. Establishing a clinical service of ‘sperm-washing’ forHTV-
discordant couples 105
m.3. Discussion 108
Chapter 4: Immunomodulatory effect of seminal plasma on dendritic cells
TV. 1. Introduction 114
TV.2. Results 116
rv.2.1. TNF-a and seminal plasma titration 117
rv.2.2. Phenotypic characterisation of CD 14  ^monocyte-derived
dendritic cells treated with seminal plasma and/or TNF-a 118
rV.2.3. Allostimulatory ability of CD 14  ^monocyte-derived dendritic
cells exposed to seminal plasma and/or TNF-a 120
rv.2.4. Identification of seminal components responsible for suppression 
of allostimulatoiy ability of CD 14  ^monocyte-derived dendritic 
cells 123
rv.3. Discussion 125
Chapter 5: Effect of seminal plasma on expression of HIV-I co-receptors 
and infection with HIV-1
V. 1. Introduction 131
V.2. Results 134
V.2.1. Surface expression of CCR5 and CXCR4 on CD 14  ^monocyte-
derived dendritic cells 135
V.2.2. Assessment of CD 14  ^monocyte-derived dendritic cell infection
with HIV-1 137
V.2.3. Assessment of antigen presenting function of HTV-l-infected
CD 14  ^monocyte-derived dendritic cells 140
V.3. Discussion 144
Chapter 6: Discussion 153
VI. 1. Summary of thesis 154
VI. 2. Significance of in vitro finding to the in vivo situation 161
VI.2.1. The effect of seminal plasma and TNF-a on DC function in the
Female reproductive tract 161
VI.2.2. The relationship between DCs in the female reproductive tract
andmV-1 165
VI.3. The role of mucosal epithelial DCs in sexual transmission of HIV-1 169
Bibliography 174
A bstract
This study analysed the reservoir of HTV-1 in semen and the effects of seminal 
plasma on the functional and phenotypic characteristics of dendritic cells (DCs), 
both in relation to immunoregulatory capabilities and susceptibility to infection 
with HFV. The reservoir of HTV-1 in semen was defined in order to assess the 
feasibility of ‘sperm washing’ as a means of reducing the risk of transmission in 
HTV-l-discordant couples.
The fact that neither viral RNA or DNA could be detected in spermatozoa and 
the lack of expression of CD4 both at the protein and mRNA levels suggests 
that spermatozoa are not susceptible to HTV-1 infection. Viral RNA was 
detected in seminal plasma and both RNA and DNA were detected in non­
sperm cells. As a result of this study, sperm washing is a service that is now 
available at the Chelsea & Westminster Hospital to HTV-l-discordant couples. 
This service has resulted in several births and no séroconversions in any woman 
who has undergone the procedure.
The effects of seminal plasma on the phenotype and function of monocyte- 
derived DCs were investigated. Seminal plasma had suppressive effects on the 
allostimulatory capacity of DCs and such effects appeared to be due to down- 
regulation of co-stimulatory molecule expression on these cells. The 
suppressive effect of seminal plasma was abrogated by the removal of lipids. 
However, prostaglandins on their own did not have suppressive effects on DC 
function, suggesting that other seminal components are required to induce the
observed induction of suppression. The suppressive effect of seminal plasma on 
the allostimulatory function of DCs was overcome with TNF-a, as did the 
presence of HFV. The expression of HTV co-receptors was assessed on DCs. 
TNF-a induced maturation of DCs as demonstrated by reduced expression of 
CCR5 and increased CXCR4. Seminal plasma also enhanced expression of 
CXCR4 and infection with X4 strains of HIV, but down-regulated CCR5 
expression and infection with R5 strains of HTV. Therefore, the regulation of 
co-receptor expression by DCs was associated with their susceptibility to 
infection with a HTV strain displaying the corresponding co-receptor usage.
In summary, semen is an important vehicle for transmission of HTV. Seminal 
plasma was demonstrated to have profound effects on DC phenotype, 
maturation and function. Such alterations would influence the outcome, in terms 
of HTV transmission, of the interaction between the DC and HTV-1 at the 
mucosal surface.
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In t r o d u c t io n
1.1. In t r o d u c t io n  t o  t h e  T h e sis
The acquired immunodeficiency syndrome (AIDS) was first recognised as a new 
disease in 1981, with a report of Pneumocystis carinii pneumonia (PCP) (Masur et 
al, 1981; Gottlieb et al, 1981). In 1983, a retrovirus was isolated from the lymph 
node lymphocytes of a French homosexual patient with generalised hyperplasic 
lymphadenopathy and hence the virus was termed lymphadenopathy-associated 
virus (LAV) (Barre-Sinoussi et al, 1983; Montagnier et al, 1984). The following 
year, Gallo’s group confirmed and extended this finding, linking this virus to the 
immunodeficiency syndrome and the virus was renamed human 
immunodeficiency virus (HIV) (Samgadharan et al, 1985). In 1986, a second 
related HIV, HIV-2, was isolated from West Africa (Franchini et al, 1987). It has 
now been shown that the first apparent HIV infection was in 1959 in Africa (Zhu 
et al, 1998). Despite the nucleotide sequence homology between HIV-1 and HIV- 
2 being only 42% and their antigenic cross reactivity is restricted, the clinical 
consequence of infection with either virus is similar (Evans and Levy, 1989).
HIV is transmitted vertically from mother to infant, by sexual contact and by 
contact with infected blood (i.e. blood transfusion and in intravenous drug users). 
This thesis focuses on HIV-1 transmission via a sexual contact. Aim of this thesis
21
is to define the HIV reservoir in semen and to elucidate the effect o f seminal 
plasma on dendritic cell (DC) function and also on the uptake of HIV-1 by DCs.
1.2. Epidemiology of HIV
The human immunodeficiency virus is a member of the lentivirus (“slow virus”) 
genus o f the Retroviridae family. HIV is grouped into two types, HIV type 1 
(HIV-1) and HIV type 2 (HIV-2), on the basis of serology and sequence analysis 
of molecularly cloned viral genomes. Phylogenetic studies have provided 
evidence that HIV-1 is closely related to a simian immundeficiency virus (SIV) 
that naturally infects the chimpanzee. Pan troglodytes troglodytes, (SIV^pJ (Gao 
et al, 1999). HIV-2 is closely related to a SIV naturally infecting sooty mangabey 
monkeys, Cercocebus atys, (Hirsch et al, 1989; Gao et al, 1994). It is
believed that zoonotic transfer of these non-human primate immunodeficiency 
viruses resulted in the emergence of HIV-1 and HIV-2 (Joag et al, 1996). HIV-1 is 
distributed throughout the world, whereas HIV-2 remains largely restricted to 
West Africa [Cameroon, Ivory Coast, Senegal (Joag et al, 1996; Miyazaki, 1995)]. 
It has been suggested that HIV-2 is less likely to be transmitted sexually than 
HIV-1 (reviewed by Li et al, 1998) and this may a reason for the more restricted 
geographic distribution of HIV-2. Both HIV-1 and 2 isolates display large 
sequence variations in the env gene. A classification scheme, based on env gene 
sequences, describes 10 subtypes/clades o f HIV-1 (A to J; Main (M) group) and 5 
subtypes of HIV-2 (A to E) (WHO network for HIV isolation and characterisation, 
1994; Gao et al, 1994). For HIV-1, an outlier (O) group is found in Cameroon,
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Gabon and Equatorial Guinea and a new (N) group was identified in two people in 
Cameroon in 1998 (Simon et al, 1998; Weiss and Wrangham, 1999). There is a 
high degree of intra-subtype diversification. Although mutation appears to be the 
major factor responsible for viral variation, recombination also occurs in 
individuals infected with viruses fi*om different clades. It has been demonstrated 
that clade A and D recombination occurs frequently in Uganda (Gao et al, 1994; 
personal communication from Dr. D. Yirrel, Edinburgh University, UK). Some 
areas of the world harbour predominantly a single subtype (eg. subtype B is 
predominant in North America and Europe, subtype C in India and South Africa 
and subtype E in Thailand), whereas two or more subtypes may be prevalent in 
other populations. Many subtypes are frequently found in Sub-Saharan Africa and 
subtype B and C viruses are predominant in Latin America and Caribbean 
countries (Quinn, 1996; Essex, 1998). In no country, however, is a single subtype 
exclusive.
According to the recent data released by United Nations AIDS program 
(UNAIDS) and World Health Organisation (WHO) in 2000, approximately 15000 
persons per day become infected, with more than 95% of new infections occurring 
in developing countries. About 36.1 million people worldwide are presently living 
with HIV. More than 10% of new infections are occurring in children under age of 
15 and nearly half o f new infections are in women. UN AIDS further estimated 3 
million deaths from AIDS worldwide in 2000 and a total since the epidemic began 
of 21.8 million deaths. Each day, nearly 1200 children die as a result o f AIDS and
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a further 1600 are infected (AIDS epidemic update, December 2000,
http://www.unaids.org) .
1.3. HIV STRUCTURE AND REPLICATION
1.3.1. The structure of HIV
The HIV-1 virion has a diameter of about llOnm with 72 external viral 
transmembrane glycoproteins expressed in a host cell derived lipid bilayer 
envelope along with host class I and II MHC antigens (Nermit et al, 1993). The 
viral glycoprotein gp41 inserts into the lipid bilayer membrane and, with gpl20, 
protrudes through to form the outer surface of the virus particle. The nucleoprotein 
core of the virion comprises two copies of the viral genomic RNA associated with 
tRNA molecules along with mature gag and pol protein products (fig.I.la and b; 
Field et al, 1996; Kam, 1995^). The 9 kb RNA genome of HIV encodes for at least 
nine proteins (table I .l)  which can be divided into three groups:
i) The major structural proteins gag, pol, and env.
ii) The regulatory proteins tat, nef and rev.
iii) The accessory proteins vpr, v if  and vpu for HIV-1 or vpx for HIV-2.
The function of each protein is listed in table I.l.
Table I.l. The proteins encoded by HIV-1 and HIV-2 (Karn, 1995 )
Gene Protein Function
Virion
Proteins
gag MA
(p i7; Matrix protein)
Membrane binding, 
nuclear localisation signal for the 
nuclear import of viral pre-integration 
complex, 
virus assembly
CA
(p24; Capsid protein)
Virus assembly, interaction with the 
Cyclophilin A required for viral 
infectivity
NC
(p9; Nucleocapsid protein)
RNA binding, 
virus assembly
pol PR
(p ll;  Protease)
Cleavage of viral polyproteins, virus 
maturation
RT
(p66/p51; Reverse 
transcriptase/ RNase H)
Virus replication (RNA-dependent 
polymerase and hydrolysis of RNA 
from RNAiDNA hybrids)
IN
(p32; Integrase)
Virus replication (insertion of linear 
ds viral DNA into the host cell 
chromosome)
env SS
(gpl20; Envelope protein)
CD4 and second co- receptor binding, 
viral infectivity
TM Contains fusion domain at N-
(gp41; Transmembrane terminus: fusion of viral membrane
envelope glycoprotein) with the plasma membrane during 
virus entry, anchor the protein in the 
lipid bilayer of the viral envelope
Accessory
Proteins
vpr Vpr
(Viral protein R)
Translocation of pre-integration 
complex to nucleus (nuclear 
localisation signal), arrest cellular 
proliferation resulting in reduced 
lysis of HIV-1 infected cells by CTLs
Vif
(Viral infectivity factor)
Facilitating viral internalisation or 
uncoating
vpx Vpx 
(Viral protein X)
Viral structural protein found in HIV- 
2 only
vpu Vpu 
(Viral Protein U)
Down-regulation of CD4 expression, 
envelope maturation and virus 
release, found in HIV-1 only
Regulatory
proteins
tat Tat
(Trans-activator protein)
Stimulates transcriptional elongation
rev Rev
(Regulator of viral expression)
Regulator of late gene expression, 
stimulates appearance of unspliced 
mRNA in cytoplasm
nef Nef
(Negative factor)
Down regulates CD4, regulate T cell 
signalling pathway
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1.3.2. The viral life cycle
The replication cycle is divided into an early and a late phase: each phase 
consists of sequential steps which involve specific interactions of viral proteins 
and nucleic acids with host factors. The early phase starts with the attachment 
to and entry o f a virion in to a cell, reverse transcription of the viral RNA 
genome into a double stranded (ds) DNA copy catalysed by viral reverse 
transcriptase, and transport of the DNA copy to the nucleus followed by 
integration into the host cell genome at a random site in the chromosome. The 
late phase involves transcription and processing of viral RNA from the 
integrated proviral DNA template and translation o f viral proteins followed by 
release of progeny virions fiom the cell.
i) Attachment and entrv of the virion to a host cell 
The envelope glycoprotein gpl20 binds to the CDR2-like region of the CD4 
receptor D1 domain with an affinity constant on the order of InM (Kam, 
1995^; Dragic et al, 1992) and also binds to a second receptor (e.g. CCR5 or 
CXCR4; refer to 1.4 for detail). It is hypothesised this binding induces 
conformational changes in the envelope protein which unmask the gp41 
fusogenic domain, leading to fusion of viral and cell membranes (Callebaut et 
a/, 1993; Benjouad et al, 1997). Fusion results in release o f the core in to the 
cell cytoplasm, followed by removal of outer core proteins, exposing the viral 
nucleoprotein complex.
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ii) Reverse transcription and integration
After entry o f the core into the cytoplasm of a susceptible cell, viral RNA is 
reverse transcribed into a double-stranded (ds) DNA copy by viral reverse 
transcriptase (RT). HIV-1 particles contain two homologous genomic RNAs 
and tRNA^^® (Fig.I.l), which are used as primers for RNA-dependent DNA 
synthesis (Jiang et al, 1993; Ratner et al, 1985). The 18 3’-terminal 
nucleotides of tRNA^^', which form the anti-codon loop, are complementary to 
a primer-binding site within the viral RNA (Isel et al, 1993; Skripkin et al, 
1996). This template-primer complex binds to viral RT. RT is a heterodimer 
consisting of p55 and p61 subunits and this heterodimeric form of RT is the 
result o f carboxyl-terminal proteolytic cleavage of one subunit o f the 
homodimer (p66/p66) (Chandra et al, 1986). HIV-1 RT is a multifunctional 
enzyme with three enzymatic activities: RNA-dependent DNA polymerase 
(RT), DNA-dependent DNA polymerase and RNase H. Both polymerase 
activities catalyse template-directed phophodiester bond formation in the 5’ to 
3’ direction. The nucleoprotein complex containing the matrix protein and 
integrase is translocated to the nucleus. The transport signals for this appear to 
be encoded by the p i 7 matrix protein (Von Schwedler et al, 1994). It has also 
been shown that an intact vpr gene is required for nuclear entry o f viral DNA 
(Heinzinger et al, 1994). The integration is mediated by the viral integrase 
which is responsible for DNA cleavage and strand exchange.
The type, activation and differentiation stage of the CD4^ cell which has 
undergone fusion with a HIV virion influences the subsequent reverse
Fig. I.l. Genomic oi^anisation of HIV (a) and the virion structure (b) (Fields 
et al, 1996; Karn 1995 “)
(a)
5’ LTR
p7 pi 7 p24 p9
NC MA CA NC 
□ #### A  000
v if
p ll p66/p51 p32 
PR RT IN
□ (b 0
vpu
gpl20
SS
O
3’ LTR
nef
gp41
TM
NC = Nucleocapsid Protein 
MA = Matrix Protein 
CA = Major Capsid Protein 
PR = Protease
RT = Reverse Transcriptase 
IN = Integrase 
SS = Surface Subunit 
TM = Transmembrane Subunit
(b)
tRNA
#Viral Genome
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transcription and integration events. In terminally differentiated cells such as 
macrophages, reverse transcription results in complete proviral DNA copies 
that integrate in to the host DNA (Wienberg et al, 1991; Lewis et al, 1992). 
Viral gene expression and virion production may then follow integration in 
such cells. In T cells however, complete reverse transcription followed by 
integration and viral gene expression requires proliferation of the host cell 
(Zack et al, 1990). In non-proliferating T cells, HIV-1 may enter the cell with 
initiation of reverse transcription. Zack et al suggest that reverse transcription 
is incomplete and the resulting DNA is labile with an in vitro half-life o f 
approximately 1 day. Others claim such extrachromosomal viral DNA may 
persist for weeks, with complete reverse transcription, integration and viral 
gene expression following subsequent activation of the cell (Stevenson et al, 
1990).
iii) Expression of viral gene
Transcription of viral DNA and viral gene expression is controlled by both 
cellular and viral factors (Fig.1.2). The integrated provirus carries duplicate 
structures, called the long terminal repeats (LTR) at both 3’- and 5’-ends o f the 
viral genome. The 5’ LTR contains promoters for transcription and the 3’ LTR 
provides a polyadenylation signal (Gaynor, 1992). As described above, viral 
gene expression in T cells requires proliferation of the host cell. Transcription 
of proviral DNA is greatly enhanced by host cell immune activation, cytokines 
[e.g. IL-1 (Kobayashi et al, 1989), lL-6 and TNF-a (Okamoto et al, 1989)] or 
gene products of other viruses (e.g. EBV, CMV, hepatitis B and herpesvirus).
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These triggers can act to up-regulate host regulatory proteins, including the 
transcription factor NF-kB which binds to a site within the LTR, thereby 
enhancing viral transcription (Duh et al, 1989; Griffin et al, 1989; Tong- 
Starksen et al, 1987). Tat stimulates transcription from the viral LTR by 
interacting with a regulatory element in the 5’ end, called the ^ raw^-activation- 
responsive region (TAR) (Sharp & Marciniak, 1989). This produces a 
modified transcription complex which is then able to transcribe the remainder 
of the HIV genome efficiently. Tat is also able to increase the density of RNA 
polymerases found downstream of the promoters and acts as an elongation 
factor. Transcription of the HIV genome results in three different mRNA 
species (Fig.1.3): 1) multiply spliced mRNAs which encode the viral 
regulatory proteins {tat, rev, and nef) and are the first mRNAs produced (Early 
mRNA), 2) later singly spliced mRNAs which encode env and accessory 
proteins (vpu, vif, and vpr) (Late mRNA) and 3) unspliced mRNAs which act 
both as the virion RNA and mRNA for gag-pol (Late mRNA) (Kim et al, 
1989). The early product tat (^ra«5-activator of transcription) enhances 
transcription from the viral LTR by interacting with a regulatory element in 
the 5’ LTR, called the /rafw-activation-responsive region (TAR) (Sharp & 
Marciniak, 1989). Accumulation o f the other early product rev results in a 
switch to production of Tate mRNAs’ while inhibiting ‘early mRNA’ 
production (Malim et al, 1989). Rev overcomes the RNA splicing mechanism 
by binding to a rev-responsive element (RRE) in the RNA resulting in 
production of singly and unspliced viral mRNAs encoding the structural 
proteins o f the virus {gag, pol and env) and full-length genomic RNA.
Fig. 1.2. HIV-1 long terminal repeat DNA with potential binding sites for 
DNA and RNA binding proteins (reviewed by On et al, 1995)
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Fig. 1.3. Regulation of HIV gene expression (reviewed by Karn, 1995 )
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Therefore, in host cell with minimal transcriptional activity, production of 
viral mRNAs and proteins would also be minimal, leading to latency of the 
integrated provirus.
iv) Assemblv and release of virions
Env glycoproteins are synthesised as a gpl60 precursor which host proteases 
cleave into amino-terminal gpl20 and carboxy-terminal gp41. Gp41 contains a 
trans-membrane domain, spanning the host cellular membrane. Other viral 
structural components accumulate on the inner surface o f the cytoplasmic 
membrane initiating the formation of an immature virus particle. The budding 
particles incorporate dimerized genomic RNA molecules, tRNA primers, the 
myristoylated gag  and gag-pol precursor glycoproteins. HIV particles become 
enclosed by an envelope o f host-cell lipid bilayer containing env glycoprotein. 
During or shortly after budding, viral particles mature. Maturation is 
accompanied by structural rearrangements leading to the assembly o f a mature 
core structure (Luciw, 1996). Protease cleavage of the gag  and gag-pol is 
essential in the maturation of retrovirus particles, as mutations in protease lead 
to production of non-infectious virus particles that contain uncleaved core
. p
proteins (Kohl et al, 1988; Katoh et al, 1985; Crawford and Goff, 1985).
HIV replication in vivo occurs continuously (Ho et al, 1995). Perselson et al 
(1996) developed a mathematical model to investigate HIV-1 dynamics in vivo 
using HIV-1 plasma viral load data collected after the administration o f a 
potent HIV-1 protease inhibitor. Ritonavir. The average life-span of
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productively infected cells was estimated to be 2.2 days and that of free virus 
in plasma was estimated to be 0.3 days. The average total HIV-1 production 
was estimated to be 10.3 x 10  ^ virions per day and the average HIV-1 
generation time (i.e. the time from release of a virion to release of a new 
generation of virions after infecting another cell) 2.6 days. The virus has a high 
mutation rate (3 x 10'  ^mutation rate per nucleotide per replication cycle) since 
RT lacks proofreading activity and does not correct errors in DNA synthesis). 
Most mutations will confer a selective disadvantage to the virion, but some 
will be selected for, either by conferring resistance to anti-retroviral drugs or 
allowing evasion of the host immune response (Kusumi et al, 1992).
1.4. C e l l u l a r  t r o p is m  o f  HIV-1
HIV-1 infects cells that express cell surface CD4, including T cells, 
macrophages, DCs and brain microglia, via interaction of gpl20 with CD4. 
CD4 was shown to be the primary receptor for HIV entry, as introduction of 
the CD4 gene rendered non-susceptible human cells susceptible to infection 
(Dalgleish et al, 1984). However, the requirement of an unknown second co­
receptor was apparent, as human CD4 expression did not render rodent cells 
susceptible. In addition, HIV strains display cell tropisms that cannot be 
accounted for by CD4 being the single receptor for HIV. HIV-1 grown in T- 
cell lines in vitro can infect CD4 T cell lines and primary T cells, but not 
macrophages. However, many primary isolates o f HIV infect primary T cells
30
and macrophages rather than T cell lines. These two types of viruses were 
initially referred to as T and M-tropic, respectively (Koyanagi et al, 1987; 
Fisher et al, 1988). M-tropic non-syncytium inducing isolates infect 
macrophages and primary T cells but not transformed T-cell lines, whereas T- 
tropic syncytium inducing isolates infect both primary T cells and T-cell lines 
but not macrophages.
1.4.1. Chemokine receptor usage by HIV-1 and tbeir natural ligands
The HIV-1 co-receptors were shown to be receptors for chemokines and are 
responsible for binding the surface membranes of the host cell and the virus 
together to allow fusion of the membranes and viral entry. M-tropic strains 
utilise CCR5 primarily (Dragic et al, 1996; Alkhatib et al, 1996) and T-tropic 
strains utilise CXCR4 (Feng et al, 1996). These different virus strains are 
termed R5 strains or CCR5-utilising virus and X4 strains or CXCR4-utilising 
virus, respectively (Berger et al, 1998). Other chemokine receptors mediating 
HIV-1 entry include CCR2b, present on macrophages and CCR3 which is 
expressed on eosinophils and only at low levels on T cells, monocytes and DCs 
(Doranz et al, 1996; Rubbert et al, 1998). The env gene, particularly a region of 
gpl20 that includes the V3 loop, determines T- versus M-tropism (Berger, 
1997) with each type o f isolate requiring different co-receptors. The co­
receptors are either a  or p-chemokine receptors (table 1.2) which are seven 
transmembrane receptors from the large family of G protein coupled receptors 
which respond to chemokines, neurotransmitters and peptide hormones. The a -
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chemokines (CXC chemokines) contain a single amino acid between the first 
and second N-terminal cysteine residues and they chemoattract and activate 
neutrophils primarily. The p-chemokines (CC chemokines) have adjacent 
cysteine residues and chemoattract and activate monocytes, lymphocytes and 
basophils. The natural chemokine ligands of these co-receptors inhibit or 
suppress infection of cells with HIV-1 by receptor competition. RANTES and 
macrophage inflammatory proteins (M IP-la and M IP-ip), the natural ligands 
of CCR5, inhibit infection with M-tropic HIV-1 strains (Cocchi et al, 1995, 
Dragic et al, 1996). Stromal cell-derived factor-1 (SDF-1), the ligand of 
CXCR4, inhibits infection with T-tropic strains (Bleul et al, 1996; Oberlin et 
al, 1996). Similarly, exotaxin competes with HIV-1 for CCR3 (Choe et al,
1996), while monocyte chemotactic proteins (MCP-2, -3) compete with HIV-1 
for CCR2 (Bisset et al, 1997; Schols et al, 1997). The macrophage-derived 
chemokine (MDC) inhibits a variety of HIV-1 strains irrespective o f their 
tropism (Pal et al, 1997). It has also been demonstrated that the occupation of 
CCR5 and CXCR4 by their natural ligands results in the internalisation o f these 
receptors, which may contribute to the suppressive effect o f chemokines on 
HIV infectivity by reducing co-receptors densities (Amara et al, 1997).
The chemokines, RANTES, M IP-la  and M IP-ip were the first CD8^ T cell 
derived factors that were identified to mediate HIV suppression (Cocchi et al, 
1995). In addition to chemokines, CD8^ T cells can release other soluble 
factors capable of suppressing viral replication, including cytotoxic molecules 
that mediate lysis of virus-infected cells such as IL-16 (Baier et al, 1995) and
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as yet unidentified factors termed ‘CD8  ^T cell antiviral factor (CAF)’. IL-16 
which is a natural ligand for CD4 was shown to inhibit HIV-1 replication in 
CD4^ T cells, macrophages and DCs in vitro (Truong et al, 1999; Hermann et 
al, 1999). It has been demonstrated that filtered CD8^ T-cell culture 
supernatants can suppress HIV-1 replication in naturally infected CD4^ T 
cells without affecting CD4^ T cell proliferation (Mackewicz and Levy, 1992; 
Brinchman et al, 1990; Mackewicz et al, 1994). Furthermore, Mackewicz and 
Levy (1992) have reported that asymptomatic individuals possess higher 
levels o f CAF which are maintained over long periods of time. As disease 
progresses, CAF levels decline and are undetectable in AIDS patients 
(Mackewicz et al, 1994). Studies examining the effect of recombinant 
cytokines on HIV replication, the effect of anti-cytokine neutralising 
antibodies on CAF activity and by directly measuring the relative levels o f 
known cytokines and chemokines in CAF-containing and non-CAF- 
containing culture supernatants, have indicated that CAF lacks identity to 
known cytokines (Mackewicz et al, 1994; Levy et al, 1996).
‘Dual’ tropism, HIV-1 isolates displaying both M- and T-tropism, is common 
among syncytium-inducing (SI) HIV strains. Such frequent dual receptor 
usage suggests that most SI isolates in fact contain a mixed population o f SI 
and non-syncytium-inducing (NSI) quasi-species of virus capable o f using 
both CCR5 and CXCR4. In addition, this ‘dual’ tropism of SI strains could 
suggest adaptation of HIV-1 to use CXCR4 during phenotypic evolution 
without losing the ability to use CCR5 (Zhang et al. 1996). However, a study
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by Scarlatti et al (1997) argues against this concept. They have found a 
consistent pattern in the evolution of viral co-receptor usage and sensitivity to 
chemokine-mediated suppression in a longitudinal follow-up of children with 
progressive HIV-1 infection. Viral isolates obtained during the asymptomatic 
stages of HIV-1 infection mainly used CCR5 as a co-receptor and were 
inhibited by its natural ligands but not by SDF-1. In contrast, the majority of 
the isolates obtained after disease progression had acquired the ability to use 
CXCR4 and, in some cases, CCR3, while gradually losing CCR5 usage. 
Furthermore, all these latter isolates were resistant to P-chemokines and most 
were resistant to SDF-1. In children who progressed to AIDS without a shift 
to CXCR4 usage, all sequential isolates were CCR5-dependent but showed a 
reduced sensitivity to P-chemokines. Changes in the V3 domain of gpl20 
were associated with a loss of sensitivity to p-chemokines and a shift in co­
receptor usage (Scarlatti et al, 1997).
[N.B. New nomenclature for chemokines listed in table 1.2 below (Zlotnik 
and Yoshie, 2000): GRO-a/MGSA-a=CXCLl, GR0-p/MGSA-P=CXCL2, 
GR0-y/MGSA-Y=CXCL3, ENA-78=CXCL5, NAP-2=CXCL7, IL- 
8=CXCL8, Mig=CXCL9, IP-10=CXCL10, SDF-1=CXCL12, MCP-1=CCL2, 
M IP-la=CCL3, MIP-lp=CCL4, RANTES=CCL5, MCP-3=CCL7, MCP- 
2=CCL8, Eotaxin= C C L ll, MCP-4=CCL13, ELC/MIP-3p=CCL19, MIP- 
3a=CCL20, Secondary lymphoid tissue chemokines (SLC)/6Ckine= CCL21]
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Table 1.2. Chemokine receptors and their natural ligands
Chemokine
family
Receptor name Natural ligands
a-
chemokine
(CXC-
chemokine)
CXCRl (IL-8RA) IL-8, GRO-a/MGSA-a, 
NAP-2
CXCR2 (IL-8RB) IL-8, GRO-a, -P, -y/ 
MGSA-a, -P, -y, NAP- 
2,
ENA-78, IP-10, Mig
CXCR3 IP-10, Mig
CXCR4 (fiisin, 
LESTR, humstr, LCR- 
1)
SDF-1
P-chemokine
(CC-
chemokine)
CCRl M IP -la ,-ip , MCP-3, 
RANTES
CCR2a (MCP-IRA) M CP-1,-2,-3
CCR2b (MCP-IRB) MCP-3
CCR3 Eotaxin, RANTES, 
MCP-2, -3, -4
CCR4 M IP-la, RANTES, 
MCP-1
CCR5 M IP-la, -ip , RANTES
CCR6 M IP-la, -3a
CCR7 MIP-3P, Secondary 
lymphoid tissue 
chemokines (SLC)
1.4.2. Chemokine receptor gene mutations
Chemokine receptor gene mutations have been described which may affect 
HIV infection and disease progression and can be divided into three groups.
i) Mutations in protein structure: CCRA32. CCR5-m303 and CCR2-64I 
A 32 base pair deletion (A32) in the CCR5 gene has been described (Paxton et 
al, 1996; Liu et al, 1996; Samson et al, 1996^). Homozygosity for CCR5A32 
is found in Caucasian populations, in Northern Europe in particular, with an 
allele frequency of 0.092 but is absent in African and Asian populations 
(Samson et al, 1996^). CCR5A32 homozygous individuals do not express
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CCR5 on the cell surface, preventing viral entry via this co-receptor. Such 
individuals are apparently resistant to infection with M-tropic viruses. A 
higher frequency of heterozygosity for CCR5A32 has been demonstrated in 
HIV-1-infected long-term non-progressors (31%) compared with rapid 
progressors (16%) among homosexual men, but not in haemophiliacs, 
suggesting that heterozygosity results in delayed disease progression within 
the homosexual population (Dean et al, 1996). CCR5A32 heterozygosity in 
children did not appear to reduce the risk of perinatal acquisition of HIV-1 or 
delay disease progression (Edelstein et al, 1997; Rousseau et al, 1997). 
Although homozygosity for the CCR5A32 confers very high resistance to 
HIV infection, homozygous individuals may still be infected (Biti et al, 
1997). These individuals might have been infected by an M-tropic strain via a 
receptor such as CCRl, CCR2b or CCR3 or by a T or dual-tropic virus (Biti 
et al, 1997).
CCR5-m303 is a rarer mutation (frequency of 0.01) with similar effects to 
A32 (Quillent et al, 1998; Voevodin et al, 1999). The CCR2b-64I mutation is 
a substitution of valine to isoleucine at amino acid 64 on the CCR2 gene 
(Smith et al, 1997). This mutation is more commonly distributed than 
CCR5A32 and does not affect HIV transmission, but is associated with a two 
to three year delay in disease progression to AIDS (Kostrikis et al, 1998; 
Rizzardi et al, 1998)].
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ii) Mutations in regulation of gene expression: e.g. CCR5-59653T 
CCR5-59653T is a mutation in the regulatory region of the CCR5 gene 
(Mummidi et al, 1997) and is inherited with the CCR2 mutation, CCR2b-64I 
(Kostrikis et al, 1998). The CCR5-59653T mutation appears to result in 
reduced expression of CCR5 on the cell surface and therefore may reduce the 
rate infection of cells by HIV-1 (Kostrikis et al, 1998).
iii) Mutation of the chemokine ligand: e.g. SDF-1 3’UTR-801G-A 
SDF-1 -3 ’UTR-801G-A is a mutation in the 3’ untranslated region of the 
SDF-1 gene (Winkler et al, 1998). The homozygous state appears to result in 
increased SDF-1 production, which may then compete with X4 strains o f 
HIV-1 for binding to CXCR4 and thus delaying disease progression (Winkler 
et al, 1998).
These mutations appear to have no effect upon the health of the uninfected 
individual, even in the homozygous state, reflecting the degenerate nature of 
the large chemokine and chemokine receptor families. Therefore, the lack of 
adverse effects o f these mutations may provide an attractive target for future 
anti-retroviral therapies.
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1.5. T r a n s m is s io n  o f  HIV
HIV is transmitted vertically from mother to child in utero, during delivery 
(intrapartum), or postnatally through breast-feeding. HIV-1 is also transmitted 
by sexual contact, or by contact with infected blood (e.g. blood transfusion, 
blood products or in intravenous drug users). Although the mechanisms of 
HIV transmission are not yet fully understood there are certain facts which are 
well documented including:
i) Transmission of HIV-1 is predominantly restricted to R5 strains (Zhu 
et al, 1993; Roos et al, 1992).
ii) HIV-1 isolates from seroconvertors who were infected by sexual 
contact represent minor variants of the viral species found in the blood 
of the transmitter (Zhu et al, 1996). Sequence homogeneity has also 
been observed in seroconverting haemophiliacs (Pang et al, 1992; 
Wolfs et al, 1992).
1.5.1. Vertical Transmission
Over 90%  of children infected with HIV are babies bom to HIV^ women 
(AIDS epidemic update, December 1999, http://www.unaids.org). Mother-to- 
child transmission may occur at three different stages: during gestation, 
during delivery and by breast-feeding (Peckham & Gibb, 1995; Logan et al, 
1988; Ziegler et al, 1985). At least two thirds of infections in non-breastfed 
children are acquired around the day of birth (during labour and delivery) and
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the other one third of infections in non-breastfed children are acquired in the 
last three weeks of pregnancy (Mock et al, 1999; Rouzioux et al, 1995; De 
Rossi et al, 1993; Ehmst et ah 1991). Breast-feeding may contribute to 
between one-third and two-thirds of infections in infants (Simonon et al, 
1994; Ekpini et al, 1997). Encephalopathy, opportunistic infections, and death 
before 2 years of age are the most severe clinical manifestations of HIV-1 
disease in children (Rousseau et al, 1997). Reported vertical transmission 
rates vary from 13% in Europe to 40% in Africa in HIV-1 infected pregnant 
women receiving no anti-retroviral therapy (Bryson, 1996). Factors associated 
with increased transmission of HIV from mother to infant include increased 
levels of virus in blood, the absence of neutralising maternal antibodies 
against the viral envelope, especially to the V3 loop, a reduced CD4^ cell 
count, the presence o f maternal p24 antigenemia at the time o f delivery, the 
presence of HIV-1 with increased in vitro replication in macrophages and 
prolonged labour and rupture of the membranes (Lathey et al, 1999; Kuhn et 
al, 1997’’; Thea et al, 1997; Cao et al, 1997; Bryson, 1996; Roques et al, 
1993; Ades et al, 1991; Rossi et al, 1989). Among these factors the HIV-1 
viral load in the blood and genital secretions o f the mother appear to play the 
most important role in mother-to-child transmission. It has been suggested 
that in utero transmission may be associated with cell-free or cell-associated 
virus crossing the placenta and increased intrapartum risk may be due to 
maternal-infant transfusions, disruptions of the placental barrier or direct 
contact with maternal blood or cervicovaginal secretions (Mock et al, 1999). 
Therefore, elective caesarean-section delivery, before the membrane ruptures.
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may reduce the risk of vertical transmission by avoiding direct contact with 
maternal vaginal secretions and infected blood (European Mode o f Delivery 
Collaboration, 1999). HIV-1 has been detected in oropharyngeal and gastric 
aspirates of neonates bom to HIV-1 infected mothers (Mandelbrot et al, 
1999). The foetus may be exposed to HIV present in cervicovaginal 
secretions (Mostad and Kreiss, 1996), through the mucosae, oropharynx and 
digestive tract (Mandelbrot et al, 1999).
Such types of exposure may be a mechanism for postnatal transmission 
through breast feeding as well as perinatal transmission (Leroy et al, 1998; 
Mandelbrot et al, 1999). HIV-1 is present as free-vims (Lewis et al, 1998) 
and cell (macrophage and T cell)-associated vims in milk o f HIV-infected 
mothers (Vonesch et al, 1992; Southern, 1998). Mastitis [an inflammatory 
process in the breast allowing inflammatory cells and extracellular fluid to 
enter the milk (Thomsen et al, 1984)] raises HIV-1 load in breast milk and 
hence may increase the risk of transmission of HIV-1 from mother to infant 
(Sem bae/a/, 1999).
1.5.2. Transmission via contact with HIV-infected blood
Transmission of HIV by blood transfusions, plasma, or blood cell products 
(e.g. platelets) occurs either via free vims or vims-infected cells (Ward et al, 
1989). Studies of transfusion recipients have suggested that the clinical stage 
of the infected donor (e.g. large number of vims-infected cells, free vims, or
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the type of vims present in the donor’s blood) can influence the progression to 
disease in the recipient.
1.5.3. Sexual Transmission
Heterosexual transmission is responsible for more than 90% of HIV-1 
infections in Africa and is increasing more rapidly than all other modes of 
transmission in the US, Europe, and most other regions of the world (Caceres 
and Hearse, 1996; Mastro and De Vincenzi, 1996; Lee et al, 1996; 
http://www.unaids.org). The rate of heterosexual transmission has been 
estimated to be approximately one in every 1000 coital acts in both North 
American (Padian et al, 1997) and Uganda (Gray et al, 2001) couples where 
one partner was HIV-1 positive. In these studies, higher rates o f transmission 
were highly associated with genital ulceration and higher plasma viral loads.
In order to establish infection within the female via the heterosexual route of 
transmission, HIV must cross the epithelial barrier of the female reproductive 
tract and ultimately infect CD4^ T cells and macrophages either within the 
underlying submucosal tissue or within the draining lymph nodes, with 
subsequent systemic infection. Therefore, the transfer of HIV across the 
mucosal epithelium is a key event in sexual transmission o f HIV-1.
The surface of the female genital tract is covered with epithelial cells which 
provide a protective barrier for the underlying tissue and is also covered with
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antimicrobial secretions including lactoferrin, lysozyme and both 
transmembrane mucins (eg. Mucin 1 or episialin) and secretory mucins 
(DeSouza et al, 1999; Gendler and Spicer, 1995; Hilkens et al, 1992; Lamblin 
and Roussel, 1993). The epithelial cells in the female genital tract are 
composed of columnar, squamous and transitional cells. The vagina and 
ectocervix, the tissues which would be exposed to HIV^ semen to the greatest 
extent, are comprised of five distinct cell layers: from the lumen the first three 
layers are the superficial, transitional, and intermediate layers (fig.1.4). Each 
is composed of approximately 10 rows of squamous epithelial cells 
(‘stratified epithelium’). Beneath these layers are the parabasal and basal 
layers, containing one to two rows of columnar epithelial cells (Witkin, 
1993). In contrast, the endocervix and uterus are composed of a single layer 
of epithelial cells (‘simple epithelium’) which is similar to the rectum. This 
may explain the higher frequency of rectal transmission in homosexual men, 
along with the greater likelihood of epithelial damage during anal sex. HIV-1 
susceptible cells, Langerhans’ cells, CD4^ T cells and macrophages are 
predominantly present in the epithelium, parabasal and basal layers o f the 
vagina and ectocervix (Johansson et al, 1999; Poppe et al, 1998; Morris et al, 
1983).
Several mechanisms have been proposed to mediate and/or facilitate the 
transfer o f HIV-1 across the mucosal epithelium:
i) Direct infection of epithelial cells with HIV
Fig.L4. The female genital tract
(a) Section through the vagina and cervix (adapted from Hall-Craggs, 1990).
(b) Schematic diagram of cervix showing the endocervix and ectocervix.
(c) Typical cornified original squamous epithelium of the vagina and ectocervix showing 
five well-defined layers: from the lumen, superficial (1), transitional or intraepithélial (2), 
intermediate (3), parabasal (4), and basal (5) layers (adapted from Jordan & Singer, 1976).
(d) Normal columnar lining epithelium of the endocervix (adapted from Patten, 1978). The 
endocervix is composed o f a single layer o f columnar epithelial cells. Most lymphocytes 
(CD4+ T cells, CD8^ T cells and macrophages) reside within the lamina propria in close 
proximity to the basal membrane. In addition, the majority o f Langerhans cells also reside 
within close proximity to the basal membrane but may be found in both the epithelium and 
lamina propria layers.
(a) (b)
Cervix ► Endocervix
o
Vagina
Ectocervix
(c) (d)
Ë###B
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HIV-1 has been shown to infect the human cervical epithelial cell line ME 180 
in vitro (Tan et al, 1993). Exposure of this cell line to cell-free HIV-1 resulted 
in non-productive infection demonstrated by DNA PCR. However, productive 
and cytopathic infection followed exposure of ME180 cells to HIV-infected T 
cell lines. HIV-1 has also been shown to transcytose through tight monolayers 
o f human intestinal and endometrial epithelial cell lines in vitro (Bomsel,
1997). Therefore, these studies describe a possible efficient mechanism for 
heterosexual transmission of HIV-1, with virus crossing the intact genital 
epithelial barrier and gaining access to the submucosal CD4^ cells. However, 
the relatively low rate HIV-1 transmission per heterosexual coital act 
described above would argue against such an efficient mechanism. Other 
studies employing primary cultures of human epithelial cells have 
demonstrated the limitations of studies using transformed cell lines, which 
may bear little relation to the in vivo situation. HIV-1 infection has been 
demonstrated in cell preparations derived fiom the human cervix, but the 
infection was restricted to CD45^ leukocytes with no evidence of epithelial 
cell infection (Patrick et al, 1993). HIV-1 virions have been shown to 
associate with human primary cervical epithelial cells and remain in an 
extracellular location (Dezzutti et al, 2001) with virus then being transferred 
to activated PBMCs. However, these cultures were not polarised monolayers 
of cells and therefore would not equate to the intact epithelium found in vivo. 
Polarised cervical epithelial cultures have been shown to be an effective 
barrier against HIV-1 (Greenhead et al, 2000). Neither productive infection 
nor virion transcytosis could be detected following exposure of intact cervical
43
epithelium to both cell-free and cell-associated HIV-1. Non-polarised cultures 
were productively infected with HIV-1, with the target cells residing within 
the submucosal tissue and infection enhanced by immune activation.
ii) Disruption of the epithelial barrier
For many sexually transmitted diseases (STDs) including HIV infection, 
mucosal integrity may be an important factor affecting transmission. 
Transmission of HIV would be particularly likely if  there are open lesions or 
ulcers and inflammatory cells present due to other STDs, thereby providing a 
portal for HIV entry (Wasserheit, 1992; Dickerson et al, 1996; Plummer, 
1998; Cohen, 1998; Gray et al, 1999). The one in 1000 rate of heterosexual 
transmission described previously (Padian et al, 1997; Gray et al, 2001) is 
increased approximately four-fold in the presence of ulcerative genital disease 
(Gray et al, 2001). In HIV^ patients, genital tract shedding of HIV is 
increased with ulcerative STDs (Ghys et al, 1997; Schacker et al, 1998; Dyer 
et al, 1998; Gadkari et al, 1998) and treatment reduces but does not abolish 
HIV shedding (Gadkari et al, 1998; Ghys et al, 1997). Bacterial vaginosis 
may also increase susceptibility to HIV-1 infection through loss of naturally 
occurring virucidal mechanisms. Bacterial vaginosis results in an absence of 
hydrogen peroxide-producing lactobacilli (Klebanoff and Coombs, 1991) and 
a reduction in myeloperoxidase activity (Klebanoff and Coombs, 1992). 
Furthermore bacterial pathogens such as C. trachomatis both recruit and 
interact with polymorphonuclear leukocytes (PMN) in vivo and the activated 
PMN in turn activate mononuclear cells by generating reactive oxygen
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intermediates during phagocytosis of the bacteria and hence increase HIV 
replication (Ho et al, 1995). In summary, the potential mechanisms by which 
STDs may increase HIV transmission include:
1) Increased number or activation of macrophages, CD4^ T cells or DCs
in the genital tract (Levine et al, 1998; Greenhead et al, 2000).
2) Disruption of the epithelial barrier (Kiviat et al, 1990).
3) Reduction in T-helper and T-cytotoxic function (Mazzoli et al, 1997).
4) Shedding of inflammatory mediators in semen (Ramsey et al, 1995) 
which may activate DCs, macrophages and T cells in the mucosa o f 
the female reproductive tract.
Contraception also influences transmission of HIV. Condoms are lubricated 
with a spermicide containing nonoxynol-9. In addition spermicidal sponges 
for use by the female also contain nonoxynol-9. Nonoxynol-9 is active 
against HIV and other sexually transmitted pathogens (Stafford et al, 1998) 
by disruption of cell membranes and viral envelopes (Reitmeijer, 1988). 
However, nonoxynol-9 may also damage the epithelium of the female 
reproductive tract, thereby increasing susceptibility to HIV infection. 
Hormonal contraception has been shown to increase susceptibility to HIV 
infection (Plummer et al, 1991). This may be due to cervical ectopy or 
thinning of the vaginal epithelium, in progesterone only contraception in 
particular (Marx et al, 1996).
iii) Infection or association of HIV with epithelial Langerhans’ cells
45
Mucosal epithelial dendritic cells (DCs) [Langerhans’ cells (LC)] have been 
suggested to be the first cells to be infected after mucosal exposure to HIV as 
shown by studies using rhesus macaque models of Simian immunodeficiency 
virus (SIV) infection (Zambruno et al, 1995; Spira et al, 1996; Blauvelt, 
1997; Joag et al, 1997; Miller and Hu 1999) and using skin explants (Reece et 
al, 1998). DCs may then transfer HIV to T cells within the lymph node 
followed by systemic spread of infection (Spira et al, 1996; Masurier et al,
1998). As this possibility is a focus o f this thesis, DC biology and association 
with HIV is now discussed.
1.6. T h e  B io l o g y  o f  D e n d r it ic  c e l l
The literal meaning of a dendritic cell would be a cell that possesses dendrites. 
This term could therefore be applied to many cell types including brain and 
nerve cells and macrophages. However, in the field of immunology, the term 
dendritic cell (DC) is used for a population of cells commonly termed antigen 
presenting cells (APC). These DCs have the unique ability to take up, process 
and present antigen in association with MHC class II to CD4 T cells followed 
by stimulation of naive T cells, thereby initiating a primary immune response 
to an antigen. However, DCs, and macrophages, may also present antigen to 
and stimulate memory T cells. The biology of this dendritic cell has been 
recently reviewed by Hart (1997) and Banchereau et al (2000).
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Another cell with immunological function with dendritic morphology is the 
follicular dendritic cell (FDC) which is found in the germinal centres of the 
lymph node. FDGs are derived from a separate lineage to DCs. FDCs have the 
capacity to capture and retain whole antigens in the form of immune 
complexes and play a critical role in the generation of the humoral immune 
response and also in activation and selection of B cells (Grouard and Clark,
1997). B cells recognise whole antigen via cell surface expression of antibody. 
Unless stated, all references to DCs in this thesis relate to the T cell 
stimulatory lineage of dendritic cells rather than the FDC.
DC functioning from antigen capture to T cell stimulation involves several 
individual steps requiring alteration of the DC functional abilities and 
phenotype, with these steps occurring in separate microenvironments within 
the body, requiring migration of the DC. The following is a summary o f the 
DC life cycle and function:
i) DCs are CD45^ bone marrow derived leukocytes. Immature DCs migrate 
to non-lymphoid tissues via the blood stream where they may encounter 
antigen. One well characterised tissue DC is the Langerhans cell (LC) located 
in the epithelium of the skin and mucosa. Mucosal tissues in particular would 
be expected to contain numerous DCs in order to meet the greater antigenic 
challenge at these exposed sites. In addition, inflammation leads to rapid 
accumulation of DCs in infected or damaged tissues.
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ii) Immature DCs in the tissues capture and internalise antigen efficiently via 
several pathways including macropinocytosis, receptor mediated endocytosis 
and phagocytosis.
iii) Maturation of the DC to an antigen presenting phenotype is associated 
with migration of the DC from the tissue to the lymph node via the afferent 
lymphatics. Therefore, antigen sampled in the tissues is transported to 
lymphocyte rich lymphoid tissue. Maturation involves a reduction in 
phagocytic capacity, up-regulation of T cell co-stimulatory molecules and 
presentation of processed antigen in association with MHC molecules.
iv) Prior to antigen presentation and T cell stimulation, the migrated DC may 
associate with several T cells in the lymph node via interaction between 
adhesion molecules, forming a DC-T cell cluster. This process would facilitate 
recognition of the presented antigen by a specific T cell.
v) Following recognition by an antigen-specific T cell, the DC stimulates the 
naïve T cell via expression of co-stimulatory molecules such as CD80 and 
CD86, thereby inducing a primary immune response to the antigen. In addition 
the DC may receive stimulatory signals from the T cell via interaction between 
CD40 expressed on DCs and CD40 ligand (CD40L/CD154) expressed on T 
cells.
There are at least three distinct subpopulations of DCs (fig. 1.5): two in the 
myeloid lineage [LCs and interstitial (dermal) DCs/DC 1] and one in the 
lymphoid lineage (lymphoid DCs). CD123^CDllc‘ pre-DCs (pDC2), also 
known as plasmacytoid or IFN-a producing cells [IPC (Celia et al, 1999;
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Siegal et al, 1999)], give rise to lymphoid DCs [CDllc'CD123^ (also known 
as DC2)] when cultured and activated with IL-3 and CD40 ligand (CD40L) 
(Grouard et al, 1997; Olweus et al, 1997). CD40L-activated DC2 produce IL- 
l a ,  IL -lp, IL-6, IL-8 and IL-10 but no IL-4 (Rissoan et al, 1999) and may 
preferentially stimulate Th2-type responses (Rissoan et al, 1999; Pulendran et 
al, 1999). The myeloid lineage DCs can be further differentiated into two 
distinct subsets. One is the LC precursor cell-derived LC subset (CD 14' 
CDllc^CDla^) and the other is the monocyte-derived DC subset 
(CD 14^CD 11 c^CD 1 a^) which is also known as interstitial (dermal) DCs 
(Nestle et al, 1994) or DCl (Rissoan et al, 1999). Monocyte-derived DCs 
produce large amounts of IL-12 on CD40L activation and may preferentially 
stimulate Thl-type response (Rissoan et al, 1999; Pulendran et al, 1999). The 
terms DCl and DC2 are based on the cytokine profile produced by these 
cells, those which produce type 1 cytokines are called DCl and those which 
produce type 2 cytokines are called DC2. The corresponding mature DC 
progeny of both subsets of myeloid lineage DCs are equally potent in 
stimulating the proliferation of naïve T cells, but only interstitial DCs induce 
the IL-2-driven differentiation of naïve B cells in vitro (Caux et al, 1997).
Immature DCs in non-lymphoid tissues are specialised in the uptake and 
processing of antigens. DCs employ three distinct mechanisms for antigen 
uptake:
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i) Fluid phase antigen uptake by macropinocytosis which is constitutive 
and allows continuous internalisation of large volumes of fluid (Sallusto et al, 
1995).
ii) Receptor-mediated endocytosis via C-type lectin receptors such as the 
mannose receptor (Engering et al, 1997; Celia et al, 1997; Jiang et al, 1995; 
Sallusto et al, 1995), DC-SIGN (Geijtenbeek et al, 2000^) and DEC-205 
which is expressed on murine DCs and thymic epithelial cells (Jiang et al, 
1995)] or via Fc receptors [e.g. FcyRI (CD64), FcyRII (CD32), FcsRI and 
low-affinity FccRII (CD23) (Celia et al, 1997; Fanger et al, 1996]. Mannose 
receptors bind to carbohydrate antigens, mediate endocytosis and release 
antigen in to a multivesicular endosome and then recycles back to the cell- 
surface, allowing continuous internalisation of antigen and maintaining a 
capacity for antigen capture (Celia et al, 1997; Sallusto et al, 1995). Human 
LCs lack functional mannose receptors and have poor endocytic capacity 
(Mommaas et al, 1999). However LCs do express an LC-specific C-type 
lectin (Langerin) (Valladeau et al, 1999^; Valladeau et al, 1999^).
iii) Phagocytosis of particles [e.g. apoptotic and necrotic cell fragments 
(Albert et al, 1998% Albert et al, 1998’’), bacteria (Inaba et al, 1993) and 
intracellular parasites (Moll et al, 1993)].
It is known that processed exogenous antigens in the form of short peptides 
are presented to CD4 T helper cells in a MHC class Il-restricted manner. 
There is evidence for MHC class I-restricted presentation of exogenous 
antigens taken up by DCs by macropinocytosis or in a receptor-mediated
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manner and are then presented to CD8^ CTLs (Rock et al, 1993; Norbury et 
al, 1995; Jondal et al, 1996; Norbury et al, 1997; Mitchell et al, 1998; 
Regnault et al, 1999). Several groups have attempted to define the 
mechanisms for MHC class I-restricted exogenous antigen presentation. 
Normal and TAP mutant cells and cell lines have been used along with 
cellular inhibitors selective for Golgi transport (Brefeldin A) or proteasomal 
activity (lactacystin and peptide aldehydes) and inhibitors targeting 
endosomal functions such as vesicular pH, proteolysis and transport. The 
suggested mechanisms for exogenous antigen presentation in a MHC class I- 
restricted manner are as follows:
i) Brefeldin A-sensitive conventional nathwav.
Internalised antigens may be released into the cytosol from the endocytic 
compartment for classical TAP-dependent MHC class I presentation (Norbury 
et al, 1997; Kovacsovics-Bankowski and Rock, 1995). The mechanism of 
antigen release into the cytosol is not fully understood but there is evidence 
for the involvement o f carrier molecules or chaperones (Schirmbeck and 
Reimann, 1994; Jondal et al, 1996).
ii) Brefeldin A-insensitive nathwav
Internalised antigens may be processed in endocytic compartments, 
generating peptides which are loaded onto post-Golgi MHC class I molecules 
in endosomes or at the cell surface after peptide regurgitation. (Liu et al, 
1995; Schirmbeck et al, 1995; Harding and Song, 1994; Jondal et a\, 1996).
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Trafficking of DCs is regulated by cytokines and chemokines. Pro- 
inflammatory cytokines including IL-1 and TNF-a promote LC emigration 
(Cumberbatch et al, 1990; Wang et al, 1999). LC precursors (CDla^CD14 ) 
express CCR6 and respond selectively to M IP-3a secreted by kératinocytes 
(Charbonnier et al, 1999). CD 14  ^ DC precursors (CDla‘CD14^) which 
differentiate into macrophage or monocyte-derived DCs (MDDCs) and are 
more closely related to dermal DCs or interstitial DCs, respond to M IP -la , 
MCP-3 and RANTES which can mediate the migration of these cells to 
injured or inflamed peripheral tissues (Charbonnier et al, 1999). Immature 
DCs express CCRl, CCR2, CCR3, CCR5 and CXCRl (Rubbert et al, 1998; 
Sallusto et al, 1998; Yanagihara et al, 1998; Dieu et al, 1998). Maturation of 
DCs up-regulates expression of receptors for chemokines produced in 
lymphoid organs and down-regulates expression o f receptors for 
inflammatory cytokines (Cyster, 1999; Sallusto et al, 1998; Sozzani et al, 
1998% Yanagihara et al, 1998; Sallusto et al, 1999; Sallusto and 
Lanzavecchia, 1999). Mature DCs express high levels of CCR7, acquiring 
responsiveness to the Secondary Lymphoid tissue Chemokine (SLC / 6Ckine) 
and to EBV-induced molecule 1 Ligand Chemokine (ELC) [also known as 
MIP-3p (Yoshida et al, 1997)] (Sallusto et al, 1998; Yanagihara et al, 1998; 
Dieu et al, 1998; Cyster, 1999). Maturation also results in up-regulation of 
CXCR4 (Canque et al, 1999; Sallusto et al, 1998; Zaitseva et al, 1997), 
whose natural ligand, SDF-1 is constitutively secreted in lymphoid tissues 
(Delgado et al, 1998; Sallusto et al, 1998; Austyn 1998). Mature DCs display
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reduced expression of CXCRl, CCRl, CCR5 (Sallusto et al, 1998) and 
CCR6 (Dieu et al, 1998; Carramolino et al, 1999).
For DC and T cell interactions to occur in lymph node T cell areas, adhesion 
molecules (Tsunetsugu-Yokota et al, 1997; Prickett et al, 1992; Starling et al, 
1995; King et al, 1989), cytokines/chemokines (Sallusto et al, 1998; Adema 
et al, 1997) and co-stimulatory molecules (Gribben et al, 1995; Pinchuk et al, 
1994; Caux et al, 1994) are required. DC-T cell cluster formation requires an 
intact DC cytoskeleton and protein kinase C activation to initiate the adhesive 
interaction (Prickett et al, 1990; Scheeren et al, 1991). Examples of adhesion 
molecules involved in DC-T lymphocyte interaction include (fig.1.6):
i) LFA-1 on DCs and ICAM-3 on resting T cells (Starling et al, 1995; 
Hauss et al, 1995).
ii) DC-SIGN on DCs and ICAM-3 on T cells (Geitenbeek et al, 2000^).
iv) LFA-3 on DCs and CD2 on T cells (Prickett et al, 1992; King et al,
1989).
DCs in the lymph node T cell areas secrete cytokines that act as 
chemoattractants for T cells. For instance, ELC/MIP-3P secreted by mature 
DCs is involved in attracting both T cells expressing CCR7 as well as antigen 
carrying DCs (Sallusto et al, 1998), DC-CKl selectively attracts naïve T cells 
(Adema et al, 1997). SDF-1, MCP-1, RANTES, M IP -la  and M IP-ip are also 
secreted by mature DCs (Sallusto et al, 1998). Expression of co-stimulatory 
molecules on DCs is enhanced on activation. Among the most important co-
TC
DCTC DC-SIGN
TC
ICAM-3
Fig.1.6. Examples of adhesion molecules involved in dendritic cell (DC) 
and T cell (TC) interaction
Intracellular adhesion molecule (ICAM)-3 on resting TC binds to (i) 
leukocyte function antigen (LFA)-l or (ii) DC-SIGN expressed on DC. CD2 
on TC binds to LFA-3 on DC (iii).
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stimulatory signals are those delivered by members o f the B7 family, which is 
to date composed of six members. B7.1 (CD80) and B7.2 (CD86), which bind 
to different sites of the CD28 molecule or to CTLA-4 on T cells, are capable 
of delivering a positive co-stimulatory signal (Thompson et al, 1989; Linsley 
et al, 199T) or a counter-regulatory negative signal (Linsley et al, 1991^; 
Waterhouse et al, 1996), respectively. B7-H1 (PD-Ll) and B7-H2 (B7-RP1) 
bind to the PD-1 (Freeman et al, 2000) and inducible co-stimulator [ICOS 
(Wang et al, 2000; Yoshinaga et al, 1999), respectively. The functions of B7- 
H1 and B7-H2 are not yet well documented. B7-H3 binds to a putative 
receptor on activated T cells that is distinct from CD28, CTLA-4, PD-1 and 
ICOS (Chapoval et al, 2001). B7-H3 co-stimulates proliferation of both CD4^ 
and CD 8  ^T cells, enhances the induction of cytotoxic T cells and selectively 
stimulates IFN-y production by T cells (Chapoval et al, 2001). Expression of 
five members o f B7 family listed above is not restricted to DCs, but B7-DC is 
expressed exclusively, as far as is known, on DCs and monocyte-derived DCs 
(Tseng et al, 2001). B7-DC which binds to PD-1, was shovm to co-stimulate 
T cell proliferation and to induce IFN-y but not IL-4 or IL-10 production by 
naïve T cells in mice (Tseng et al, 2001). CD40, a member of the TNF 
receptor family, is expressed on DCs and interacts with CD40L (CD 154) 
(McLellan et al, 1996) expressed on activated, but not resting T cells (Caux et 
al, 1994). This induces IL-12 production by the DC (Shu et al, 1995), which 
is in turn required for activation of Thl T cells.
1.6.1 Dendritic cells and their potential role in HIV-1 transmission
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DC susceptibility to HIV infection has been shown both in vivo and in vitro 
(Patterson et al, 1994; Patterson et al, 1995), although the proviral load in T 
cells is 3-100 times higher than that in DCs (Patterson et al, 1998). There is 
evidence for transfer of virus between DCs and T cells by phylogenetic 
analysis o f the V3 loop and flanking regions of the virus isolated from 
symptomatic HIV patients’ DCs and T cells (Patterson et al, 1998). In vitro 
studies showed that HIV infection of DCs can be blocked by neutralising 
monoclonal antibodies and hence cell-to-cell transmission of the virus from 
DCs to T cells can be halted (Frankel et al, 1998). In addition, immature DCs 
can transmit R5 viral strains to blood monocytes and monocyte-derived 
macrophages with higher efficacy than mature DCs, with the CD 11/CD 18 
family o f adhesion molecules mediating DC-monocyte/macrophage 
interaction (Kacani et al^  1998).
There is evidence that subepithelial DCs, may be the first cells to be infected 
after mucosal exposure to HIV, as has been shown in studies using rhesus 
macaque models o f SIV (Spira et al, 1996; Joag et a\, 1997; Miller and Hu, 
1999) and using skin explants (Reece et al, 1998). Therefore, it has been 
suggested that LCs may play a role in establishing HIV infection in lymph 
node T cells (Spira et al, 1996; Masurier et al, 1998). However, it has also 
been suggested that endocervical T cells may be the first cells to be infected 
in the female (Zhang et al, 1999) and this is discussed in chapter VI. DCs 
express CD4 and the co-receptors required for HIV fusion and entry
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(Patterson et al, 1995; Wright-Browne et al, 1997; Lee et al, 1999^). The 
newly identified DC-specific ICAM-3 receptor, DC-SIGN, was also shown to 
bind to gpl20 and hence to be involved in capture of HIV-1. Furthermore, an 
interaction between DC-SIGN and ICAM-3 facilitates the infection of T cells 
(Geijtenbeek et al, 2000^). Freshly isolated LCs from skin epidermis express 
CCR5, the principal co-receptor for fusion and entry of R5 viral strains. These 
LCs do not express CXCR4 (Zaitseva et al, 1997) providing an explanation 
for the preferential sexual transmission of R5 viral strains. Such data does not 
however explain the M-tropic-restricted transmission that also occurs via 
other routes including vertical transmission and blood. M-tropic strains of 
virus, but not T-tropic strains, may enter DCs derived from the tonsil and 
thymus (Cameron et al, 1996). Peripheral blood DCs which are generally 
thought to be immature DCs, express CCR5 but low levels o f CXCR4 (Lee et 
al, 1999’^ ). Expression of CXCR4 may be increased on DC maturation 
(Zaitseva et al, 1997; Zoeteweij et al, 1998; Lee et al, 1999'’). Expression of 
CXCR4 is also regulated by cytokines as is demonstrated by the fact that Th2 
type cytokines, IL-4 and TGF-(51 up-regulate, whereas Thl type cytokines 
IFN-a, IFN-P and IFN-y inhibit CXCR4 expression (Zoeiteweil et al, 1998). 
A relative increase in type-2 cytokines, which can occur during HIV infection 
(Stylianou et al, 1999; Meroni et al, 1996), may up-regulate CXCR4 
expression on mature DCs favouring infection with X4 viral strains 
(Zoeteweij et al, 1998). HIV infection of DCs is blocked by the natural co­
receptor ligands RANTES and SDF-1 (Rubbert et al, 1998; Granelli-Pipemo 
et al, 1996). Evidence for the presence of a SDF-1 receptor other than
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CXCR4 on DCs, which is used by both R5 and X4 viral strains, has been 
shown by a study of HIV infected individuals homozygous for A32CCR5 and 
by an inhibition assay with SDF-1 (Rubbert et al, 1998).
1.7. SEMEN
1.7.1. Composition of seminal fluid
Seminal fluid consists of various secretions o f the male accessory 
reproductive organs (Geigy Scientific Tables, vol.l, 8* edition)(fig.I.7). The 
three main secretions are acid phosphatase (prostatic secretion), spermatozoa 
(testicular and epididymal secretion) and fructose (seminal vesicle secretion). 
About 10% of the dry mass of the total ejaculate consists of inorganic 
materials and 90% is organic (Table 1.3). Some semen specimens contain 
antibodies of the IgA type which are capable of agglutinating spermatozoa 
and are significant with respect to male infertility. The normal pH of semen 
is slightly alkaline (7.2-8.0). Cell types other than spermatozoa in human 
semen include leukocytes, epithelial cells and immature germ cells. These are 
collectively referred to as ‘non-spermatozoal cells’ (NSC) or ‘round cells’. 
Leukocytospermia (leukocyte counts in seminal fluid of more than 2xlOVml) 
may indicate infection in the reproductive tract and large numbers of 
epithelial cells in semen may be an indication of infection or overactive 
masturbation. The presence of erythrocytes may indicate reproductive tract
Table 1.3. Substances found in seminal fluid.
Material Example Characteristics
Inorganic substances Chloride -
Phosphorus As phosphorylcholine and 
glycerylphosphrylcholine
Potassium Mostly from the prostatic secretion; 
concentration increased in cystic fibrosis
Sodium -
Calcium Mostly from the prostatic secretion; 
concentration increased in cystic fibrosis
Magnesium Mostly from the prostatic secretion; 
concentration increased in cystic fibrosis
Zinc Almost exclusively firom the prostatic secretion; 
bound to glycoproteins; concentration increased 
in cystic fibrosis and decreased in prostatitis
Copper -
Nitrogaious
substances
Ammonia Increased on prolonged incubation at 37”C 
due to progressive proteolysis
Amino acids 24 different amino acids identified
Choline Released from phosphorylcholine 
by acid phosphatase
Phosphrylcholine Hydrolysed to form phosphate and choline 
within 1 hour of ejaculation
Glycerylphophoryl-
choline
From the epididymis
Carnitine Mainly from the epididymis
Polyamines Putrescine, Spermidine, Spermine (refer text); 
from the prostatic secretion
Proteins Gradually broken down by proteolytic enzymes 
and peptide hydrolases; eg. albumin, transferrin, 
lactoferrin, IgA, IgG, IgM, Lysozyme, Lactate 
dehydrogenase and acid phosphatase
Carbohydrate & 
Metabolites
Glucose Energy source for the spermatozoa
Fructose Formed almost entirely in the seminal vesicles; 
most important energy source for the 
spermatozoa
Sialic acid Equally from both prostatic secretion 
and seminal vesicles
Fucose -
Myoinositol Mostly from the prostatie secretion
Sorbitol -
Lactic acid & 
Pyruvic acid
Metabolites produced by the anaerobic 
metabolism of the spermatozoa
Citric acid Almost exclusively from the prostate
Lipids Phopholipids Phosphatidylcholine is 
preponderant in the plasma
Cholesterol -
Prostaglandin Refer text
Vitamins Vit. Bi2 & 
Ascorbic acid
-
Hormones Pregnenolone, 
Androstenedione, 
Dihydrotestosterone, 
Estradiol, Prolactin, 
Follicle-stimulating 
hormone, etc.
-
Fig. I. 7, The male reproductive system (adopted from Burkitt et al, 1993). 
Section through the male pelvis (a) and testis (b)
The male reproductive system mat be divided into four fimctional components;
• The testes, paired organs lying in the scrotal sac, are responsible for production 
o f the spermatozoa and secretion o f  male sex hormones.
• A paired system of ducts, each consisting o f ductuli efferentes, epididymis, 
ductus deferens and ejaculateatory duct, collect, store and conduct spermatozoa 
from each testis. The ejaculatory ducts converge on the urethra from which 
spermatozoa are expelled.
• Two exocrine glands, the paired seminal vesicles and the single prostate gland, 
secrete a nutritive and lubricating fluid medium (seminal fluid).
• The penis is the organ o f copulation. A pair o f small accessory glands, the 
bulbo-urethral glands of Cowper, secrete a fluid which lubricates the urethra for 
the passage o f semen during ejaculation.
(a)
Ureter
Urinary
bladder
Ductus
deferens
Prostatic
urethra
Penile
urethra
Penis
Scrotum
Testis
Seminal
vesicle
Prostate
gland
Rectum
Epididymis Bulbourethral gland of Cowper
(b)
Ductus deferens
Ductuli
efferentes
Serous
cavity
Tunica
vaginalis
Tunica
albuginea
Septa e
Seminiferous
tubules
Testicular
lobules
Epididymis
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infection or damage to a small capillary. Ejaculation is immediately followed 
by coagulation of seminal fluid mediated by a clotting enzyme (proteinase) 
from the prostate acting on a fibrinogen-like protein from the seminal 
vesieles. Within 5 to 10 minutes of ejaculation, the gelatinous-viscous seminal 
fluid beeomes liquefied due to proteolytie degradation of the coagulation 
product by a plasmin-like enzyme from the prostate gland. Chymotrysin-like 
enzymes, dipeptidases and aminopeptidases also hydrolyse the elot fragments 
to tripeptides, dipeptides and free amino aeids. The density and viseosity o f 
the total ejaeulate depends on the quantity of spermatozoa. The spermatozoa 
formed in the testieles migrate into the epididymis, where they are stored and 
subjected to a maturation process. The number o f spermatozoa varies between 
individuals from less than 2xl07m l to over SxlOVml. A high proportion of 
motile spermatozoa benefit fertility. In vitro, motility is temperature- 
dependent and is considerably higher at 37°C than at room temperature. The 
proportion of highly motile spermatozoa decreases with age. The 
spermatozoon eonsists o f three parts: a head, mid-pieee and tail. The head of 
spermatozoa contains the nucleus and acrosome. The acrosome is a modified 
lysozome eontaining a charaeteristic lipoglyeoprotein complex whieh is 
associated with a number o f enzymes. Some of the enzymes, in partieular a 
trypsin-like proteinase (aerosin), are important for fertilisation and are 
involved in breaking open of the ovarian cumulus and penetration o f the 
pellucid zone. The mid-pieee of spermatozoa is rich in lipids and contains 
coenzymes. The fibrils of the axial filament eontain adenosine triphosphatase 
required for energy transfer and henee ensure spermatozoal motility.
58
1.7.2. Immunological functions of seminal plasma
The main functions of seminal plasma (reviewed by Alexander and Anderson, 
1987 and Kelly, 1997^) include:
i) Facilitating spermatozoal transport.
ii) Prevention of a rapid loss of spermatozoa from vagina by providing a 
eoagulating system.
iii) Provision of an energy souree (fruetose, glucose) and motility 
stimulant for spermatozoa.
iv) Serving as a highly buffered medium to overcome the aeidie pH of the 
vagina.
v) Suppression of the host immune system by presence of 
immunosuppressive components sueh as prostaglandins, prostasome, 
polyamines, transforming growth factor (TGF)-P and complement 
inhibitors.
The immunologieal functions of the eomponents of seminal plasma, in 
particular prostaglandins are addressed below.
i) Prostaglandins
It is known that human and primates have high levels o f prostaglandins in 
semen at a eoncentration some 10  ^ times more than that of peripheral blood 
(reviewed by Kelly% 1997). Prostaglandins in human seminal plasma inelude
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four main species, 19-hydroxy prostaglandin E (19-OH PGE) 1, 19-OH 
PGE2, PGEl and PGE2. Prostaglandins, which are released by macrophages 
together with stimulatory agents and other suppressive agents, have 
immunomodulatory effects. For instance, PGE2 has been shown to have a 
pro-inflammatory role and aetivates/matures eultured DCs (monocyte-derived 
DCs) and subsequently induces IL-12 produetion by DCs (Rieser et al, 1997; 
Rieser et al, 1998; Portanova et al, 1996). In contrast to this pro-inflammatory 
activity of PGE2, PGE2 is also known to inhibit the produetion o f pro- 
inflammatory cytokines by lipopolysacharide (LPS)-activated maerophages 
(Strassmann et al, 1994). PGE2 has also been shown to inhibit IL-12 
production (Kraan et al, 1995; Kelly et al, \99T ) and stimulate IL-10 
production in whole blood eulture (Strassmann et al, 1994; Kelly et al, 
199T). This eytokine switeh to a Th2-type may induee anergy or peripheral 
tolerance (Groux et al, 1996). Spermatozoa are allogeneic but whether or not 
they exhibit MHC antigens on their surface is eontroversial (Vinee et al, 
1995; Schaller et al, 1993; Hutter and Dohr, 1998). The cytokine switeh 
induced by prostaglandins in seminal plasma could result in toleranee to 
spermatozoal antigens in female reproductive tract and may also influence 
viral infection. Immunosurveillance and killing mechanisms might be 
compromised by repeated exposure to prostaglandins in semen by indueing T 
eell anergy (Groux et al, 1996) and inhibition of cytotoxic responses.
ii) Prostasomes
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Prostasomes are submicron organelles, enclosed in a lipid membrane 
(Ronquist and Brody, 1985). Their known immunosuppressive effeets are the 
inhibition of T eell proliferation (Kelly et al, 1991) and modulation of 
phagocytie activity (Skibinski et al, 1992).
iii) Polvamines
Polyamines have been found to inhibit nitric oxide produetion, whieh is 
required for killing and phagocytie aetion in monocytes (Szabo et al, 1994) 
and have also been shown to inhibit pro-inflammatory cytokine produetion 
(Zhang et al, 1997).
iv) Complement inhibitors
Complement inhibitors in semen inelude deeay aeeelerating factor (DAF; 
CD55), which promotes C3 breakdown (Rooney et al, 1993^), membrane eo- 
factor protein (CD46) which inactivates C3 (Simpson and Holmes, 1993) and 
protectin (CD59) whieh binds to spermatozoa to provide proteetion from 
complement attaek (Rooney et al, 1993'’). Complement inhibitors have also 
been shown to be incorporated into the HIV envelope and induee resistance to 
eomplement attaek (Saifuddin et al, 1995).
1.7.3. HIV-1 in semen
Semen is eonsidered to be an important vehicle for the sexual spread of HIV- 
1 and thus the level of virus in semen would be an important determinant in
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the sexual transmission of HIV-1. Since the first quantitation of HIV-1 in 
semen by Borzy and co-workers in 1988 using reverse transcriptase aetivity 
assays in a ‘virus pellet’ obtained by differential suerose density 
eentrifugation of cell-free seminal plasma from symptomatie individuals 
(Brozy et al, 1988), many researehers have quantitated HlV-1 RNA levels in 
semen (Rasheed et al, 1995; Liuzzi et al, 1996; Liuzzi et al, 1995; Gupta et 
al, 1997; Coombs et al, 1998; Dyer et al, 1998). Some researchers have 
detected HIV-1-infected seminal non-sperm cells (Quyale et al, 1997; 
Vemazza et al, 1996; Baccetti et al, 1991; Bagasra et al, 1988; Bagasra et al,
1990). Therefore, HlV-1 is present in semen both as cell-free virus and eell 
(seminal non-spermatozoal cell)-associated virus. However, the possibility 
that HlV-1 is carried by the spermatozoa themselves has been suggested. 
Several studies have been carried out to investigate the presence o f HlV-1 
DNA in spermatozoa and whether spermatozoa express CD4. A number of 
groups have presented data suggesting that HIV attaches to and infects 
spermatozoa (Bagasra et al, 1988; Bagasra et al, 1994; Baccetti et al, 1994; 
Scofield, 1992; Seofield et al, 1994; Gobert et al, 1990), possibly via a CD4- 
like molecule (Ashida and Seofield, 1987; Bagasra et al, 1994; Scofield et al, 
1992; Seofield et al, 1994; Gobert et al, 1990). Some groups have failed to 
detect CD4 expression on sperm (Wolff and Anderson, 1988% W olff and 
Anderson, 1988% El-Demiry et al, 1986) and eould not detect HlV-1 particles 
or proviral sequenees in sperm cells (Mermin et al, 1991; Van Voorhis et al, 
1991; Quayle et al, 1997). CD4 or CD4-like molecules on spermatozoa eould 
play an important role in infeetion of spermatozoa with HlV-1 sinee CD4 is
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the primary eell reeeptor for HIV-1. Also binding o f sperm to somatie eells 
via HLA-DR (Ashida and Scofield, 1987; Scofield et al, 1992) carries 
potential signifieance for HIV transmission, because HLA-DR is present on 
mucosal cells within the primate female reproductive tract, many of which are 
susceptible to HIV infeetion in vitro (Langhoff et al, 1991; Seofield et al, 
1992). It has also been shown that carbohydrates appear to be critical for 
sperm binding to HLA-DR and thus sulphated carbohydrates sueh as heparin, 
dextran sulphate, and chondriotin sulphate, eould enhance adhesion of sperm 
to HLA-DR, possibly by stabilising the sperm-HLA-DR interaction (Scofield 
et al, 1992). Technical differences in HlV-1 detection and sperm preparation 
methods, or contamination of spermatozoal preparations with seminal non­
sperm eells, may have resulted in discrepancies in results obtained by 
different groups. The data obtained in this study are presented in chapter 111.
Molecules other than CD4 have been identified on spermatozoa, which may 
play a role in binding of HIV-1. Galactosylceramide or a related compound is 
present on the surface membrane of the mid-pieee and equatorial segment o f 
human spermatozoa (Baccetti et al, 1994) and has been shown to be an 
essential component o f the neural receptor for HlV-1 gpl20 (Bath et al, 1991; 
Harouse et al, 1991). Glycolipid molecules, most likely galaetosyl-alkyle- 
glyeerol which is structurally similar to galactosylceramides, has been 
detected on the surface of the mid-piece of spermatozoa and on the membrane 
of immature germ cells, preferentially in the spermatogonia. Furthermore, it 
has been demonstrated that these sperm glycolipids are capable o f binding to
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g p l20 (Brogi et al, 1995). Since the mid-piece of sperm contains 
mitochondria that are responsible for generating energy for sperm motility, it 
may be possible that HlV-1 infection results in disrupted mitochondrial 
function leading to sperm immotility. Such data suggest that glycolipids may 
function as HIV receptors and this may explain the inhibition of 
spermatogenesis observed in AIDS patients (Martin et al, 1991). However, 
whether galactosylceramide functions as a receptor for HIV infeetion of 
spermatozoa, has not been confirmed.
Semen appears to be an isolated reservoir of HlV-1. There is evidence that 
seminal HIV may not arise from the same reservoir as peripheral blood:
i) HlV-1 viraemia in semen does not always correlate with that in blood 
plasma (Rasheed et al, 1995; Liuzzi et al, 1996; Gupta et al, 1997; 
Coombs et al, 1998) or with blood CD4 cell count (Gupta et al, 1997; 
Liuzzi et al, 1996).
ii) Genetic analysis of envelope (Zhu et al, 1996; Delwart et al, 1998) 
and protease (Kiessling et al, 1998) genes of HlV-1 isolates from 
paired specimens of blood and semen have revealed significant 
divergences of the two viral populations.
iii) Genetic characteristics of envelope gene sequenees of sexually 
transmitted virus differ from those in the blood of the transmitter (Zhu 
et al, 1996).
iv) Detection of culturable HlV-1 in semen correlated strongly with HIV 
RNA levels in cell-free seminal plasma but only weakly with HIV
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RNA levels in blood plasma or with CD4 cell count (Liuzzi et al, 
1996; Coombs et al, 1998).
The means by which vims may gain entry to semen is not yet understood. 
Possibilities include that vims arises from the site from which the seminal 
leukocytes originated (‘Hypothesis 1 ’), or alternatively that vims enters from 
another reservoir and infects seminal leukocytes within the seminal fluid 
(‘Hypothesis 2’). The origin of leukocytes in semen is not yet well defined 
but these cells may arise from within the germ cell compartment. This 
hypothesis is supported by the following observations:
i) Vasectomy reduces seminal leukocyte numbers (Olsen and Shields, 1984)
ii) Leukocyte numbers have a direct correlation with sperm with ideal 
morphology (Kiessling et al, 1995; Tomlinson et al, 1993). One proposed 
role of leukocytes in the germ cell compartment is to eliminate defective 
germ cells (Yeung et al, 1994).
Evidence against hypothesis 1 comes from the fact that the testis and 
epididymis (fig.1.7) are isolated from routine immune surveillance 
mechanisms by a combination of anatomic barriers (Holash et al, 1993) and 
Fas-FasL interactions (Griffith et al, 1995) thereby protecting spermatozoa 
which are highly immunogenic to their host. Vasectomy, which eliminates 
proximal sources of HIV from germ cells and leukocytes and secretions from 
the testes, epididymis and vas deferens, has minimal impact on the infectivity 
o f semen (Krieger et al, 1998), suggesting that germ cells are not a source o f
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HIV. This study also suggests that cell-free and cell-associated HIV arises 
distal to the vas deferens (e.g. in seminal vesicles, prostate, urethra or 
Cowper’s gland). HIV has been detected in the pre-ejaculate which is 
produced by the urethral and Cowper’s gland (Ilaria et al, 1992). 
Granulocytes, macrophages and T lymphocytes (both CD4 and CDS) have 
been found in pre-ejaculate (Pudney et al, 1992). The immunosuppressive 
properties of seminal vesicle and prostate fluids supports the hypothesis that 
these organs may be sites of immune-privileged HIV-infected cells. 
Furthermore, CD4^ T cells are more abundant in the normal prostate 
compared with CD8^ T cells (Ball et al, 1982). Taken together it seems that 
virus may gain entry to semen from the peripheral circulation via accessory 
organs (eg. prostate and seminal vesicles). Variations in seminal viral burden 
may be influenced by prostatitis or urethritis, which in turn could increase 
leukocyte numbers in the semen-producing organs and consequently the 
semen viral burden. Infection of the accessory organs may also result in 
compromised immunologic control mechanisms in germ cell compartments 
(which is protected from HIV infection early in the disease) and hence may 
lead to HIV infection o f CD4^ cells in germ cell compartments.
1.7.4. ‘Sperm-washing’
‘Sperm washing’ is a technique used to improve the quality o f sperm before 
intra-uterine insemination or in vitro fertilisation. It has been used for the 
management o f infertility resulting from cervical or male infertility factors
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and was first employed in 1973 to remove sperm antibodies (Halim et al, 
197^L
HIV is present in seminal fluid as both free-virus and non-sperm cell- 
associated virus as described above (1.5.3). Thus sperm washing may be used 
as a means of minimising the exposure of an uninfected female partner of an 
HIV^ male to potentially infected material, by reducing the free-virus and the 
HIV-infected cells. This application of ‘sperm-washing’ for HIV-discordant 
couples wishing to have children was first described in 1992 by Semprini et 
al (Semprini et al, 1992). To conceive, such HIV-discordant couples (the man 
is HIV positive and the woman is HIV negative) must abandon condom- 
protected intercourse and risk HIV transmission to the woman and to her 
child. ‘Sperm-washing’ as a risk reduction program has been a controversial 
area. It has been suggested that the risk of transmission is sufficiently low 
that such couples may attempt natural conception (Mandelbrot et al, 1997). 
92 HIV negative women and their HIV positive partners received pre- 
conceptual counselling on the risk of transmission and were advised to 
pinpoint ovulation to reduce the risk. Two women seroconverted at seven 
months of pregnancy and another two post-partum, with séroconversions 
restricted to couples with inconsistent condom use. In contrast, Semprini’s 
group have already carried out 1690 inseminations in 543 couples resulting in 
almost 240 pregnancies with no seroconversion in mothers or the resulting 
babies (Semprini et al, 1999, personal communication). Based on this clinical 
data, ‘sperm-washing’ appears to be a method of reducing the risk of
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heterosexual transmission in HIV-discordant couples wishing to have 
children. However, the safety of sperm-washing has only been evaluated by 
the relatively insensitive method of antibody detection of viral antigen, p24, 
on the purified spermatozoa (Semprini et al, 1992). This thesis investigated, 
for the first time, the presence of both viral RNA and proviral DNA in the 
purified spermatozoa and the expression of receptors used for viral entry on 
these cells.
1.8. A im  o f  t h e s is
Understanding mechanisms of sexual transmission of HIV-1 is o f importance 
in designing vaccine against HIV-1. Semen is considered to be an important 
vehicle in transmission of STDs including HIV-1 and immature DCs in the 
mucosa (LCs) are suggested to be the first cells to become infected. Therefore 
aim o f this thesis is to investigate the role o f semen in HIV transmission by 
answering following four questions: 
i) Where does virus reside in seminal fluid?
ii) Does ‘sperm-washing’ really reduce risk of HIV transmission in HIV-
discordant couples who wish to have children?
iii) What effect does seminal plasma have on DC phenotype and function?
iv) What effect does seminal plasma have on HIV infection of DCs?
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II
M a t e r ia l s  a n d  M e t h o d s
Suppliers for each reagent are listed in the section II.8 and suppliers for 
equipment are indicated where appropriate in the text.
II. 1. S u b je c t s
Both semen and blood samples from HIV-1 positive patients were donated 
from HIV-1 positive men attending the St. Stephen’s Clinic, Chelsea and 
Westminster Hospital, London. Control semen samples were donated from 
HIV negative donors attending the fertility clinic at the Chelsea and 
Westminster Hospital and from laboratory workers. Control blood samples 
were obtained from laboratory workers. For propagation of virus (II.6.1) buffy 
coat from HIV negative individuals was obtained from the North London 
Blood Transfusion Centre, Colindale, London, UK. The number of samples for 
each study is indicated individually in appropriate figures. Ethical approval for 
the studies was granted by the Riverside Research Ethics Committee. All the 
samples from HIV-1 positive patients were prepared in a containment level 3 
laboratory.
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II.2. S a m p l e  p r e p a r a t io n  a n d  c e l l  c u l t u r e s
11.2.1. Peripheral Blood Mononuclear Cell separation
Blood samples were collected intravenously into vacutainers containing 
ethylenediamine tetraacetic acid (EDTA) or sodium heparin (Becton 
Dickinson, Oxford, UK). Plasma and peripheral blood mononuclear cells 
(PBMCs) were separated by gradient centrifugation over Histopaque. The 
blood was overlaid on Histopaque and centrifuged at 600g for 30 minutes at 
room temperature. Plasma was stored at -70°C until use. The interface 
containing PBMCs was transferred into a fresh universal tube and washed 
twice in wash medium [serum-free RPMI1640 medium supplemented with 
2mM L-glutamine, 50U/ml of penicillin, 50pg/ml o f streptomycin and
1.5pg/ml of amphotericine B] by centrifugation at 400g for 10 minutes at 
room temperature. The viable cells were counted by ‘trypan blue exclusion’.
11.2.2. Semen Separation
Semen samples were donated by masturbation into a sterile plastic container. 
The samples were kept at 37°C until processing and all specimens were 
processed within 2 hours of donation. Unfractionated semen samples were 
diluted 1:4 in pre-warmed (37°C) complete Earl’s Balanced Salt (EBS) 
medium [EBS solution supplemented with ImM pyruvic acid and ImM  lactic
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acid and pH adjusted to 7.2 using concentrated HCl]. A fraction of the diluted 
whole semen was stored at -70°C. Seminal plasma, spermatozoa and seminal 
non-sperm cells (NSCs) were prepared by differential gradient centrifugation 
over 80% and 40% Medicol Medium Isotonic (MMI) at 400g for 30 minutes at 
room temperature. The semen sample was separated into 4 fractions: seminal 
plasma, upper interface containing NSCs, lower interface containing dead or 
less motile spermatozoa and the pellet containing mainly live and motile 
spermatozoa (fig.II.l). The cells from both interfaces and the pellet were 
washed twice in complete EBS medium by centrifugation at 400g for 10 
minutes at room temperature. Following the final wash the spermatozoal 
pellet was overlaid with 3ml of medium and incubated at 37°C, 5% CO 2  for 20 
minutes to allow motile spermatozoa cells to swim up. The supernatant 
containing motile spermatozoa was collected. In some experiments, the 
spermatozoa fraction at the 40% / 80% interface was also collected. This 
fraction should contain mostly dead spermatozoa, however when treated in the 
same way as the pellet from the gradient a number o f viable ‘swim-up’ 
spermatozoa were recovered. The seminal plasma fraction was filtered through 
a 0.2pm filter (Sartorius, Surrey, UK) and stored at -70°C. Seminal plasma 
samples from six HIV-negative individuals were mixed together to make a 
pool of seminal plasma and stored at -70°C. This ‘seminal plasma pool’ was 
used to pulse monocyte-derived dendritic cells (MDDCs) as described in II.2.6 
for studies presented in chapter 4 and chapter 5. For some experiments, lipids 
from seminal plasma (HIV-negative) were extracted at low pH using reverse
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phase columns as previously described (Kelly et al, 199T). Seminal plasma 
was adjusted to pH4 using concentrated HCl prior to passing through C-18 
reverse phase columns (SepPak, Waters, UK) which were pre-treated with 
methanol and washed with distilled water. The lipid-extracted seminal plasma 
was filtered through a 0.2pm filter.
II.2.3. Freezing and Thawing Cells
Cells for DNA and RNA extraction were snap frozen at -70°C. Cells for 
culture were re-suspended in 0.5ml of freezing mix [90% PCS and 10% 
Diemethyl sulphoxide (DMSO)] at a concentration of SxlOVml and were 
frozen in an isopropanol-insulated chamber (‘Mr. Frosty’) placed at -70°C, 
over night. The next day, the cells were transferred to and stored in liquid 
nitrogen. Frozen vials were thawed quickly in a 37°C water-bath and 
immediately diluted with cold RIO medium [serum free RPMI1640 
supplemented with 2mM L-glutamine, 50U/ml o f penicillin, 50pg/ml o f 
streptomycin, 1.5pg/ml of amphotericine B and 10% PCS]. The cells were 
washed twice at 400g for 7 minutes at room temperature, resuspended in RIO 
medium and incubated at 37°C, 5% COj.
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11.2.4. Separation of CD14^ Cells Using MicroBeads
CD 14  ^ cells were positively selected from PBMCs using CD 14 MicroBeads 
according to the manufacturer’s instructions. Briefly, PBMCs were washed in 
cold MiniMACS buffer [0.2mM EDTA, 0.5% PCS in PBS]. 10" cells in 80pl 
of MiniMACS buffer were incubated with 20pl of CD 14 MicroBeads at 6- 
12°C for 15 minutes with occasional mixing. The cells were washed once by 
centrifugation at 400g for 10 minutes at 6°C and then resuspended in 1ml of 
cold MiniMACS buffer. The cell suspension was applied to a pre-wet MS+ 
column (Miltenyi Biotec) which was placed in the magnetic field of a MACS 
separator (Miltenyi Biotec). The magnetically labelled CD 14  ^ cells were 
retained in the column while the unlabelled CD 14' cells ran through. The 
CD 14' cells were washed off from the column twice with 500pl of MiniMACS 
buffer. After removal of the column from the magnetic field, the magnetically 
retained CD 14  ^cells were eluted as for the positively selected cell fraction.
11.2.5. Generation of Dendritic Cells from CD14^ Monocytes
3ml of CD 14  ^cells at a concentration of lOVml in dendritic cell (DC) culture 
medium [RIO medium supplemented with 50ng/ml of GM-CSP and 20ng/ml 
of rIL-4] were placed in a 6-well tissue culture plate (Greiner, Gloucestershire, 
UK) and cultured at 37°C, 5% CO2  for 5 days. 50ng/ml GM-CSP and 20ng/ml 
rIL-4 were added every 3 days and cultured for 5 days to obtain CD 14^
73
monocyte-derived DCs (MDDCs). Phenotype of MDDCs after 5 days of 
culture is shown in fig.II.2.
II.2.6. Pulsing of dendritic cells with Seminal Plasma, PGE2 or 19-OH 
PGE2 and/or TNF-a
Seminal plasma (at a final concentration o f 0.1% and 1%; a pool of seminal 
plasma as described in II.2.2 was used), prostaglandin E2 [PGE2 (at a final 
concentration of 0.0071 pM, 0.07IpM  and 0.71 pM)] or 19-hydroxy PGE2 [19- 
OH PGE2 (at a final concentration of 0.0353pM, 0.353pM and 3.53pM)] was 
added to MDDC cultures at day 5 and incubated overnight at 37°C, 5% CO2 . In 
some experiments, cells were pulsed overnight with 200U/ml o f TNF-a alone 
or together with seminal plasma, PGE2, or 19-OH PGE2. The next day, the 
cells were washed twice in RIO medium by centrifugation at 400g for 10 
minutes at room temperature before setting up further experiments. The 
optimum concentration of TNF-a (200U/ml) was determined experimentally 
and the data is shown in chapter 4. The amounts o f PGE2, 19-OH PGE2 used 
were calculated as follows, 
a) PGE2 fCalbiochem)
Molecular weight of PGE2 = 352.5 
PGE2 in dry pellet (Img) was dissolved in 1ml of ethanol to give 
concentration of 2.84mM (concentration of PGE2 stock).
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Fig.II.2. Flow cytometric analysis showing the CD14^ monocyte population after 
CD14^ cell separation using MicroBeads and the CDla^ immature DC population 
after 5 days of culture in the presence of IL-4 and GM-CSF.
CD 14^ monocytes were separated from PBMCs using MicroBeads as described in IL2.4 
(a). The purified cells were stained with monoclonal anti-CD 14 antibody (c) and were 
cultured for 5 days in the presence o f IL-4 and GM-CSF (b). At day 5 the cells were 
stained with monoclonal anti-CD la  antibody (d).
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Average concentration o f PGE2 in seminal plasma is 25pg/ml (Kelly et al,
25
1997“) which is equivalent to 71 pM (i.e. ^^2500^ ^ lO'^M or 71pM).
Therefore, 0.1% seminal plasma contains 0.071 pM and 1% seminal plasma 
0.7 IpM  of PGE2. The volume of PGE2 stock to be added to MDDC cultures 
to give a final concentration equivalent to 0 .1 % or 1 % seminal plasma was 
calculated using following equation:
Volume of PGE2 stock to add = x 0.071 [(for 0.1% seminal plasma) or
0.71 (for 1 % seminal plasma)] 
(where A is final volume of MDDC culture)
(h) 19-OH PGE2 rCavmanI
Molecular weight of 19-OH PGE2 = 368.5 
Concentration of 19-OH PGE2 solution was 500pg/ml which is equivalent to
1.36mM.
Average concentration of 19-OH PGE2 in seminal plasma is 130pg/ml (Kelly 
et al, 1997“) which is equivalent to 353pM.
130
[i.G. = -3.53 X 10-^M or 353pM]
Therefore, 0.1% seminal plasma contains 0.353pM of 19-OH PGE2 and 1% 
seminal plasma contains 3.53pM of 19-OH PGE2. The volume of 19-OH 
PGE2 stock to be added to MDDC cultures to give a final concentration which 
is equivalent to 0 . 1 % or 1 % seminal plasma was calculated using following 
equation:
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Volume of PGE2 stock to add = x 0.353 [(for 0.1% seminal plasma) or
1360
3.53 (for 1% seminal plasma)] 
(where A is final volume of MDDC culture)
II.2.7. Allogeneic Mixed Lymphocyte Reaction
MDDCs treated with seminal plasma as described in II.2.6 were used as 
stimulators in an allogeneic mixed lymphocyte reaction (MLR). Fresh PBMCs 
were used as responder cells. An increasing number o f irradiated (3,000 rads 
for 9 minutes) MDDCs (0 to 8,000 cells/well) and 10  ^ responder cells were 
added to a 96-well U-bottomed tissue culture plate (Greiner) in RIO medium. 
After 4 days, the cells were pulsed with [^H]-thymidine and harvested on a 
filtermat (Wallac) the next day (16-hour pulse with 0.5pCi/well). Proliferation 
was measured as [^H]-thymidine incorporation. Results are shown as mean 
stimulation indices (SI) with standard error (SE) throughout this thesis in order 
to overcome difficulties in summarising results from different samples due to a 
large variance in mean counts per minute (CPM) readings between samples. 
Representative graphs of each experiment are also presented as a mean CPM 
with SE. The number of experiments performed was stated individually in 
appropriate figures presented throughout this thesis and each experiment was 
set up in triplicate.
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11.2.8. Recovery of allogeneic T cell proliferation
The MDDCs were pulsed with seminal plasma overnight as described in IL2.6. 
The cells were washed twice, irradiated and used to set up allogeneic MLRs 
( 4 x 1 MDDCs in 0.5ml + 10  ^ responder cells in 0.5ml o f RIO medium) in a 
24-well tissue culture plate (Greiner). At day 3, the cells were harvested, 
washed twice, counted (‘trypan blue exclusion’) and then employed as 
responders in a second MLR. Untreated fresh MDDCs from the same donor as 
those in the first MLR were used as stimulators. The second MLR was set up 
in a 96-well tissue culture plate as follow: i) untreated MDDCs only, ii) 20 
units o f rIL-2 alone or iii) both MDDCs and rIL-2. In all conditions described 
10  ^ cells from the primary MLR were added. At day 6 , the cells were pulsed 
with 0.5|LiCi/well of pH]-thymidine and harvested next day. The results were 
shown as mean SI with SE. This experiment was performed three times and 
each experiment was set up in triplicate.
II.3. F l o w  c y t o m e t r y
II.3.1. Surface Marker Staining
Cells were washed once with MiniMACS buffer by centrifugation at 400g for 
10 minutes at 6 °C. 1-10x10^ cells in lOOpI of MiniMACS buffer were
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incubated with appropriate antibodies [lpg/10^ cells (table II. 1)] on ice for 30 
minutes in dark. Unbound antibodies were washed off by centrifugation at 
400g for 10 minutes at 6 °C. Stained cells were re-suspended and fixed in 500pl 
o f FACS Fix [1% (or 2% for samples from HIV positive patients) 
paraformaldehyde in MiniMACS buffer]. When indirect immunofluorescence 
or multiple colour staining was required the subsequent antibody was added to 
the cells after washing off unbound first or second layer of antibodies. The 
cells were then analysed within 24 hours on a Becton Dickinson FACScalibur 
using Cellquest software.
II.3.2. Intracellular Cytokine Staining
Cells to be stained for intracellular cytokines were incubated with lOpg/ml o f 
Brefeldin A (BFA) overnight. Cells without BFA as control were also set up. 
When required, Ipg/ml of lonomycin and 25ng/ml o f Phorbol 12-Myristate 
13-Acetate (PMA) were added to stimulate cytokine production to the culture 
in conjunction with BFA. Following all surface staining as described in II.3.1, 
the cells were permeabilised using FACS Permeabilising Solution. The FACS 
Permeabilising Solution (lOx) was diluted in distilled water to make a working 
concentration (Ix). 500pl of the diluted FACS Permeabilising Solution was 
added to the cell pellet, vortexed and incubated for 1 0  minutes at room 
temperature in the dark. The permeabilised cells were washed in MiniMax 
buffer containing 0.1% Sodium Azide (NaNg) prior to staining with specific 
antibodies for cytokines. Intracellular cytokine staining procedures were
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carried out at room temperature. Stained cells were analysed within 24 hours 
of staining on a flow cytometer (Becton Dickinson FACScalibur using 
Cellquest software).
II.4. N u c l e i c  a c i d  e x t r a c t i o n
TM11.4.1.Tri Reagent
Following the manufacturer’s instructions, 10  ^cells were homogenised in 1ml 
o f Tri Reagent™ (a mixture of guanidine thiocyanate and phenol in a mono­
phase solution) and the mix was frozen at -70°C immediately, and thawed 
slowly on ice. 0.2ml of chloroform was added to the sample. The resulting 
sample was shaken vigorously and was allowed to stand for 5 minutes on ice 
followed by centrifugation at 12,000g for 10 minutes at 4°C. This resulted in 
separation of the mixture into 3 phases: a red organic phase containing protein, 
an interface containing DNA, and a colourless upper aqueous phase containing 
RNA.
11.4.1.1. RNA Isolation
The aqueous phase containing RNA was transferred to a 1.5ml-eppendorf tube 
(Elkay, Hampshire, UK). 0.5ml o f isopropanol was added to the sample and
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mixed. The resulting mixture was left to stand for 5 minutes at 4°C and was 
centrifuged at 12,000g for 10 minutes at 4°C. The RNA pellet was washed 
with 1ml of 75% ethanol: the sample was mixed well and centrifuged at 
2,000g for 5 minutes at 4°C. The washed RNA pellet was air-dried and re­
suspended in 30pl of nuclease-free water and stored at -70°C. The 
concentration of RNA was measured using a spectrophotometer (II.4.4). RNA 
was prepared in a cold room.
II.4.1.2. DNA Isolation
The interface containing DNA was transferred to a 1.5ml-eppendorf tube. 
0.3ml of absolute ethanol was added to the sample and mixed. The resulting 
mixture was left to stand for 3 minutes at 4°C and then centrifuged at 2,000g 
for 5 minutes at 4°C. The DNA pellet was washed twice in Wash Solution 
[O.IM sodium citrate, 10% ethanol]. During each wash, the DNA pellet was 
allowed to stand for 30 minutes at 4°C with occasional mixing. After the final 
wash, the DNA pellet was re-suspended in 1.5ml o f 75% ethanol and was left 
to stand for 15 minutes at 4°C followed by centrifugation at 2,000g for 5 
minutes at 4°C. The washed DNA pellet was air-dried and resuspended in 
lOOpl o f nuclease-free water. If  the DNA pellet was difficult to resuspend a 
larger volume of water was added or the DNA suspension was heated to 80°C 
until complete resuspension was achieved. The concentration of DNA was
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measured using a spectrophotometer (II.4.4) and Ipg/pl DNA stock was 
prepared and stored at -20°C until use.
II.4.2. RNAzol™ B
Following manufacturer’s instructions, 5-10x10^ cells were homogenised in 
0.2ml o f RNAzol™ B. Chloroform (one tenth volume of the homogenate) was 
added to the lysed cell suspension. The mixture was shaken vigorously for 15 
seconds and allowed to stand for 5 minutes at 4°C followed by centrifugation 
at 12,000g for 15 minutes at 4°C. This resulted in the separation of the mixture 
into 2  phases: a lower blue phenokchloroform phase and a colourless aqueous 
phase containing RNA in 50% of the initial volume of RNAzol™ B. This 
aqueous phase was transferred to a 1.5ml-eppendorf tube. An equal volume of 
isopropanol was added to the tube and mixed. This mixture was incubated at 
4°C for 15 minutes followed by centrifugation of the mixture at 12,000g for 15 
minutes at 4°C. The RNA pellet was washed once with 1ml o f 75% ethanol. 
The washed RNA pellet was air-dried, re-suspended in 3 Dpi o f nuclease-free 
water and stored at -70°C. The concentration of RNA was measured using a 
spectrophotometer (II.4.4).
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II.4.3. NucliSens™ Lysis Buffer
All the reagents used in this part of the experiment were supplied by Organon 
Teknika and were used as per the manufacturer’s instructions. lOOpl o f blood 
plasma; lOOpl of seminal plasma (1:4 diluted); lOOpl of unfractionated semen 
(1:4 diluted); 10^10^ spermatozoa, or 10^10^ NSCs were used to extract 
nucleic acid. The samples were added to 0.9ml of the lysis buffer provided 
(Tris/HCl, Triton X-100, 5M guanidine thiocyanate: GuSCN) and centrifuged 
for 30 seconds at 10,000g. 20pl of calibrator provided was added to .the  
mixture which was then vortexed and centrifuged at 10,000g for 30 seconds. 
After mixing the silica suspension well, 50pl of the silica suspension was 
added to the sample mix. The resulting mixture was left to stand for 10 
minutes at room temperature (with vortexing every 2  minutes) to allow the 
nucleic acids to be captured on the silica, and was then centrifuged at 1 0 ,0 0 0 g 
for 30 seconds to pellet the nucleic acid bound silica. The silica-nucleic acid 
pellet was washed twice with 1ml of the wash buffer (Tris/HCl, 5M GuSCN) 
to remove DNase and RNase. The silica-nucleic acid pellet was then washed 
twice with 1ml of 70% ethanol to remove GuSCN and to precipitate nucleic 
acids. Finally 1ml of acetone was added. Following the acetone wash, the 
silica pellet was dried at 56°C for 10 minutes using a dry heating block (since 
acetone interferes with PCR reactions it is necessary to dry the pellet well). 
50pl of the elution buffer (Tris/HCl) was added to the dried silica pellet, the 
resulting suspension was mixed well by vortexing and was left at 56°C for 10
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minutes with occasional mixing to allow the silica bound nucleic acids to be 
released. Finally the nucleic acid was pelleted by centrifugation at 10,000g for 
2 minutes at room temperature.
II.4.4. Spectrophotometer
The quantity of nucleic acid extracted was measured using a
spectrophotometer. The RNA or DNA was diluted 1 in 100 using nuclease-free
water and transferred to a cuvette which was placed in a spectrophotometer
The spectrophotometer was calibrated based on a ‘blank’ (i.e. 1ml of nuclease-
free water only). The optical density of the DNA and RNA was read at 260nm
and 280nm. Calculation of nucleic acid purity was based on the ratio o f ODjgo
to OD2 8 0 : if  the ratio of OD2 6 0  to OD2 8 0  is above 1.5 for DNA and above 1.8 for
RNA the nucleic acid prepared is regarded as pure.
Calculation of quantity of nucleic acid (pg/pl):
ODo^ X Constant x Dilution factor 
~  1000
(Constant =50 for DNA and 44 for RNA)
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II.5. M o l e c u l a r  a n a l y s i s  o f  t h e  c e l l s
11.5.1. Reverse Transcription-Polymerase Chain Reaction for CD4
The reverse transcription (RT) reaction mix [PCR buffer II, 4mM dNTP, 5mM 
MgCl2 , 2.5mM Oligo d(T)i6 ] was prepared on ice. 0.3 pg of RNA template was 
added per 20pl RT reaction mix. This was heated to 80°C in a thermocycler 
(Perkin-Elmer; Techne) for 5 minutes to denature the dsRNA, cooled to 4°C 
and then placed on ice before adding MuLV reverse transcriptase (50 
units/20pl RT reaction mix) and 20 units of RNase inhibitor. The complete RT 
reaction mix was returned to the thermocycler immediately and reverse 
transcription was performed as follows:
42°C 60 minutes (reverse transcription)
99°C 5 minutes (inactivation of the reverse transcriptase and
dénaturation of RNA-cDNA duplex)
-  Cool down to 4°C
The cDNA synthesised was kept at -20°C until use. PCR was performed with 
2pl of the cDNA template per reaction as described in II.5.2.
11.5.2. Polymerase Chain Reaction for viral (HIV-1) DNA detection
The PCR mix [PCR buffer II for Ampli-Taq Gold DNA polymerase, or Stoffel 
buffer for Ampli-Taq DNA polymerase, Stoffel fragment, ImM dNTP,
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3.75mM MgClj, IpM  primer, and 2 units of Ampli-7hg Gold DNA 
polymerase or Amç\i-Taq DNA polymerase, Stoffel fragment] was prepared 
on ice in a DNA-free clean room. 0.2pg of the DNA template for DNA PCR or 
2pl o f cDNA from reverse transcription (II.5.1) was added per 20pl reaction 
mix. Nested PCR was performed for HIV proviral DNA detection and p- 
globin primers were used as positive controls. For nested PCR 0.5pl of the 
first round PCR product was used as template. P-actin primers were used as a 
positive control primer for RT-PCR for CD4. The PCR reaction mix was 
heated to 95°C for 5 minutes to denature dsDNA (pre-PCR), cooled to 4°C and 
then transferred onto ice to add the enzyme, Taq DNA polymerase. The 
complete reaction mix was returned to the PCR thermocycler immediately and 
PCR was performed as follows:
95°C 12 minutes for Ampli-7hr^ Gold DNA polymerase
5 minutes for Ampli-Ta^ DNA polymerase 
(pre-PCR dénaturation/activation o f Ampli-TTzg Gold DNA 
polymerase)
95°C 1 minute (dénaturation)
Annealing for 1 minute*
72°C 1 minute (extension)
72°C 10 minutes (extension)
Cool down to 4°C
40 cycles
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* Annealing temperature for T‘ round proviral DNA detection was 50°C and for 
nested reaction was 45°C. The annealing temperature for CD4 cDNA 
amplification was 56°C.
Primers for P-globin and HIV-1 env were quoted from Simmonds et al (1990) 
and synthesized by Perkin-Elmer. Primers for P-actin and CD4 were designed 
by Dr. M. Hope and synthesized by Gibco-BRL.
Table II.2. Primers
Gene Primer sequence (5’-----3 ’) Product size 
(bp)
P-globin
(ist
round)
5’ GGTTGGCCAATCTACTCCCAGG 3’ 535
5’ GCTCACTCAGTGTGGCAAAG 3 ’
p-globin
(Nested)
5’ ACACAACTGTGTTCACTAGC 3 ’ 109
5’ CAACTTCATCCACGTTCACC 3 ’
HIV-1
env
(ISt
round)
5’ TCAGGAAGGGGACCCAGAAATT 3 ’ 501
5’ GATCCCATAGTGCTTCCTGCTGCT3’
m v - 1
env
(Nested)
5’ GGGGAATTTTTCTACTGTAAT 3 ’ 304
5’ CTTCTCCAATTGTCCCTCATA 3 ’
p-actin 5’
TGGGTCAGAAGGATTCCTATGTGG 3’
465
5’ GTCGGCAATGCCAGGGTACATGG 3 ’
CD4 5’ ATAAAGATTCTGGGAAATCAGGGCTCC 
3’
751
5’ TGCAACTTTCCTGTTTTCGCTTCAAGG 3 ’
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TMII.5.3. Quantitation of HIV-1 RNA Load Using NucliSens
Nucleic acid was extracted as described in II.4.3 and used for quantitation of 
HIV-1 RNA load using the following procedure.
11.5.3.1. Amplification
All the reagents used in this part of the experiment were supplied by Organon 
Teknika and were used as per the manufacturer’s instructions. 5pi o f nucleic 
acid suspension was mixed with lOpl of primer mix provided and was left to 
stand at 65°C for 5 minutes to denature the nucleie acids and then placed at 
4 r C  for 5 minutes to anneal the primers. 5pi of the enzyme mix (Avian 
myeloblastosis virus reverse transeriptase, Phage T7 RNA polymerase, and E. 
coli RNase H) was added to the nucleie acids/primers mix. The resulting 
mixture was gently mixed by rotating the tube and incubated at 41°C for 5 
minutes for dsDNA template synthesis. The amplification mixture was 
centrifuged at 10,000g for 30 seconds and was incubated at 42°C for further 90 
minutes to generate ssRNA product.
11.5.3.2. Detection
All the reagents used in this part of the experiment were supplied by Organon 
Teknika and were used as per the manufacturer’s instructions. 5pi o f the
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amplificate and an appropriate amount of the detection buffer to give a dilution 
of 1 in 21 were mixed well. 5pl of the diluted amplificate was added to each 
tube containing 20pl of four oligo-beads/detection probe mix. The resulting 
amplificate/probe-bead mix was incubated at 4TC for 30 minutes to allow 
hybridisation o f probe-bead with diluted amplificate. The hybridised RNA 
with probe-bead was detected by an electrochemieal luminescence technique 
using an automated detection machine and HIV-1 RNA QT software.
II.5.4. Gel Electrophoresis
5pi of loading buffer [20% glycerol, 0.25% bromophenol blue, O.IM EDTA in 
distilled water] was added to the 20pl of the PCR product and lOpl o f the 
mixture was loaded to eaeh well o f a gel. The agarose gel which was prepared 
in Tris-Borate EDTA (TEE) buffer was placed in TEE buffer and run at 70V, 
100mA for 30-40 minutes. Total RNA, genomic DNA, RT-PCR products, and 
PCR products were visualised on a 1% or 1.5% agarose gel in the presenee of 
ethidium bromide under a transilluminator.
II.6. I n  v itr o  i n f e c t i o n  o f  d e n d r i t i c  c e l l s  w i t h  HIV-1
II.6.1. Propagation of Virus
PBMCs from the huffy coat (North London Blood Transfusion Centre) were 
separated as described in 11.2.1. The cells were stimulated with lOU/ml o f rlL- 
2 and lOpg/ml of phytohaemaglutinin (PHA) in R15 medium [serum free 
RPMI1640, supplemented with 2mM L-glutamine, 50U/ml of penicillin, 
50pg/ml of streptomycin, 1.5pg/ml of amphotericine B and 10%, 15% PCS] 
for 3 days. The PHA blasts from the two different donors were mixed and 
resuspended in R15 media at a concentration of 2xlOVml. Viral stock (table 
II.2; kind gift from Prof. J. Weber and Dr S. Beddows, St. Mary’s Hospital, 
London, UK) were added (>125 ID 5 0 ) to the PHA blasts and incubated at 37°C, 
5% CO2  for 2 hours. 3ml o f R15 medium with lOU/ml of rIL-2 was then added 
to the eulture and incubated overnight at 37°C, 5% CO2 . 10  ^o f 3 day-old PHA 
blasts in 5 ml o f R15 media containing rIL-2 were added to the eulture. To 
maintain the viral cultures, half the volume of medium was replaeed twice per 
week and fresh medium containing 3x10^ PHA blasts were added once a week. 
The virus in the supernatant was harvested by eentrifugation at 400g and 
0.2pm filtered. Aliquots of the viral stock were kept at -70°C for viral 
quantifieation (II.6.2) and for in vitro infection study. All the procedures were 
performed in class II hoods in containment level III facility. Concentrations of 
propagated virus were measured by p24 protein ELISA (II.6.2) and results are 
shown in fig.II.3. The p24 protein concentration was evaluated using ‘Growth
(a)
-  120
100
20
0
1.510.50
Mean OD at 405nm
Amount of p24 of 
standard control (ng)/ml
Mean OD at 405nm for 
standard control
0 0.093
0.0316 0.0136
0 . 1 0.0139
0.316 0.217
1 0.425
3.16 0.699
1 0 0.872
31.6 0.969
1 0 0 1.06
(b)
Viral isolate Amount o t pz4 (ngj/ml
JRCSh Day J U.Ô
Day 7 0 . 8
Day 13 1.5
PK106~ Day 3 0.7
Day 7 0.4
Day 13 1.3
JW5 Day 3 0.5
Day 7 0 . 6
Day 13 0.5
Fig.II.3. Virus propgation: measurement of p24 protein production by ELISA
Vims was grown in PHA/IL-2-stimulated HIV-negative PBMCs (II.6.1). Vims in 
supernatants were harvested at different time points indicated and optical density (OD) 
at 405nm was read. Concentrations of p24 protein in each vims stock were evaluated 
from the standard curve (fig.II.3a) and are shown in fig.II.3b.
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Function’ (Excel 97) which allows predicted exponential growth by using 
existing data (i.e. standard curve that were plotted from the ELISA readings of 
known p24 protein concentration). The detection limit was 0.0316ng/ml. The 
highest concentration of p24 protein was obtained between 7 and 14 days of 
culture. For in vzYro-infection studies the viral stocks were used at a final p24 
protein concentration of O.lng/ml.
Table II.3. Viral isolates used to infeet DCs.
Viral isolates Properties
JRCSF M-tropic or R5 strain, laboratory adapted
PE106 Dual-tropic or R5/X4 strain, primary isolate
JW5 T-tropic or X4 strain, primary isolate
II.6.2. p24 Enzyme Linked Immunosorbent Assay (ELISA)
The protocol was developed by Dr S. Beddows, St. Mary’s Hospital, London, 
UK. The anti-p24 antibody (D7320) was diluted 1:100 in Coating Buffer 
(lOOmM NaHCOg, pH adjusted to 8.5 using NaOH). lOOpl o f the diluted 
antibody was added to each well of a 96 well microtitre ELISA plate, covered 
and incubated overnight at room temperature. The plate was washed three 
times with Ix TBS [0.144M NaCl, 0.05% Tween 20, 25mM Tris, pH adjusted 
to 7.5 using concentrated HCl]. 200pl of Blocking Buffer [3% milk powder in 
Ix  TBS] was added to each well and incubated at room temperature for 30
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minutes and washed three times with Ix TBS. The samples to be assessed for 
p24 production were pre-treated with 0.1-0.2% Empigen (detergent) for 30 
minutes at 56°C in a water-bath to inactivate HIV without destroying the 
antigenic epitopes. lOOpl of the empigen-inactivated samples were added to 
each well, covered and incubated overnight at room temperature. The wells 
were washed six times with Ix TBS next day. The biotinylated anti-p24 
antibody was diluted 1:100 in TMT/SS [2% milk powder, 20% lamb serum, 
0.5% Tween 20 in Ix TBS]. lOOpil of the diluted biotin-conjugated anti-p24 
antibody was added to each well and incubated at room temperature for 2  
hours. The plate was washed six times with Ix TBS. The streptavidin-AP was 
diluted to give 2 units/ml. lOOpl of the diluted streptavidin-AP was added to 
each well, incubated at room temperature for 1  hour and washed again six 
times with Ix TBS. 0.1 mg of the substrate (pNPP phosphatase substrate) in 
lOOpl o f Reaction Buffer [lOmM Ethanolamine, 0.5mM MgClj^ pH adjusted to 
9.8 using concentrated HCl] was added to each well and incubated at room 
temperature in the dark until the optical density (OD) of the lOOng/ml control 
was more than 1.0. A p24 antigen control stock [(kind gift from Prof. J. Weber 
and Dr. S. Beddows, St. Mary’s Hospital, London, UK) (1 mg/ml)] was titrated 
in PBS/E/S (0.1% Empigen, 10% lamb serum in PBS) to give a standard curve 
(ie. lOOng/ml, 31.6ng/ml, lOng/ml, 3.16ng/ml, Ing/ml, 0.316ng/ml, O.lng/ml 
and 0.0316ng/ml) and PBS/E/S was used as a negative control. The plate was 
read at an OD of 405nm. Concentrations of p24 protein were evaluated from 
the standard curves which are obtained from OD readings of the p24 antigen
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controls (‘standard control’). The p24 antigen control ELISA was set up in 
duplicate and the standard curves were obtained from the mean OD readings of 
duplicate.
II.6.3. In  Vitro Infection of Dendritic Cells with HIV-1
Virus was treated with DNase (ie. 50 units o f RQl RNase-free DNase). The 
DNase was added to 1ml of virus suspension, mixed well and incubated at 
37°C for 15 minutes on a dry-hot block (Techne). lOOpl of the DNase treated 
viral supernatant was added to 1ml o f the 5 day-old MDDC culture (lOVml;
II.2.5) to give a final p24 protein concentration of O.lng/ml and incubated 
overnight at 37°C, 5% COj. lOOpl o f the DNase treated viral suspension was 
kept to check for presence of HIV proviral DNA. The cells were washed three 
times, resuspended in MDDC culture medium and incubated for a further 5 
days. The supernatant fi*om the culture was collected and kept at -70°C for p24 
ELISA and the cells were harvested for molecular analysis.
II.7. S t a t i s t i c a l  A n a l y s i s
Statistical analyses of allogeneic MLR and flow cytometry data were 
performed using SPSS 10.0 software. Statistical method employed was the 
‘independent-sample T test’ I to comparing two groups (e.g. control vs. 0.1%
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seminal plasma-pulsed MDDCs, control vs. HIV-1 infected MDDCs). The 
equality of variance was assessed by ‘Levene’s test’. If the P values were less 
than 0.05 (i.e. 95% confidence) the results were regarded as significant. Data 
from allogeneic MLRs are presented in the form of stimulation indices (SI) 
with standard errors (SE) unless stated, which were evaluated using following 
equation:
SI = ££Mi ....— ........... (1)
CPM2
P values comparing the general trend curves presented in allogenic MLR data 
were determined based on the slope of each curve which was calculated using 
a Excel 97 software. General trend curves showing statistical significance are 
only presented in the appropriate figures. Data from flow cytometric analyses 
were presented in the form of mean fluorescence intensity (MFI) with standard 
errors and in the form of percentages of positive cells with standard errors. 
The MFI of each marker was determined by subtracting MFI o f isotype 
matched control antibodies from the MFI of specific antibodies. The 
percentages of positive cells were determined by comparison with cells 
incubated with isotype matched control antibodies. Positive markers were 
placed on profiles so that less than 2 % of cells stained with isotype control 
antibody fell within this marker. The degree of increase or decrease in levels o f 
expression (or % positive cells) was calculated using following equation:
AMFI tor % positive cells) ^
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MFIj (or % positive cells)
(Where AMFI (or % positive cells) is difference in mean fluorescence 
intensities (or % positive cells) between control and treated MDDCs; MFI, (or 
% positive cells) is MFI (or % positive cells) of control MDDCs.
I I . 8 .  R e a g e n t s  a n d  s u p p l i e r s
Acetone Merck
Agarose Sigma
Antibodies Refer Table II. 1.
Anti-p24 antibody (D7320) NIBSC
Biotinylated anti-p24 antibody NIBSC
Brefeldin A (BFA) Sigma
Bromophenol blue Sigma
C-18 reverse phase column SepPak, Waters
CD 14 MicroBeads Milltenyi Biotec
Chloroform Sigma
Diemethyl sulphoxide (DMSO) Sigma
DNA ladder marker Gibco-BRL
Earls balanced salt (EBS) medium Sigma
Empigen Calbiochem
Ethanol Merck
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Ethanolamine Sigma
Ethidium bromide Sigma
Ethylenediamine tetraacetic acid (EDTA) Sigma
F ACS permeablising solution 
Foetal calf serum (FCS) 
Glycerol
[^H]-thymidine 
Histopaque 
lonomycin 
Isopropanol 
Lactic acid 
Lamb serum
Magnesium Chloride (MgClz) 
Medicol Medium Isotonic 
Nuclease-free water 
NucliSens HIV-1 RNA assay kit 
01igod(T),6 
P24 antibody (D7320)
PCR reagents
Becton Dickinson
Sigma
Sigma
GM-CSF (Lucomax 1.11x10^ units/mg) Norvatis
Amersham Pharmacia Biotec
Sigma
Sigma
Sigma
Sigma
Gibco-BRL
Sigma
Medi-Cult
Biogenesis
Organon Teknika
Perkin Elmer
NIBSC
Perkin Elmer
(Buffer, MgCl2 , dNTP, Amç\i-Taq DNA polymerase) 
pNPP phosphatase substrate Sigma
Phosphate buffered saline (PBS) Sigma
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Phorbol 12-Myristate 13-Acetate (PMA) Sigma
Phytohaemaglutinin (PHA) Sigma
Primers Perkin Elmer/Gibco-BRL
Pyruvic acid
Recombinant IL-2 (rIL-2) 
Recombinant IL-4 (rIL-4) 
Prostaglandin E 
19-OH prostaglandin E2 
Reverse transcriptase (MuLV) 
RNAzol™ B 
RNase inhibitor 
RPMI 1640 medium 
RQl-RNase-free DNase 
Sodium Azide (N aN j 
Sodium bicarbonate (NaHCOg) 
Sodium chloride (NaCl) 
Sodium citrate 
Streptavidin-AP 
TNF-a 
Tri reagent™
Tri-Borate EDTA (TBE)
Trizma
Trypan blue
Sigma
Sigma
Sigma
Calbiochem
Cayman
Perkin Elmer
Biogenesis
Perkin Elmer
Sigma
Promega
Sigma
Sigma
Sigma
Sigma
Boehringer Mannheim
Sigma
Sigma
Sigma
Sigma
Sigma
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Tween 20 Sigma
Supplier addresses:
Amesham Pharmacia Boitech 
Becton Dickinson 
Biogenesis
Boehringer Mannheim 
Cayman
Calbiochem
Gibco-BRL, Life Technoligy
Medi-Cult
Merck
Milltenyi Biotec
NIBSC
Novartis
Organon Teknika 
Perkin Elmer 
Promega 
SepPak, Waters 
Sigma
Cambridge, U.K.
Oxford, U.K.
Poole, Dorset, U.K.
Lewes, East Sussex, U.K. 
Alexis Corporation-Europe, 
Bingham, Nottingham, U.K. 
CN Biosciences (UK) Ltd, 
Beeston, Nottingham, U.K. 
Paisley, U.K.
Surrey, U.K.
Luttrworth, U.K.
Bisley, Surrey, U.K.
Potters Bar, Hertfordshire, U.K. 
Famborough, Hampshire, U.K. 
Cambridge, U.K.
Warrington, Cheshire, U.K. 
Southampton, U.K.
Watford, Hertfordshire, U.K. 
Poole, Dorset, U.K.
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III
E v a l u a t io n  o f  Sp e r m -W a s h in g  a s  a  
P o t e n t ia l  M e t h o d  o f  R e d u c in g  H IV  t r a n s m is s io n  in  
H IV -D is c o r d a n t  C o u p l e s  W is h in g  t o  H a v e
C h il d r e n
I I I . l .  I n t r o d u c t io n
Semen is an important vehicle in sexual transmission of HIV-1 and thus the level 
of virus in semen may be an important factor affecting the rate o f transmission. 
HIV-1 is present in semen both as cell-free virus (Vemazza et al, 1996; Liuzzi et 
al, 1995; Liuzzi et al, 1996; Menzo et al, 1992; Gupta et al, 1997; Baccetti et al, 
1991; Bagasra et al, 1988; Bagasrra et al, 1990; Rasheed et al, 1995; Coombs et 
al, 1998; Dyer et al, 1996) and non-sperm cell-associated virus (Vemazza et al, 
1996; Baccetti et al, 1991; Bagasra et al, 1988; Bagasra et al, 1990), in particular 
associated with T lymphocytes and macrophages (Quyale et al, 1997). However, 
whether spermatozoa are infected with HIV remains controversial. A number o f 
groups have presented data suggesting that HIV attaches to, and infects, 
spermatozoa (Bagasra et al, 1988; Bagasra et al, 1994; Baccetti et al, 1994; 
Scofield, 1992; Scofield et al, 1994; Gobert et al, 1990), possibly via CD4-like 
molecules (Ashida and Scofield, 1987; Bagasra et al, 1994; Socfield et al, 1992;
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Scofield et al, 1994; Gobert et al, 1990), however some groups have failed to 
detect CD4 expression on sperm (Wolff and Anderson, 1988®; W olff and 
Anderson, 1988^; El-Demiry et al, 1986). If  CD4 or CD4-like molecules are 
present on sperm they could play an important role in infection of sperm with 
HIV-1 since CD4 is the primary cell receptor for HIV-1. Whilst some laboratories 
have provided evidence that spermatozoa are infected with HIV (Bagasra et al, 
1988; Bagasra et al, 1994; Baccetti et al, 1991; Baccetti et al, 1994 Scofield et al, 
1994) others could not detect HIV-1 particles or proviral sequences in 
spermatozoa (Mermin et al, 1991; Van Voorhis et a l ,\9 9 \ \ Quayle et al, 1997).
There are a number of discordant couples, in whom the male is HIV positive and 
the woman HIV negative, who wish to have children. To conceive, they must 
abandon condom-protected intercourse risking HIV transmission to the woman 
and subsequently to her child. Semprini et al have conducted a program of 
assisted conception for such discordant couples since 1989 to minimise the risk of 
HIV transmission (Semprini et al, 1992). The assumption in this program was that 
spermatozoa are a reservoir for HIV in semen and therefore the spermatozoa are 
washed to remove seminal plasma and non-sperm cells (NSCs) by gradient 
centrifugation and ‘swim-up’ procedures, before use in artificial insemination. 
Such ‘sperm washing’ may reduce the amount of virus present in the 
spermatozoa sample, or even eliminate it completely, but this has previously only 
been evaluated by the relatively insensitive method of antibody detection o f viral 
antigen on the processed sperm (Semprini et al, 1992). Artificial insemination 
timed with ovulation may also minimise the number of exposures o f the
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uninfected female partner to potentially infected material. To date Semprini’s 
group have already carried out 1,690 inseminations for 543 couples resulting in 
almost 240 pregnancies with no seroconversion in mothers or their babies 
(Semprini, personal communication, 1999). Also, Marina et al reported that 101 
inseminations using washed spermatozoa resulted in 31 pregnancies and both 28 
mothers (3 miscarriages) and their 37 babies remained HIV seronegative (Marina 
et al, 1998). The aim of this part o f thesis was to determine where HIV resides in 
semen. In particular we wished to determine whether HIV associates with 
spermatozoa, or are infected or have the potential to be infected by HIV and thus 
to evaluate whether ‘sperm washing’ is effective in risk reduction. A summary of 
methods used for ‘sperm washing’ and assays performed in this chapter are 
illustrated in fig.III.l.
III.2. Results
III.2.1. HIV-1 RNA Load in Seminal Fractions and Blood Plasma
Blood and semen samples were obtained from eleven HIV-1 positive patients with 
blood CD4 counts of 93-786 cells/pl. Whole semen was separated into plasma, 
live ‘swim-up’ spermatozoa and NSC by differential gradient centrifugation 
followed by a ‘swim-up’ process (fig.III.l). The ‘swim-up’ procedure reduced the 
sperm count by up to one log compared with that in the whole ejaculate as 
reported by others (Lasheeb et al, 1997). The level of viral RNA in spermatozoa
Fig.III.l. Diagram showing semen sample preparation and analyses of each 
seminal component
Each semen sample was separated into seminal plasma, non-spermatozoa and 
motile spermatozoa by differential centrifugation over 40%/80% Medicol 
Medium Isotonic (MMI) followed by a ‘swim-up’ process. All three fractions 
were assessed for HIV-1 RNA load and presence of viral DNA. Expression of 
CD4, CCR5 and CXCR4 on non-sperm cells and spermatozoa were analysed by 
flow cytometry.
Sample preparation Analysis
Seminal fluid
40% MMI
80% MMI
Centrifugation
HIV-1 RNA load assay
Seminal plasma
NSC fraction
Spermatozoa 
(dead/less motile)
Live spermatozoa
HIV-1 RNA load assay 
HIV-1 viral DNA assay 
Expression of CD4 
CCR5 
CXCR4
Wash pellet containing 
live spermatozoa and 
incubate (‘swim-up’)
^—  Motile spermatozoa
HIV-1 RNA load assay 
HIV-1 proviral DNA assay 
Expression of CD4 
CCR5 
CXCR4
100
was compared with that in whole semen and in blood plasma. Viral load assays 
were performed using a commercial assay, NucliSens™ which has previously 
been reported to be a more reliable assay for evaluation of viral load in semen 
samples compared with Amplicor (Roche) (Dyer et al, 1996). It has also been 
shown that semen has inhibitory activity against Taq DNA polymerase resulting 
in insufficient viral load assay (Dyer et al, 1996), and we demonstrated that 
inhibition could be avoided by extraction of RNA with silica as employed in the 
NucliSens™ system. The assay was performed on lOOpl of blood plasma, lOOp-1 
of seminal plasma (diluted 1:4), lOOpl unseparated semen (diluted 1:10), 1-10 x 
10  ^ spermatozoa, or 1-10 x 10  ^ NSCs. Frozen and thawed blood plasma and 
seminal plasma samples were used. NSCs and spermatozoa fractions in lysis 
buffer were snap frozen prior to the assay (II.4.3. and II.5.3). The aim was to 
determine where HIV was located and also to examine whether ‘sperm washing’ 
significantly reduced the viral load in the spermatozoa to be used for 
insemination. Table III.l illustrates that in all semen samples the ‘swim up’ 
procedure reduced the amount of virus in the spermatozoa to lower than the 
detection limit (LDL; ranged from 20 to 80 copies per ml per sample tested). HIV- 
1 RNA was not detected in the non-swim up spermatozoa or the 80%/40% 
interface (non-motile spermatozoa). The NucliSens™ assay incorporates three 
standard calibrators into each sample before RNA extraction, which demonstrates 
efficient RNA extraction and amplification for every sample tested. The 
calibrators amplified with the same efficiency in all samples tested (with the 
exception of patient 6  in the spermatozoal fraction) and therefore there was no 
evidence to suggest that there was any variation in the extraction o f RNA or
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amplification between fractions tested. No evidence that spermatozoa, even when 
dead or non-motile, were reservoirs of HIV RNA, was found. Four out of eleven 
samples were positive for HIV RNA in the NSC fraction, all o f whom had 
significant viral loads in the whole semen sample. The data in Table III. 1 indicates 
that the viral reservoirs in semen are the seminal plasma and the NSCs.
III.2.2. Proviral DNA Detection in Seminal Cells and PBMCs
It was possible that washed spermatozoa may contain latent virus in the form of 
integrated proviral DNA. Therefore each o f the seminal fluid cellular fi-actions 
and PBMCs were tested for HIV-1 DNA by nested PCR (II.5.2) using primers 
designed to specifically amplify a highly conserved region o f the HIV-1 envelope 
region and primers for P-globin as a positive control. DNA from PBMCs (10^ 
cells) was extracted using Tri Reagent™ (II.4.1). Only a small number o f NSCs 
(between 3x10^ and 5x10^ total) were recovered and therefore initially Tri 
Reagent™ was used as this allows extraction of both DNA and RNA fi*om same 
sample. However, this method was not efficient in extracting DNA and also the 
nucleic acid extracted was not amplified by PCR due to PCR inhibitory factors in 
semen (Dyer et al, 1996) as mentioned above. Thus extracting DNA by the silica 
capturing method of the NucliSens™ (II.4.3) was used as an alternative when 
extracting DNA firom semen, spermatozoa and NSCs. We have also found that 
spermatozoa were not easily lysed using Tri Reagent^^.
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The sensitivity of the DNA PCR was tested by isolating and amplification of 
DNA from a defined number of OMlO.l cells (NIBSC); each cell carries a single 
copy of HIV proviral DNA. By logarithmic end point dilution of the DNA and 
PCR using P-globin and the HIV e^v-primers it was demonstrated that these 
products were amplified with the same efficiency, and that the PCR could detect 
an input of 1 to 10 P-globin or HIV env sequences i.e. 1-10 cells (fig.III.2). A 
negative result was concluded only if  the sample was negative in three separate 
experiments. Ten o f the eleven patients had viral DNA present in PBMCs, 
unfractionated semen and NSCs. Patient 4 did not have detectable viral DNA 
present in PBMCs or NSCs although the unfractionated semen sample was 
positive in two out of three reactions (fig.III.3). Patient 4 also did not have 
detectable viral RNA in any of the compartments studied (Table III.l). Viral DNA 
was undetected in all spermatozoa samples analysed (Fig.III.3).
III.2.3. Expression of CD4 and HIV-1 co-receptors on seminal Cells
The potential of the spermatozoa to be infected by HIV-1 or the possibility that 
virus could simply attach to the spermatozoa cell surface was determined by 
evaluating expression of CD4 or the HIV co-receptors CCR5 or CXCR4 by flow 
cytometry in these cells (II.3.1). The data illustrated in Fig.III.4 are representative 
(sample 1) of the profiles obtained from 5 healthy volunteers. The percentages of 
positive cells were determined by comparison with cells incubated with isotype 
matched control antibodies. Positive markers (M l) were placed on profiles so that 
less than 2 % of cells stained with isotype control antibody fell within this marker.
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Fig.III.3. Viral DNA detection by Nested PCR
Viral DNA in peripheral mononuclear cells and seminal cellular components were assessed 
by a nested PCR and visualized on 1.5% agarose gel in the presence of ethidium bromide. 
The representative gel shown is patient 7 (a). The assay result from patient 4 shows that 
proviral DNA was detected only in unffactionated semen (b). Lane 1 represents P-globin 
gene amplification (product size 109 bp). Lane 2 represents HIV-1 envelope gene 
amplification (product size 304 bp).
(a)
Patient 7
M 1 2 1 2 1 2 1 2
Patient 1 + + + + 4- 4- 4- -
Patient 2 + + + - 4- — 4- —
Patient 3 + + + + 4- 4- 4- -
Patient 4 + - + 4- 4- - 4- -
Patient 5 + 4- + 4- 4- 4- 4- —
Patient 6 + + + 4- 4- 4" 4- -
Patient 7 + + + 4- 4- 4- 4- -
Patient 8 + + + 4- 4- 4- 4- -
Patient 9 + + + 4- 4- 4- 4- -
Patient 10 + + + 4- 4- 4- 4- —
Patient 11 + + + 4- 4- 4- 4- -
HIV-1 env (304 bp) 
P-globin (109 bp)
PBMC Semen NSC Sperm
(b)
PBMC Semen NSC Sperm
1 0 0  bp
Patient 4
HIV-1 env (304 bp) 
P-globin (109 bp)
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The ‘swim-up’ procedure yielded very pure populations o f spermatozoa cells 
(Fig.III.4g). Fig.IIL4h and Fig.III.4j demonstrate absence of detectable CD4 and 
CCR5 on the spermatozoa cell surface. Two different clones of anti-CD4 
antibodies were used (fig.III.4h for Q4120 and fig.III.5c for MT310). Low levels 
o f CXCR4 expression were observed (Fig.III.4i) on spermatozoa. Whether this 
level of CXCR4 would be sufficient to allow X4 viruses to bind must be 
confirmed in vitro, although lack of expression of CD4 and CCR5 on spermatozoa 
suggests that these cells are very unlikely to be readily infected with R5 strains. 
Within the NSCs a population o f cells exists with intense expression o f CD4 
(Fig.III.4b). These cells may be CD3^ lymphocytes or monocytes as shown by 
expression of CD 14 (Fig.III.4e). Within the NSC low levels of CXCR4 were 
detected compared with the isotype control (fig.III.4c), but there was a distinct 
population of CCR5 expressing cells (Fig.III.4d). This may suggest the possibility 
of compartmentalisation of CCR5 utilising viruses within semen which is 
discussed below. A summary of phenotypic analyses of seminal cells obtained 
from 5 heath individuals is illustrated in table III.2.
To determine whether seminal cells co-express both CD4 and CCR5 or CD4 and 
CXCR4, two colour staining was attempted but was not successful:
i) Staining cells with anti-CD4 antibody first, followed by washing and staining 
with anti-CCR5 antibody (fig.III.6 a) or anti-CXCR4 antibody (fig.III.7a).
ii) Staining cells with anti-CCR5 antibody (fig.in.6 b) or anti-CXCR4 antibody 
(fig.III.7b), followed by washing and staining with anti-CD4 antibody.
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iii) Staining cells with anti-CD4 antibody and anti-CCR5 antibody (fig.III.6 c) or 
anti-CXCR4 antibody (fig.III.7c) together at the same time.
As shown in fig.III . 6  and III.7 the cells were only stained with first antibody or 
did not stain at all when stained as in (iii). This could be due to the fact that CD4 
and HIV-1 co-receptors are expressed close to each other on the cell surface 
(‘steric hindrance’) (Xiao et al, 1999; Lapham et al, 1999).
Table III.2. Summary of phenotypic analyses of seminal cells from HIV-1 
negative individuals
(a) Percentages o f NSCs expressing CD4, CCR5, CXCR4 or CD 14.
CD4 CCR5 CXCR4 CD14
Sample 1 43.2% 19.0% 9.4% 14.7%
Sample 2 44.0% 11.5% 6.2% 8.6%
Sample 3 24.8% 23.0% 5.8% 18.1%
Sample 4 38.8% 2T2% 7.8% 10.4%
Sample 5 41.3% 18.1% 8.9% 18.5%
Mean±SE 38.8+3.5 18.6+1.9 7.6+0.7 14.0+2.0
(a) Percentages of spermatozoa expressing CD4, CCR5 or CXCR4.
CD4 CCR5 CXCR4
Sample 1 0.8% 0.03% 10.2%
Sample 2 1.0% 0.5% 7.5%
Sample 3 0.8% 0.5% 2.7%
Sample 4 0.6% 1.6% 7.5%
Sample 5 1.0% 0.5% 7.5%
Mean+SE 0.8+0.07 0.6+0.3 7.1+1.2
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111.2.4.RT-PCRfor CD4
Expression o f CD4 on spermatozoa was undetectable by flow cytometry 
(fig.IIL4h). To confirm the data obtained by flow cytometry, expression o f CD4 
was also examined at the mRNA level by RT-PCR (II.5.1) using P-actin primers 
as a positive control. RNA from PBMC (10^ cells) was extracted using Tri 
reagent™ (IL4.1.1.) and from spermatozoa using NucliSens™ Lysis buffer. 
Again, extraction of RNA from the seminal cellular fraction was attempted using 
Tri reagent™ and RNAzol™ B (II.4.2) but failed. Spermatozoa did not appear to 
be lysed using Tri reagent™ and RNAzol™ B. The results demonstrated that CD4 
mRNA was not detectable in spermatozoa (fig.III.8 ) thus confirming the flow 
cytometry data.
111.2.5. Establishing a clinical service of ‘sperm-washing’ for HIV-discordant 
couples
Together with the Assisted Conception Unit, the Obstetrics and Gynaecology 
department and the HIV medicine department at Chelsea & Westminster Hospital 
we now provide a ‘sperm-washing’ service to HIV discordant couples. Patients 
undertake a series of counselling sessions and sign a consent form indicating that 
they understand that they are participating in a risk reduction, not a risk-free 
programme. Prior to receiving the ‘sperm-washing’ service both male and female 
partners undertake sexual health and gynaecology screens (table III.3).
PBMC Sperm
I II 1
M / 6»^ /
751 bases (CD4)
465 bases (P-actin)
Fig. III.8. RT-PCR for CD4 mRNA from PBMC and spermatozoa
RNA was extracted from PBMC (positive control RNA) using Tri reagent and from 
spermatozoa using NucliSens Lysis buffer. cDNA was synthesised using oligo d(T)i6  and 
MuLV reverse transcriptase followed by PCR for P-actin as a positive control and CD4. 
The RT-PCR products were visualised on 1.5% agarose gel in the presence o f ethidium 
bromide with lOObp marker (M).
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Semen sample preparation and analysis are carried out in the Immunology 
department. In v/Yro-fertilisation (IVF) medium is incubated at 37°C, 5% CO2  
overnight prior to semen preparation. The semen samples are processed within 
one hour of donation as described in II.3.2, except that Medicol Medilum Isotonic 
(MMI) was replaced by PureSperm® as MMI is commercially no longer available. 
Semen parameters are initially assessed as outlined by the World Health 
Organisation (table III.4).
Table III.4. Normal semen parameters outlined by WHO
Volume >2 .0 ml
pH 7.2-8.0
Sperm concentration >2 0 x 1  oVml
Total sperm count > 1 0 0 x 1 0 *
Motility >50% with forward progression 
or
25% or more with rapid 
progression within 60 minutes 
o f ejaculation
Morphology >30% with normal forms
Vitality >75% live
White blood cell count <2 x 1  o V l
Immunobead test <2 0 % spermatozoa with 
adherent particles
MAR test < 1 0 % spermatozoa with
(test for presence of IgG 
on the spermatozoa)
adherent particles
A fraction of the purified spermatozoa cells to be used for the HIV-1 RNA test 
( 1 0  ^cells) is snap frozen and thawed quickly prior to the assay to ensure complete 
cell lysis since we found that spermatozoa cells are not readily lysed by other 
methods. HIV-1 RNA levels in the purified spermatozoa cell fraction are 
quantitated using NucliSens™ (10^ cells per test). The woman is inseminated with
‘washed’ sperm only when HIV-1 RNA load in the tested fraction o f washed
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sperm is below the detection limit. Each patient may undergo three insemination 
attempts and if the woman fails to become pregnant after three attempts, the 
couple may be advised to receive in vitro fertilisation with washed sperm. Table 
III.5 illustrates semen and purified spermatozoa analyses. The motility of 
spermatozoa after ‘Sperm-washing’ procedure was between 85% and 100%. In 
some patients, motility of sperm cells and total sperm counts in whole semen were 
lower compared with normal semen parameters outlined by WHO (table III.4). 
This may be because HIV interferes with spermatogenesis. Arrested 
spermatogenesis in the testes in AIDS has been reported (Muciaccia et al, 1998). 
It also has been shown that TNF-a, which has been shown to be increased in 
blood plasma of HIV patients (Lore et al, 1999), has negative effects on sperm 
motility (Estrada et al, 1997). Spermatogonia express galactosylceramides (Brogi 
et al, 1995) which is a component of the neural receptor for HIV (Bath et al, 
1991; Harouse et al, 1991), suggesting that this glycolipid could be involved in a 
potential interaction of HIV with spermatogonia, but this hypothesis has not been 
confirmed. Following 63 inseminations in 31 women, 12 women have become 
pregnant. However, 5 miscarriages have occurred but there have been 3 live births 
with 4 currently ongoing. In addition 9 women have undergone IVF treatment 
resulting in 1 pregnancy. All these women have remained seronegative.
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III.3. D isc ussio n
The viral reservoir in semen was investigated and furthermore, whether 
spermatozoa are infected or have potential to be infected with HIV was also 
determined. Whether spermatozoa are infected with HIV has been controversial. 
This is of particular importance in the evaluation o f ‘sperm washing’ as a viable 
risk reduction option for HIV discordant couples wishing to have children. We did 
not demonstrate the presence of CD4 on the spermatozoa cell surface using two 
different clones of anti-CD4 antibodies and also mRNA for CD4 was not 
detected. There was no surface expression of CCR5 on spermatozoa. Although a 
low level o f CXCR4 expression was observed it would be very unlikely that 
spermatozoa are susceptible to infection with HIV since we demonstrated clearly 
that there was no detectable surface expression of CD4 on spermatozoa cells or 
CD4 mRNA in spermatozoa cells. Neither HIV-1 RNA nor DNA was detected in 
any spermatozoa fraction of any of our subjects. Our data demonstrate that ‘sperm 
washing’ achieves substantial reductions in the level of virus present, although 
due to our sample size it is not possible to guarantee that the LDL would be 
achieved with all patients. Our data is in concordance with clinical data from 
Semprini and colleagues where no HIV infection has occurred after 1,690 
inseminations with washed sperm (Semprini, 1999, Personal communication). 
Our data was further supported by recent studies led by Izopet (Pasquier et al, 
2000) who demonstrated removal of HIV-1 after a ‘sperm washing’ process. A 
study by Lasheeb et al indicated that ‘sperm washing’ reduced HIV viral load in 
semen, although in this case the spermatozoa were separated after freezing o f the
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semen sample, which could result in cell lysis, allowing RNA contamination of 
the cellular compartments (Lasheeb et al, 1997). In our experiments semen was 
donated from patients with a range of viral loads in peripheral blood (LDL to 400, 
000 copies ml'^). Six individuals had HIV RNA present in the seminal plasma, 
four of whom had viral RNA present in the NSCs. Nine individuals had 
detectable proviral DNA in the NSC. The main viral reservoir in semen was the 
seminal plasma and NSC (Table III.l). The NSCs represent a heterogeneous 
population containing immature germ cells, leukocytes and epithelial cells. The 
leukocyte fraction contains CD6 8 ^ macrophages, CD3^ T cells (both CD4^ and 
CD 8 ^) and CD 103^ T cells which are found in the epithelium and lamina propria 
(Quayle et al, 1997). The main reservoir for HIV appears to be the lymphocyte 
and macrophage populations, but not the immature germ cells (Quayle et al, 
1997). Poor correlation was found between the viral load in semen and that in 
peripheral blood (Table III.l). For example patient 5 had 380,000 copies ml'^ in 
blood and LDL in semen, and patient 9 had only 1,200 copies per ml in blood but 
56,000 copies ml'^ in unfractionated semen. Other groups report similar findings 
(Liuzzi et al, 1996; Coombs et al, 1998; Gupta et al. 1997). Shedding of virus into 
semen may be intermittent with the level of seminal virus increasing with factors 
such as decreased CD4 count and asymptomatic genital tract infection (Vemazza 
et al, 1997; Xu et al, 1997). Therefore because the presence of HIV in blood 
plasma is not always correlated with its presence in semen, detection o f virus in 
blood plasma may not be a good surrogate for infectivity via sexual transmission. 
The data also suggests that blood and semen may represent two distinct 
compartments in terms of HIV replication. There is some evidence provided by
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other groups (Rasheed et al, 1995; Liuzzi et al, 1996; Liuzzi et al, 1995; Gupta et 
al, 1997; Coombs et al, 1998; Zhu et al, 1996; Delwart et al, 1998; Kiessling et 
al, 1998; Bym et al, 1997; Roos et al, 1992) as discussed in chapter I, suggesting 
that HIV in semen may not arise from the same reservoir as in peripheral blood.
It has been postulated that during sexual transmission of HIV the selection o f the 
R5 viruses takes place at the mucosal surface, since it is the Langerhans cells 
(LCs) which may be the first cells to become infected (Spira et al, 1996; Blauvelt, 
1997; Zambruno et al, 1995; Miller and Hu, 1999), and these cells express 
functional CCR5 but not CXCR4 (Zaitseva et al, 1997). It has been postulated 
that semen is a major reservoir for the CCR5 utilising viruses thus allowing 
preferential transmission of R5 strains. This hypothesis is supported by 
phenotypic and genotypic analyses of viral isolates from blood and semen (Zhu et 
al, 1996; Kroodsma et al, 1994) which found predominantly M-tropic virus 
present in semen regardless of the tropism of virus found in the periphery. We 
have shown that the NSCs express CCR5, but negligible amounts o f CXCR4 
suggesting that this may contribute to the selection of R5 viruses within semen. 
However, restriction o f SI variants from the male genital tract is not always 
observed (Delwart et al, 1998). As sexual transmission accounts for the vast 
majority o f HIV transmission it is of pivotal importance to determine whether the 
virus within semen represents a distinct compartment of viral replication and 
hence viral phenotype. An effective prophylactic vaccine must confer protection 
against the phenotype shed in genital secretions.
I l l
‘Sperm washing’ as a risk reduction program has been a controversial area. 
Mandelbrot et al (Mandelbrot et al, 1997) believe the risk of transmission is 
sufficiently low that HIV discordant couples may attempt natural conception. 
They report a follow up of 92 HIV negative women with HIV positive partners. 
Most couples had received pre-conceptual counselling on the risk o f transmission, 
and were advised to pinpoint ovulation to reduce the risk. Two women 
seroconverted at seven months of pregnancy and another two post-partum, with 
séroconversions restricted to couples with inconsistent condom use. Perhaps 
advising individuals that they may abandon condoms to conceive may encourage 
intermittent condom use. Our data suggest that isolating the sperm for 
insemination could greatly reduce such a risk.
Antiretroviral therapy has a marked effect on HIV shedding in semen, as 
treatment-induced changes in viral load in blood are generally reflected by 
corresponding changes in viral load in semen (Vemazza et al, 1997). Thus a 
further risk reduction exercise might be to encourage all HIV’*’ males who wish to 
participate in such a programme to consider commencing potent antiretroviral 
therapy, however the teratogenicity of many of the dmgs currently in use has not 
been completely evaluated. Our data suggests that the primary reservoir for HIV 
RNA in semen is the seminal plasma and NSC, and that the level of viral RNA 
could be reduced to LDL in the washed spermatozoal fraction. Secondly all the 
spermatozoa fractions analysed for latent proviral DNA in this study were 
negative where the unfiractionated semen ( 1 0  out o f 1 1  patients) were positive. 
We have failed to detect the presence of CD4 or CCR5 on spermatozoa and the
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expression o f CXCR4 on the spermatozoa was low, suggesting that these cells are 
not likely to be readily infected by HIV. Therefore, we provide evidence to 
suggest that ‘washing sperm’ reduces the amount of HIV present and hence will 
reduce the risk of HIV transmission. Taken together with the clinical data from 
Semprini’s group we would promote ‘sperm washing’ as an efficient and simple 
procedure to reduce the risk o f HIV transmission in HIV discordant couples 
wishing to have children. Furthermore, it has been shown that the ‘sperm- 
washing’ process also reduced the risk of hepatitis C virus infection (Pasquier et 
al, 2000). We have tested for the presence of hepatitis C virus in purified 
spematozoa in one patient with known hepatitis C status and hepatitis C virus was 
undetected (data not shown). The ‘sperm-washing’ service is in the place within 
this hospital trust and we have performed 63 artificial inseminations in 31 women 
with 12 pregnancies and 3 live births.
Further work
i) Characterisation of the virus present in semen
Our data demonstrated that there is a distinct population of cells expressing CCR5 
in NSC fraction. The tropism of the virus in semen could be determined.
ii) In vitro infection of LCs or LC-like DCs with viral isolates from semen 
Whether viruses in semen can infect LCs or LC-like DC could be assessed 
(chapter V).
iii) In vitro infection of spermatozoa with X4 strains o f HIV-1
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Although we have demonstrated that spermatozoa do not express CD4 on the cell 
surface (Fig.III.3i) and do not produce mRNA for CD4 (fig.III.6 ) there was a low 
level of CXCR4 expressed on spermatozoa. To further analyse whether 
spermatozoa may be infected with HIV-1, in vitro infection o f spermatozoa with 
virus could be performed.
iv) In vitro infection of NSCs with HIV-1
In vitro infection of NSCs with X4 strains o f HIV-1 would allow assessment of 
whether the level of CXCR4 on NSC is in fact sufficient for infection with X4 
viruses.
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IV
Im m u n o m o d u l a t o r y  e f f e c t s  
OF Se m in a l  p l a s m a  o n  D e n d r it ic  c e l l s
I V . l .  I n t r o d u c t i o n
Dendritic cells (DCs) are bone marrow derived cells [except for the follicular 
DCs that are present within the B-lymphoid follicles of lymphoid tissue 
(Matsumoto et al, 1997)] and are the most potent antigen presenting cells 
(APCs). DCs initiate primary immune responses as they can take up, process 
and present antigens to and stimulate naïve T cells. Mature DCs are more than 
100 times more potent than macrophages in activating naïve T cells in vitro 
(Banchereau and Steinman, 1998). DCs can also potentiate secondary immune 
responses by presentation to and stimulation of memory T cells. DCs at 
different maturation stages are found in both the non-lymphoid and the 
lymphoid tissues. DC progenitors migrate to non-lymphoid tissues, where they 
develop into ‘immature’ DCs. The ‘immature’ DCs have high capacity for 
capturing and processing antigen but poor T cell stimulatory capacity as they 
have little or no co-stimulatory activity (Austyn, 1998; Banchereaue and 
Steiman, 1998; Hart, 1997; Celia et al, 1997). ‘Immature’ DCs in tissues 
include Langerhans’ cells (LCs) in the epidermis of skin and the mucosa. LCs 
take up antigen by macropinocytosis or by mannose receptor-mediated 
endocytosis (Sallusto et al, 1995). Pro-inflammatory cytokines such as TNF-a,
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IL -ip  (Sallusto and Lanzavecchia, 1994; Sallusto, et al, 1995) and IL - 6  
(Jonuleit, et al, 1997), and also the uptake of antigen, induce activation in 
vitro. The activated DCs migrate to the draining lymph nodes where they 
mature. Mature DCs have poor ability to capture and process antigen but 
express increased levels o f cell-surface MHC class II and co-stimulatory 
molecules [e.g. CD80/B7.1, CD86/B7.2 and B7-DC (Tseng et al, 2001)]. 
Hence the mature DCs acquire the ability to present antigen acquired at the 
immature stage and can activate naïve T cells via a co-stimulatory.
Both semen and LCs in the mucosa may play an important role in transmission 
of sexually transmitted diseases (STDs). For example, in HIV infection via 
sexual contact, LCs in the lamina propria of the mucosa may be the first cells 
to become infected (Spira et al, 1996; Joag et al, 1997; Blauvelt et al, 1997; 
Zambruno et al, 1995; Miller and Hu, 1999) and semen is the vehicle for the 
virus. Seminal plasma also contains immunosuppressive components such as 
prostaglandins, prostasomes, polyamines and TGF-p (Alexander and 
Anderson. 1987; Kelly, 1995). It is known that prostaglandins which are 
present in human semen at about 1 0  ^ fold higher concentrations than in 
peripheral blood (Kelly, 1997^), have immunomodulatory effects. For 
instance, prostaglandin E2 (PGE2) is a pro-inflammatory molecule and 
activates/matures DCs and subsequently induce IE-12 production by DCs 
(Riesser et al, 1997; Riesser et al, 1998; Portanova et al, 1996). PGE2, is also 
known to inhibit the production of pro-inflammatory cytokines by 
lipopolysaccharide (LPS)-activated macrophages (Strassmann et al, 1994). 
Thus, PGE2 inhibits LPS-induced IL-12 production by macrophages and
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stimulates IL-10 production in whole blood culture (Kraan et al, 1995; Kelly 
et al, 1997^). This cytokine switch to Th2-type may induce anergy or 
peripheral tolerance. Taken together, PGE2 has both pro-inflammatory and 
suppressive activities for APCs. Prostaglandins in human seminal plasma 
include four main species which are 19-hydroxy PGE2, 19-hydroxy PG El, 
PGEl and PGE2. 19-OH PGEl and 19-OH PGE2 are, as far as is known, 
unique to semen (reviewed by Kelly, 1997*’). Cells in the mucosa of female 
reproductive tract do not recognise and respond to sperm or non-sperm cells in 
seminal fluid as foreign antigens, however, at the same time, they need to 
respond to potential pathogens in semen.
In this part of thesis a study of the effects of seminal plasma on the phenotype 
and function of DCs generated from CD 14^ cells (Sallusto and Lanzavecchia 
1994), and the possible role o f seminal plasma in transmission of STDs, 
including HIV, are assessed. A summary of these experiments is illustrated in 
fig.IV.l.
IV.2. R e s u l t s
Data from allogeneic mixed lymphocyte reactions (MLRs) was presented in 
the form of mean counts per minute (CPM) with standard errors (SE) for 
triplicates and in the form of mean stimulation indices (SI) with SE, for single 
representatives and for summary of all experiments, respectively. Data from 
flow cytometric analyses was presented in the form of mean fluorescence 
intensity (MFI) with SE. The live MDDC population was gated and designated
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as RI (fig.IV.4d, 5d, 6d) and expression of CD la, CD4, HLA-DR, CD80 and 
CD86 on MDDCs was analysed within this population. The degree of increase 
or decrease in levels of expression was calculated using equation 2 described 
in II.7. The percentages of positive cells were determined by comparison with 
cells incubated with isotype matched control antibodies. Positive markers (M l 
in fig.IV.4) were placed on profiles so that less than 2% of cells stained with 
isotype control antibody fell within this marker. Single representatives o f each 
flow cytometry profile are also shown.
IV.2.1. TNF-a and seminal plasma titration
Optimal concentrations o f TNF-a and seminal plasma for use in this study and 
studies described in chapter 5 were determined. Fig.IV.2 shows the effect o f 
different concentrations of TNF-a on the allostimulatory capacity o f MDDCs. 
200U/ml of TNF-a had the most potent effect on allostimulatory capacity o f 
MDDCs compared with control MDDCs and hence 200U of TNF-a per ml o f 
MDDC culture (10^ cells/ml) was used in subsequent experiments.
MDDCs were pulsed with a pool of seminal plasma from six HIV-negative 
individuals as described in II.2.6. Overnight incubation of MDDCs with 10% 
seminal plasma resulted in a very low viable cell yield [‘trypan blue exclusion’ 
(II.2.1); less than 10  ^ cells/ml] when examined under a light microscope. 
Furthermore, seminal plasma titration experiments demonstrated that cells 
pulsed with 10% seminal plasma failed to stimulate allogeneic T cells 
(fig.IV.3). This is maybe due to a toxic effect of seminal plasma resulting from
14 -1
12 -
10 -
CO
I
500 1000 2000125 250 4000
DC No. per well
□  Control
□  50U TNF 
H 100U TNF 
■  200U TNF
□ 400U TNF
DC No. per well 125 230 500 1000 2000 4000 General trend
P values
(vs. control)
50U TNF-a 0.2 0.4 1.0 0.6 0.7 0.4 0.3
lOOUTNF-a 0.2 0.1 0.5 0.5 0.2 0.1 0.06
200U TNF- a 0.02 0.1 0.3 0.2 0.04 0.09.. 0.002
400U TNF- a 0.1 0.2 0.7 0.5 0.4 0.7 0.1
Fig. IV.2. TNF-a titration
MDDCs were pulsed with graded concentrations (50U/ml, lOOU/ml, 200U/ml, 
400U/ml) o f TNF-a overnight after 5 days of cultivation. Cells were washed next day, 
an allogeneic MLR was set up and cultured for further 4 days. Cells were pulsed with 
0.5pCi of [^H]-thymidine per well at day 4 and harvested at day 5. The graph shows a 
mean stimulation index (SI) with standard error for 3 experiments and each 
experiment was set up triplicate. The table below the graph shows P values comparing 
allostimulatory ability of TNF-a-pulsed DCs with that of control DCs. P value for the 
general trends of each curve {italic) are also shown.
□ Control 
g  0 .1  %  S P M  
■  1 % S P M
□  1 0 %  S P M
125 250 500 1000 2000 4000
DC No. per well
Fig.IV.3. Seminal plasma titration
MDDCs were pulsed with graded doses of seminal plasma (0.1%, 1%, 10%) 
overnight after 5 days of cultivation. Cells were washed next day, an allogeneic 
MLR was set up and cultured for further 4 days. Cells were pulsed with 0.5pCi 
of pH]-thymidine per well at day 4 and harvested at day 5. The graph shows 
mean stimulation indices (SI) with standard errors for 2 experiments. Each 
experiment was set up in triplicate. Due to a small number of samples statistical 
analysis was not performed.
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an interaction with bovine serum in MDDC culture medium, inducing the 
oxidative deamination of polyamines (spermine, spermidine and putrescine) in 
seminal plasma giving rise to formation of several toxic products such as 
aldehydes, ammonia and hydrogen peroxide (Agostinelli et al, 1994; Averill- 
Bates et al, 1993; Labib and Tomasi, 1981; Katsuta et al, 1975). Therefore, in 
subsequent experiments, a maximum of 1% seminal plasma was used to pulse 
MDDCs.
IV.2.2. Phenotypic characterisation of MDDCs treated with seminal 
plasma and/or TNF-a
The phenotype of MDDCs exposed to seminal plasma and/or TNF-a (as an 
example of a pro-inflammatory cytokine) was analysed by flow cytometry. 
The live MDDC population was gated and designated as R1 (fig.IV.4d, IV.5d, 
and IV.6d) and expression of CDla, CD4, HLA-DR, B7.1/CD80 and 
B7.2/CD86 was analysed within this population. The percentages o f positive 
cells were determined by comparison with cells incubated with isotype 
matched control antibodies. Positive markers (M l; fig.IV.4d, IV.5d, and 
IV.6d) were placed on profiles so that less than 2% of cells stained with 
isotype control antibody fell within this marker.
Seminal plasma induced changes in expression of surface co-stimulatory 
molecules (fig.IV.4). MFI of CD80 expressed on CD80^ MDDCs decreased 
significantly by 43.9%(±9.9) [i.e. from 31.2(±2.7) to 17.8(±4.3);
AMFI=13.4(±2.9)] when MDDCs were pulsed with 1% seminal plasma
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compared with that of control MDDCs (P=0.04; fig.IV.4b). However, such a 
decrease in the level of CD80 expression on MDDCs by 1% seminal plasma 
did not result in a complete disappearance of the molecule as demonstrated by 
the observation that numbers of CD80 positive MDDCs remained unchanged 
(P=0.8; fig.IV.4c). The MFI of CD86 expression on the total MDDC 
population was decreased significantly by 55.0%(±8.0) with 1% seminal 
plasma (P=0.04; fig.IV.4a): a decrease from 331.0(167.5) to 144.2(129.5) 
[AMFI=186.8(151.1)]. This reduction in the level of CD86 expression in the 
total MDDC population appeared to be associated with the reduced level of 
expression on CD86^ MDDCs (fig.IV.4b) as the P value was tending towards 
significance (P=0.07). Again, seminal plasma lowered the level o f CD86 
expression but did not reduce the proportion of CD86^ MDDCs in MDDC 
population (R l) (fig.IV.4c). Decreases in expression of co-stimulatory 
molecules, in particular, CD86 were observed in 5 in 7 experiments and 2 
showed no changes in expression of these molecules.
When MDDCs were exposed to TNF-a alone numbers of CD86 positive cells 
increased significantly (P=0.04) from 82.2(13.6) to 92.6(12.4): A% positive 
cells= 10.4%(11.7) which is 13.1%(12.6) (fig.IV.5c). TNF-a increased the 
levels of expression of CD86 on CD86^ MDDCs but did not reach statistical 
significance as indicated by the P value (P=0.09; fig.IV.5b). All 5 experiments 
demonstrated increased levels of CD86 expression (MFI).
When MDDCs were pulsed overnight with both 200U/ml o f TNF-a (10^ 
cells/ml) and seminal plasma, expression of CD86 on these cells was increased
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but not significantly (P=0.2; fig.IV.6a; P=0.2; fig.IV.6b) whereas the number 
of CD86^ MDDCs remained unchanged, when compared with MDDCs pulsed 
with TNF-a only (fig.IV.6c). A decrease in the expression o f co-stimulatory 
molecules induced by seminal plasma alone (fig.IV.4) was not seen when 
MDDCs were exposed to both TNF-a and seminal plasma together. 3 in 5 
experiments demonstrated increased levels of CD86 by 1% seminal plasma. 
Taken together the data suggests that both TNF-a and seminal plasma alter the 
expression o f co-stimulatory molecules on MDDCs and also TNF-a abrogates 
the effects of seminal plasma on MDDC phenotype. TNF-a alone increased 
(fig.IV.5) whilst seminal plasma alone decreased (fig.IV.4) co-stimulatory 
molecule expression. However, presence of seminal plasma did not induce any 
significant differences in the expression of co-stimulatory molecules on TNF- 
a  stimulated MDDCs (fig.IV.6).
IV.2.3. Allostimulatory ability of DC treated with seminal plasma and/or 
TNF-a
To assess APC function, seminal plasma-pulsed MDDCs were assessed for 
their ability to stimulate proliferation of allogeneic T cells. Fig.IV.7c describes 
a mean stimulation indices (SI) of 11 experiments and demonstrates that 
seminal plasma significantly suppressed the allostimulatory potentials o f 
MDDCs at cell numbers of above 500. P values comparing the allostimulatory 
capacity of MDDCs which were pulsed with 1% seminal plasma, with that o f 
control MDDCs, were less than 0.05 or tending towards significance (cell 
number of 8000) except when allogeneic T cells were stimulated by a small
Fig. IV.7. Allogeneic MLR with MDDCs pulsed with two different concentrations of 
seminal plasma
MDDCs were pulsed with 0.1% or 1% seminal plasma (SPM) overnight. Cells were 
washed next day, an allogeneic MLR was set up and cultured for further 4 days. Cells 
were pulsed with 0.5pCi of -thymidine per well at day 4 and harvested at day 5. 
Graphs (a) show a representative of 7 experiments (left graph) and mean SI of these 7 
experiments with SE (right graph) demonstrating suppression of allostimulatory potentials 
of MDDCs by seminal plasma. P values show that both 0.1% seminal plasma- and 1% 
seminal plasma-pulsed MDDCs demonstrated significantly reduced allostimulatory 
capacity. [P=0.003 (#): comparing allostimulatory capacity of 0.1% seminal plasma-pulsed 
MDDCs with that o f control MDDCs; P=0.001 (❖): comparing allostimulatory capacity of 
1% seminal plasma-pulsed MDDCs with that of control MDDCs]. Graphs (b) show a 
representative o f 4 experiments (left graph) and mean SI o f 4 experiments with SB (right 
graph) demonstrating no effect on allostimulatory potentials of MDDCs by seminal 
plasma. Graph (c) shows mean SI with SE of all 11 experiments. Each experiment was set 
up in triplicate. The table below graph (c) shows P values comparing ability of 0.1% or 
1% seminal plasma-pulsed MDDCs to stimulate proliferation of allogeneic T cells with 
that of control, and P values comparing ability of 1% SPM-pulsed MDDCs to stimulate 
proliferation of allogeneic T cells with that of 0.1% SPM-pulsed MDDCs. P values both 
for the different number of MDDCs (125-8000) and for the trend curves {italic) are 
shown.
(a)
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(c)
1
125 250 500 1000 2000 4000 8000
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m % sP M  
—  Trendline (control) 
... Trendline (1% SPM)
DC No. per well 125 250 500 1000 2000 4000 8000 General trenc
P values 
(vs. control)
0.1% SPM 0.9 0.2 0.3 0.4 0.2 0.1 0.2 0.1
1% SPM 0.4 0.1 0.05* 0.0& 0 . 0 0 6 o.ooi 0.09 0.008
P values 
(vs. 0.1% SPM
1% SPM 0.4 0.7 0.4 0.3 0.1 0.07 0.4 0.07
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number o f DCs (cell number of less than 500). P values comparing the general 
trend in the allostimulatory capacity of MDDCs also showed that 1% seminal 
plasma-pulsed MDDCs have significantly reduced allostimulatory potentials 
(P=0.008). Allostimulatory potentials of MDDCs pulsed with 1% seminal 
plasma also decreased compared with 0.1% seminal plasma-pulsed MDDCs 
but not significantly (P=0.07). 7 experiments (fig.IV.7a; left graph: a 
representative of 7 experiments; right graph: mean SI o f 7 experiments with 
SE) demonstrated suppression induced by seminal plasma (P=0.008 untreated 
vs. 0.1% SPM treated MDDCs; P=0.000, untreated vs. 1% SPM treated 
MDDCs) and 4 experiments (fig.IV.7b; left graph: a representative o f 4 
experiments; right graph: mean SI o f 4 experiments with SE) demonstrated no 
effect on allostimulation capacity of MDDCs by seminal plasma (P>0.8, 
untreated vs. 0.1% or 1% seminal plasma treated MDDCs).
Significantly enhanced allostimulatory capacity of MDDCs treated with TNF- 
a  alone compared with untreated MDDC was observed with greater than 95% 
confidence except when 1000 cells were used to stimulate allogeneic T cells 
(fig.IV.8b). Such a significant increase was observed in all 8 identical 
experiments and a single representative was presented (fig.IV.8a). The P value 
evaluated from the general trend curves (P=0.04) also showed a significant 
increase in allostimulatory potential of TNF-a treated MDDCs. Increased 
allostimulatory capacity of TNF-a treated MDDCs may result from the 
increased number of MDDCs expressing CD86 (fig.IV.5). Seminal plasma did 
not have any effect on the allostimulatory capacity of TNF-a stimulated 
MDDCs and this phenomenon was observed in all 6 experiments (fig.IV.9).
3 0 0 0 0  -
2 5 0 0 0  -
20000  -
c  1 5 0 0 0  -
10000  -
-A—Control 
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Fig. IV.8. Allogeneic MLR with MDDCs pulsed with TNF-a at day 5
MDDCs were pulsed with 200U/ml of TNF-a overnight. Cells were washed next day, an 
allogeneic MLR was set up and cultured for further 4 days. Cells were pulsed with O.SpCi 
of pH]-thymidine per well at day 4 and harvested at day 5. The graph (a) is a 
representative o f 8 experiments and shows mean counts per minute (CPM) with standard 
errors. The graph (b) shows mean stimulation indices (SI) with standard errors for 8 
experiments. Each experiment was set up in triplicate. The table below the graph shows P 
values comparing SI of TNF-a-pulsed MDDCs with SI of control MDDCs (ie. not 
exposed to TNF-a). P(^)=0.009
Fig. IV.9. Allogeneic MLR with MDDCs pulsed with TNF-a and two different 
concentrations of seminal plasma at day 5
MDDCs were pulsed with 200U/ml of TNF-a together with 0.1% or 1% seminal 
plasma (SPM) overnight. Cells were washed next day, an allogeneic MLR was set up 
and cultured for further 4 days. Cells were pulsed with 0.5pCi of pH]-thymidine per 
well at day 4 and harvested at day 5. The graph (a) shows a representative for 6 
experiments and show mean counts per minute (CPM) with standard errors. Each 
experiment was set up in triplicate. The graph (b) shows mean stimulation indices (SI) 
with standard errors of 5 experiments. The table below graph (b) shows P values 
comparing ability of TNF-a/0.1% SPM-pulsed DCs or TNF-a/1% SPM-pulsed 
MDDCs to stimulate proliferation o f allogeneic T cells with that o f MDDCs pulsed 
with TNF-a only. P values for allostimulatory capacity of MDDCs pulsed with both 
TNF-a and seminal plasma at different MDDC numbers (125-4000) and for that 
comparing the general trends o f each curve {italic) are shown.
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When MDDCs were exposed to both TNF-a and seminal plasma the 
suppressive effect of seminal plasma on the allostimulatory ability o f these 
cells was no longer observed. These data suggest that TNF-a could block or 
overcome the suppressive effect of seminal plasma. This phenomenon is 
associated with phenotypic analyses which demonstrated the increased number 
o f CD86^ MDDCs upon TNF-a stimulation (fig.IV.5) and the presence of 
seminal plasma did not induce any alteration in the phenotype of TNF-a 
stimulated MDDCs (fig.IV.6). Pro-inflammatory cytokines, like TNF-a, play a 
role in activation and maturation of DCs. Mature DCs which are seen in the 
lymph node have higher ability to stimulate T cells compared with immature 
DCs in the mucosa.
Whether seminal plasma-induced suppression of the allostimulatory ability of 
MDDCs may be due to induction of anergic T cells was investigated. 
Fig.IV.lO demonstrates that IL-2, fresh MDDCs which have never been 
exposed to seminal plasma, or both together restored the proliferation o f 
allogeneic T cells previously exposed to seminal plasma-treated MDDCs, 
indicating that the suppression of proliferation of allogeneic T cells induced by 
the seminal plasma-pulsed MDDCs is unlikely to be due to the induction o f 
anergic T cells.
% 1500
No SPM 1%SPM
□ None
□ 1000 DC
□ IL-2 only
□ IL-2+1000DC
DC treatment No SPM 1% SPM
1ÜÜÜ DCs only Ü.Ü3 0.03
lL-2 only 0.01* 0.008*
1L-2+1UÜÜ DCs 0.02 0.02
Fig.IV.lO. Recovery of cell proliferation
The MDDCs were pulsed with 1% seminal plasma overnight. Seminal plasma- 
pulsed MSDCs (right column) and MDDCs which were not exposed to seminal 
plasma (left column) were washed and an allogeneic MLR was set up next day and 
cultured for 3 days. Cells were washed, counted and secondary MLR was set up 
using 10  ^ cell/well from the first MLR as responder cells. Additives to the 
secondary MLR were i) 9 days-old MDDCs (1000 cells/well) from the same donor 
as that used in the first MLR ( ^  ), ii) 20 units of IL-2 ( [Hj] ), or iii) both MDDCs 
and IL-2 together ( 10;). As a control, nothing was added ( | 0 ) .  Cells were further 
cultivated for 3 days and washed, pulsed with O.SpCi of [3H]-thymidine per well 
next day. The graph shows mean counts per minutes with standard errors o f 3 
experiments. Each experiment was set up in triplicate. The table below the graph 
shows P values comparing allogeneic T cell proliferation with and without 
additives.
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IV.2.4. Identification of seminal eomponents responsible for suppression 
of allostimulatory ability of MDDC
Lipids were extracted from seminal plasma using a reverse phase column as 
described in II.2.2. Allogeneic MLRs were set up using MDDCs which were 
pulsed overnight with lipid-extracted seminal plasma. By extracting lipids 
from seminal plasma, most of prostaglandins are eliminated from the seminal 
plasma (Kelly et al, 1997^). Such experiments allowed examination o f the role 
o f prostaglandins in the alteration of seminal plasma-pulsed MDDCs’ 
function. Fig.IV .ll demonstrates that lipid extraction abrogated the 
suppressive effect of seminal plasma on MDDCs (previously seen in fig.IV.8). 
No significant differences between three groups of MDDCs (i.e. untreated, 
0.1% lipid-extracted seminal plasma treated, and 1% lipid-extracted seminal 
plasma treated MDDCs) were detected (P>0.05). These findings suggest that 
lipids in seminal plasma could be responsible for suppression of 
allostimulatory ability.
To further identify whether PGE2, in particular, is responsible for suppressive 
effect of seminal plasma, MDDCs were pulsed with exogenous PGE2 instead 
of seminal plasma at day 5. It is known that prostaglandins which are present 
in human semen at higher concentrations than in peripheral blood (Kelly, 
1997®), have immunomodulatory effects including ability to induce tolerogenic 
DCs which are also known as type-3 polarised effector DCs (Steinbrink et al, 
1997) and to induce type-2 effector DCs which have capacity to stimulate T 
cells efficiently Kalinstki et al, 1997; Kalinski et al, 1998). The average
F ig .IV .ll. Allogeneic MLR with MDDCs pulsed with two different concentrations 
of lipid-extracted seminal plasma
MDDCs were pulsed with 0.1% or 1% lipid-extracted seminal plasma (SPM) 
overnight. Cells were washed next day, an allogeneic MLR was set up and cultured for 
further 4 days. Cells were pulsed with 0.5pCi of pH]-thymidine per well at day 4 and 
harvested at day 5. The graph (a) shows a representative of 3 experiments and shows 
mean counts per minute (CPM) with standard errors. The graph (b) shows mean 
stimulation indices (SI) with standard error for 3 experiments. Each experiment was 
set up in triplicate. The table below graph (b) shows P values comparing SI of MDDCs 
pulsed with 0.1% or 1% lipid-extracted SPM with SI of control MDDCs (ie. untreated 
DCs).
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concentration of PGE2 in seminal plasma is about 25pg/ml (=71|LiM) and that 
o f 19-OH PGE2 is about 130pg/ml (=0.353mM) (Kelly et al, 1997). MDDCs 
were exposed to graded doses of PGE2 [0.0071 pM -0.71 pM which is 
equivalent to 0.001%-1% seminal plasma (fig.IV.12)]. Exogenous PGE2 did 
not induce the same effect on MDDCs as seminal plasma. PGE2 enhanced the 
allostimulatory ability o f MDDCs (fig.IV.12a). When TNF-a was added 
together with PGE2 increased proliferation of allogeneic T cells was observed 
at a low number of MDDCs, but overall such an increment was not significant 
as indicated by P values evaluated from trend lines (fig.IV.12b). Neither 19- 
OH PGE2 (0.0353pM-3.53pM which is equivalent to 0.001%-!% seminal 
plasma) alone, nor 19-OH PGE2 together with TNF-a have significant effects 
on allostimulatory ability of MDDCs (fig.IV.13). In one experiment an 
increased allostimulatory ability of MDDCs pulsed with 3.53pM of 19-OH 
PGE2 was demonstrated (P=0.004; fig.IV.13a, left hand graph). These data 
suggests that although lipids in seminal plasma may play a role in the 
suppressive effect on allostimulatory potential o f MDDCs, we failed to show 
the direct involvement of either PGE2 or 19-OH PGE2. It is possible that the 
suppressive effect o f seminal plasma may be a result o f combined activities of 
prostaglandins and other immunosuppressive components present in seminal 
plasma and hence exogenous prostaglandins do not have the same effect as 
seminal plasma on the allostimulatory potentials o f MDDCs.
Fig. IV. 12. Allogeneic MLR with MDDCs pulsed with FGE2
MDDCs were pulsed with graded doses of PGE2 (0.0071 pM-0.71pM) alone 
(a) or together with 200U/ml of TNF-a (b) overnight. Cells were washed next 
day, an allogeneic MLR was set up and cultured for further 4 days. Cells were 
pulsed with 0.5pCi of pH]-thymidine per well at day 4 and harvested at day 5. 
Histograms on the left show mean stimulation indices (SI) with standard errors 
for 4 experiments. Graphs on the right are single representatives of 4 
experiments and show mean counts per minute (CPM) with standard error. 
Each experiment was set up in triplicate. The table below IV. 12a shows P 
values comparing SI of MDDCs pulsed with PGE2 to stimulate proliferation of 
allogeneic T cells with that o f control MDDCs (ie. untreated MDDCs). The 
table below IV. 12b shows P values comparing SI of MDDCs pulsed with 
PGE2 together with TNF-a with SI of MDDCs pulsed with TNF-a only.
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Fig. IV.13. Allogeneic MLR with MDDCs pulsed with 19-OH PGE2
MDDCs were pulsed with graded doses of 19-OH PGE2 (0.0353pM-3.53pM) 
alone (a) or together with 200U/ml of TNF-a (b) overnight. Cells were washed 
next day, an allogeneic MLR was set up and cultured for further 4 days. Cells 
were pulsed with 0.5pCi of pH]-thymidine per well at day 4 and harvested at 
day 5. Graphs on the right show mean stimulation index (SI) with standard 
errors for 4 experiments. Graphs on the left are single representatives of 4 
experiments and show mean counts per minute (CPM) with standard errors. 
Each experiment was set up in triplicate. The tables below IV. 13a show P 
values comparing SI o f MDDCs pulsed with 19-OH PGE2 with SI o f control 
MDDCs (ie. untreated MDDCs). The table below IV. 13b shows P values 
comparing SI o f MDDCs pulsed with 19-OH PGE2 together with TNF-a with 
SI of MDDCs pulsed with TNF-a only. P=0.04 (*)
(a) 16000
14000
12000
10000  -
2 0 0 0  i l
Control
0.0353nlVI 19-OH PGE2 
TÎr—0.353nM 19-OH PGE2 
O— 3.53nlVI 19-OH PGE2
2000 4000 6000
DC No. per well
8000
□  Control 
ü0.0353nM  19-OH PGE2 
■  0.353^iM 19-OH PGE2
□  3.53nM 19-OH PGE2
125 250 500 1000 2000 4000 8000
DC No. per well
DC No. per well 125 250 500 1000 2000 4000 8000
vs control 0.0353 19-OH PGE2 0.4 0.2 0.4 0.8 0.8 0.8 1.0
0.353p m  19-OH PGE2 0.6 0.8 0.9 0.7 0.8 1.0 1.0
3.53p m  19-OH PGE2 0.7 0.8 0.9 0.5 0.5 0.6 0.5
vs 0.03 53 pM 19-OH PGE2 0.353 p m  19-OH PGE2 0.6 0.4 0.6 0.6 0.6 0.8 1.0
3.53 pM 19-OH PGE2 0.2 0.2 0.4 0.4 0.4 0.5 0.6
vs 0.353|iM 19-OH PGE2 3.53 PM 19-OH PGE2 0.2 0.7 0.9 0.7 0.7 0.7 0.6
(b) 20000
Q.
Ü
15000 -
10000
0— TNF-a only 
X—TNF-a+0.0353nlVI 19-OH PGE2 
A^TNF-a+0.353nM 19-OH PGE2
8 — TNF-a+3.53nlVI 19-OH PGE2
2000 4000 6000
DC No. per well
8000
w
□  TNF-a only 
m TNF-a+0.0353nlVI 19-OH PGE2 
■  TNF-a+0.353|iM 19-OH PGE2
□  TNF-a+3.53nM 19-OH PGE2
125 250 500 1000 2000 4000 8000
DC No. per well
DC No. per well 125 250 500 1000 2000 4000 8000
vs TNF-a only TNF-a+0.0353 19-OH PGE2 0.4 0.2 0.3 0.4 0.4 0.6 0.5
TNF-a-t-0.353pM 19-OH PGE2 0.5 0.8 0.7 0.7 0.6 0.6 0.7
TNF-a-F3.53pM 19-OH PGE2 0.2 0.2 0.3 0.4 0.5 0.4 0.7
vs 0.0353 PM 19-OH PGE2 TNF-a-F0.353pM 19-OH PGE2 0.2 0.1 0.2 0.3 0.2 0.3 0.3
TNF-a-F3.53pM 19-OH PGE2 0.06 0.03 0.06 0.1 0.2 0.2 0.3
vs 0.353PM 19-OH PGE2 TNF-a-F3.53pM 19-OH PGE2 0.3 0.2 0.6 0.6 0.8 0.7 1.0
125
IV .3 . D is c u ss io n
In this part of thesis, the effect of seminal plasma and/or TNF-a on the 
phenotype and functional ability to stimulate allogeneic T cells of the CD 14^ 
monoeyte-derived DCs (MDDCs) was studied. It has been well established 
that DCs generated from monocytes using GM-CSF and IL-4 have the 
properties o f immature DCs since they have a high capacity for endoeytosis 
and low T cell stimulation function (Sallusto, et al, 1995; Sallusto and 
Lanzavecchia, 1994). To assess APC function, MDDCs were tested for their 
ability to stimulate proliferation of allogeneic T cells since DCs always carry 
allo-peptides.
TNF-a induced maturation of MDDCs as demonstrated by assessment o f 
allostimulatory capacity of the cells (fig.IV.8). When TNF-a was present in 
the MDDC culture, the cells showed increased allostimulatory capacity 
compared with those which had not been treated with TNF-a. It has been 
shown that inflammatory cytokines and bacterial products can stimulate DC 
maturation and migration as has been demonstrated by systemic administration 
o f TNF-a, IL -lp and IL-6 (Sallusto and Lanzavecchia, 1994; Sallusto et al, 
1995; Jonuleit et al, 1997; Cumberbaten et al, 1990) or LPS (Celia, et al, 
1997; Roake, et al, 1995) which induced depletion of DCs from non-lymphoid 
organs and migration into lymph nodes. DCs produce ceramides on 
stimulation by TNF-a, IL-1 and CD40L and ceramides can inhibit endoeytosis 
which is a characteristic of immature DCs (Sallusto et al, 1996). IL-1 
(Kobayash et al, 1989), IL-6 and TNF-a (Okamoto et al, 1989) activate NF-
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kB. Mature DCs express high levels of the NF-kB family o f transcriptional 
control proteins which regulate the expression of immune and inflammatory 
proteins. This, consequently, may induce further activation of DCs and may 
also induce migration of other immune cells to the site of inflammation. 
Phenotypic analyses showed that TNF-a significantly increased numbers 
MDDCs expressing one of co-stimulatory molecules, CD86/B7.2 (fig.IV.6b) 
which are involved in presentation of antigen in the context of MHC class II to 
CD4 helper T cells. However, TNF-a did not increase expression of HLA-DR 
or decrease CD la  which are thought to occur during maturation o f DCs.
Seminal plasma reduced the expression of co-stimulatory molecules on 
MDDCs (fig.IV.4). These data were supported by data obtained from 
functional ability of MDDCs to stimulate allogeneic T cells (fig.IV.7). Lower 
concentration of seminal plasma used in this study (0.1%) did not have any 
effect on neither the phenotype nor the allostimulatory function o f MDDCs. 
However, the suppression did not appear to be due to induction o f anergic T 
cells by seminal plasma since addition of IL-2, fresh MDDCs (i.e. not 
previously exposed to seminal plasma) or both together restored the 
proliferation of allogeneic T cells (fig.IV.lO). Investigation o f the cytokine 
production by seminal plasma-pulsed MDDCs is required to further 
characterise the cells. Increased IL-10 and decreased IL-I2 production may 
induce anergy (Groux et al, 1996; Van Parijs et al, 1997). When MDDCs were 
exposed to TNF-a, the suppressed allostimulatory ability o f the cells which 
was induced by seminal plasma was no longer observed. There was not any 
significant difference in neither phenotypes nor allostimulatory potentials of
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MDDCs. This data suggests that TNF-a counterbalances the effect of seminal 
plasma or vice versa. This phenomenon may be what is expected in vivo. The 
immature mucosal DCs do not recognise the seminal cells as foreign and 
semen does not induce immune response against itself. Pro-inflammatory 
cytokines like TNF-a may be present at a high level in semen o f patients with 
genitourinary (GU) infections (Ramsey et al, 1995) and may act as a ‘danger’ 
signal (Matzinger, 1994). The results presented in this study suggest that under 
such circumstances the masked function of mucosal DCs as APCs which is 
induced by semen is blocked and hence, are ready to present the pathogens in 
the semen but whether the mucosal DCs recognise seminal components as 
foreign antigen in such scenarios requires to be investigated.
It has been shown that PGE2 and 19-OH PGE2 which are the main 
prostaglandin constituents of human seminal plasma induce Th2 type of 
responses (Kelly et al, 1997*’; Kalinski, et al, 1997; Groux et al, 1996; 
Kalinski, et al, 1998) and may induce anergy (Groux et al, 1996; Mannie et 
al, 1995; Phipps and Scott, 1983; Goldings et al, 1986). The effect of seminal 
plasma on allostimulatory capacity of MDDCs was abrogated when the cells 
were treated with lipid-extracted seminal plasma (fig.IV.lO) suggesting that 
lipids in semen may play a role in altering the function of the cells. To further 
identify whether PGE2 and/or 19-OH PGE2 are the key component 
responsible for the suppressive effect o f seminal plasma, experiments using 
commercially available exogenous PGE2 and 19-OH PGE2 were performed. 
The results showed that exogenous prostaglandins do not have the same effect 
as seminal plasma (fig.IV.12 & 13). Our data was supported by studies by
1 2 8
Riesser and her colleagues who have shown that PGE2 alone activated DCs 
inducing IE-12 production in DCs (Rieser, et al, 1997). PGE2 affects 
development o f immature DCs. The presence o f PGE2 in immature DC 
culture results in induction of type 2-polarised effector DCs which produce 
reduced amounts of IE-12 and hence induces a bias towards Th2 type cytokine 
production in naïve T cells (Kalinski et al, 1997; Kalinski et al, 1998). These 
type 2-polarised effector DCs induced by PGE2 have enhanced stimulatory 
potential (Kalinski et al, 1998). The data from our study demonstrated an 
increased allostimulatory potential of MDDCs by PGE2 or 19-OH PGE2 
although it was not statistically significant. Taken together it suggests that 
there are other factors in seminal plasma responsible for the functional 
changes of DCs, such as prostasome, polyamine, TGF-P and IL-10 although 
IL-10 present in semen at a very low concentration (Kelly, 1995; Alexander 
and Ansderson, 1985). Although prostaglandin by itself did not induce the 
suppressive effect in vitro it cannot be ruled out the possibility that the 
suppressive effect o f seminal plasma may be the result of combined activity of 
prostaglandin and other components present in semen.
In conclusion the data from this chapter has shown that semen has 
immunomodulatory properties on MDDCs. Seminal plasma alone suppressed 
antigen presentation of MDDCs and this effect was abrogated when pro- 
inflammatory cytokines such as TNF-a were present. This has important 
implications. Seminal plasma has a role in protecting sperm from recognition 
in the female reproductive tract by possibly switching to Th2-type responses 
which may induce anergy or tolerance (Kelly et al, \99T ). However, when
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high levels of pro-inflammatory cytokines are present in semen, as may be 
found in patients with GU infections (Ramsey et al, 1995), the eytokines and 
pathogens in semen act as ‘danger’ signals (Matzinger, 1994) and may induce 
activation of LCs in the mucosa resulting in enhanced ability to present 
antigens and to stimulate T cells in the lymph node. More importantly, under 
such circumstances seminal plasma may not play a protective role any longer. 
Possible mechanisms for the suppressive effect of seminal plasma and for the 
way in which TNF-a may overcome the suppressive effect o f seminal plasma 
are summarised in fig.IV. 14.
Future work
1. Detection of IL-10 in seminal plasma
It has been shown that IL-10 has an immunomodulatory effect on immature 
DCs. IL-10 inhibits both IL-12 production in immature DCs (De Smedt et al, 
1997; Kalinski et al, 1998) and the stimulatory ability of DCs, possibly by 
down-regulating expression of co-stimulation molecules (Chang et al, 1995; 
Willems et al, 1994; Ding et al, 1993) and thus inducing the development o f a 
tolerogenic type of DC (Steinbrink et al, 1997). Since seminal plasma-pulsed 
MDDCs had a suppressed capacity for allostimulation, the presence o f IL-10 in 
semen needs to be studied.
2. Measurement of level of prostaglandins in seminal plasma
Since prostaglandins (PGE2 and 19-OH PGE2) have been shown to have an 
immuno-suppressive effect (Kraan et al, 1995; Kelly et al, 1997*’) the amount of 
19-OH PGE2 in individual semen samples needs to be measured. Also
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individual lipids separated from seminal plasma using a reverse phase column 
could be eluted and used to treat DCs in the place of seminal plasma.
3. Cvtokine production bv DCs and T cells
Whether seminal plasma and/or TNF-a induces changes in cytokine production 
by DCs needs to be studied. Several studies have shown that DCs are important 
inducers of Thl and Th2 cytokines in naïve T eells and sueh discrimination 
appears to be due to the level of IL-12 production rather than the ability to 
produce IL-12 (Macatonia et al, 1993; Hilkens et al, 1997; Ronchese et al, 
1994; Stumbles et al, 1998; Snijders et al, 1998). This is of importance since the 
different types of Th eells induce different immune responses. Thl-type 
cytokines promote cellular immunity and Th2-type cytokines support humoral 
immunity. The type of cytokines produced by T cells exposed to seminal 
plasma-pulsed DCs could be evaluated. Intracellular cytokine staining appeared 
to be not sensitive enough to detect IL-10 or IL-12 in DCs (data not shown). 
Other methods such as ELISA or bioassay could be used to measure cytokine 
production by DCs and by allogeneic T cells after stimulation with DCs.
4. Antigen-uptake capacity of DCs
To complete the functional studies on seminal plasma- and/or TNF-a-pulsed 
DCs, the antigen-uptake capacity of these cells needs to be assessed using 
fluorescien-conjugated dextran or nitroblue tetrazolium/zymosan granules, as 
has been previously described (Robinson et al, 1999). Antigen-uptake by DCs is 
as important as stimulatory capacity of DCs in terms of DC function.
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Y
E f f e c t  o f  S e m in a l  p la s m a  o n  E x p r e s s io n  
OF HIV-1 C o - r e c e p t o r s  a n d  I n f e c t i o n  w i t h  HIV-1
V .l .  In t r o d u c t io n
Heterosexual transmission accounts for most cases of HIV-1 infection 
(Caeeres et al, 1996; Mastro et al, 1996; Lee et al, 1996; AIDS epidemic 
update, December, 2000, http://www.unaids.org). Evidence that DCs could be 
involved in HIV transmission was deduced from the observation that HIV 
readily associates with DCs and caused formation of syncytia in vitro, as a 
result o f DC-T cell fusion (Pope et al, 1995; Pope et al, 1994; Cameron et al, 
1992). Infection in females may take place primarily in the vagina and cervix, 
particularly if HIV-susceptible inflammatory cells are present (Levy, 1993; 
Nuovo et al, 1993). The surface of the female genital tract is covered by 
layers of epithelial cells which provide a protective barrier for the underlying 
structures. The epithelial cells in the female genital tract are composed of 
columnar, squamous and transitional cells. The vagina and ectocervix which 
are most exposed to HIV inoculation are comprised o f five distinct cell layers 
(fig.1.4; Witkin, 1993). In contrast, the endocervix and uterus are composed o f 
a single layer of epithelial cells (‘simple epithelium’). HIV-1 susceptible 
eells, Langerhans’ cell, CD4^ T cells and macrophages are predominantly 
present in parabasal and basal layers o f vagina and ectocervix (Johansson et
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al, 1999; Poppe et al, 1998; Morris et al, 1983). For sexually transmitted 
diseases (STDs) including HIV infection, mucosal integrity plays an obvious 
and important role in transmission. Transmission of HIV would be 
particularly likely if there are venereal diseases with open lesions and many 
inflammatory cells present due to other STDs that may provide a portal for 
HIV entry (Wasserheit, 1992; Dickerson et al, 1996; Plummer, 1998; Cohen, 
1998; Gray gf a/, 1999).
LCs in the mucosal epithelium may be the first cells to become infected after 
mucosal exposure to HIV-1 as has been shown in studies using the rhesus 
macaque model of SIV (Spira et al, 1996; Joag et al, 1997; Blauvelt et al, 
1997; Zambruno et al, 1995; Miller and Hu, 1999) and using skin expiants 
(Reece et al, 1998). It has also been observed that SIV can be efficiently 
transferred to lymph nodes within two days of vaginal inoculation o f the virus 
in rhesus macaques (Joag et al, 1997; Spira et al, 1996). HIV-1-carrying DCs 
migrate to the draining lymph node where interaction with T cells may 
establish productive infection, and ultimately lead to systemic spread o f HIV- 
1. Animal studies using the SIV-macaque model demonstrated that DC-T cell 
clusters are a major site of viral replication (Hu et al, 1999).
Immature DCs express CCR5, CCR2 and CCR3 (Rubbert et al, 1998; Sallusto 
et al, 1998; Sozzani et al, 1998^; Sallusto and Lanzaveccheia, 1999) which are 
used as eo-receptors by R5 strains o f HIV-1 although CCR2 and CCR3 usage 
by this virus is less common than CCR5. More importantly, freshly isolated 
LCs express functional CCR5 (Zaitseva et al, 1997) as well as CD4 (Patterson
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et al, 1995, Wright-Browne et al, 1997; Lee et al, 1999) allowing entry o f R5 
strains of the virus. Upon maturation of DCs, expression of CXCR4 is induced 
allowing potential entry o f X4 strains o f virus (Zaitseva et al, 1997; Sallusto et 
al, 1998; Canque et al, 1999) and expression of CCR5 is down-regulated 
(Sallusto et al, 1998). Expression of CCR5 and CXCR4 on CD4^ lymphocytes 
is regulated by cytokines. CCR5 expression on CD4'*' cell populations is up- 
regulated by type 1 cytokines sueh as IFN-y and IL-2 and down-regulated by 
type 2 cytokines such as IL-10 (Patterson et al, 1999). Expression o f CXCR4 
on DCs is up-regulated by IL-4 (Jourdan et al, 1998) and TGF-p and down- 
regulated by IFN-a, IFN-P and IFN-y (Zoeteweij et al, 1998). Therefore, an 
increase in type 2 cytokine production or lack of type 1 cytokine production, 
which can occur during HIV infection (Maggi et al, 1994; Barcellini et al, 
1994; Jason et al, 1995; Meroni et al, 1996; Stylianou et al, 1999), may 
promote infection of DCs with X4 strains of virus. Expression of CXCR4 
(Canque et al, 1999; Sallusto et al, 1998; Zaitseva et al, 1997) and CCR7 
(Sallusto et al, 1999; Dieu-Nosjean et al, 1999; Sallusto et al, 1998; 
Yanagihara et al, 1998) whose natural ligands (SDF-1 for CXCR4; SEC and 
ELC for CCR7) are produced in lymphoid organs, is increased on mature DCs, 
facilitating migration of DCs to the lymph node where DC-T cell interaction 
occurs. It has been demonstrated that productive infection of DCs with HIV 
and the ability of DCs to capture virus are mediated through separate pathways 
(Blauvelt et al, 1997). Productive infection of DC is CD4-, CCR5- and 
CXCR4-dependent, whereas capture of virus is independent of CD4, CCR5 
and CXCR4 and is facilitated by the unique dendritic morphology o f DCs. A 
newly identified DC-specific ICAM-3 receptor, DC-SIGN which is
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abundantly expressed by DCs present in the mucosa, was also shown to bind 
to the HIV-1 gpl20 and hence to be involved in efficient capture of HIV-1. 
Furthermore, an interaction between DC-SIGN and ICAM-3 facilitates the 
infection of T cells (Geijtenbeek et al, 2000*’).
In the previous chapter, the effect of seminal plasma on function and 
phenotype o f non HIV-infected DCs was discussed. This part of thesis 
describes in vz/ro-infection of DCs with HIV-1, the expression o f HIV-1 co­
receptors on seminal plasma pulsed-DCs, which may influence infection o f the 
cells with HIV-1 and finally the effect of seminal plasma on in vzYro-infection 
of DCs. The allostimulatory capacity of in vzYro-HIV-1 infected DCs is also 
described. A pool of seminal plasma as described in II.2.6 was again used to 
pulse DCs in this chapter. A summary of experiments performed in this part of 
thesis is illustrated in fig.V.l.
V .2 .  R e s u l t s
Data from allogeneic mixed lymphocyte reactions (MLRs) was presented in 
the form of mean counts per minute (CPM) with standard errors (SE) for 
triplicates for single representatives and in the form of mean stimulation 
indices (SI) with SE for summary of all experiments. Data from flow 
cytometric analyses were presented in the form of mean fluorescence intensity 
(MFI) with SE. The live MDDC population was gated and designated as R1 
(fig.V.2a, 2e, 2i) and expression of HIV-1 co-reeeptors on MDDCs was 
analysed within this population. MFI of isotype matched control antibody was
I
HIV-negative 
SPM-pulsed MDDCs
Expression of CCR5 
and CXCR4
HIV-negative PBMCs
^  CD 14^ cell selection
CD 14^ monocytes
1
5 days culture in the presence o f 
GM-CSF and IL-4
Immature DCs
In vitro HIV-1 
infection of MDDCs
MDDCs pulsed with 
HIV-positive SPM
Proviral DNA assay 
p24 ELISA 
Allogeneic MLR
Fig. V .l. Flow chart showing experiments performed in chapter 5
CD 14^ monocytes were positively selected from HIV-negative PBMCs using CD 14 
MicroBeads (IL2.4). CD 14^ monocyte-derived DCs (MDDCs) were generated in the 
presence o f GM-CSF and IL-4 (IL2.5). After 5 days of culture cells were pulsed with two 
different concentrations of HIV-negative seminal plasma (SPM) and/or HIV-1 viral 
isolates (II.6.3). In some experiments MDDCs were pulsed with HIV-positive SPM. HIV-1 
infected MDDCs were assessed for proviral DNA (II.5.2), p24 protein production (II.6.2) 
and allogeneic capacity (II.2.7). HIV-negative SPM-pulsed DCs were assessed for 
expression of CCR5 and CXCR4 (II.3.1).
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not subtracted from MFI of CCR5 or CXCR4 expression since we are 
comparing levels of CCR5 or CXCR4 expression on MDDCs which were 
treated differently (e.g. untreated MDDCs vs. seminal plasma and/or TNF-a- 
treated MDDCs or between two different concentration o f seminal plasma- 
treated MDDCs). The percentages of positive cells were not assessed since 
specific antibody binding showed a slight shift compared with isotype matched 
antibody binding. The degree of increase or decrease in levels of expression 
was calculated using equation 2 described in II.7. Single representatives of 
each flow cytometry profile are also shown (fig.V.2a-2c, 2e-2g, 2i-2k).
V.2.1. Surface expression of CCR5 and CXCR4 on CD14-monocyte- 
derived DCs (MDDCs)
Whether seminal plasma and/or TNF-a influenced expression of CCR5 
and CXCR4 on the MDDC surface was assessed by flow cytometry. 
MDDCs were derived from HIV-negative PBMCs (II.2.5). MDDCs were 
pulsed overnight with two different concentrations of seminal plasma pool 
(II.2.2) and/or 200U/ml (10^ cells/ml) of TNF-a. MDDCs were washed in 
1% FCS/PBS twice before staining. Staining procedures are as described 
in II.3 except that incubations were at room temperature.
MDDCs expressed both CCR5 and CXCR4 [fig.V.2d, green bars; P=0.06 for 
CCR5 and P=0.02 for CXCR4 compared with isotype matched control 
antibody binding (orange bars)]. Expression of CCR5 on MDDCs was 
decreased by seminal plasma, TNF-a and both seminal plasma and TNF-a 
although such a decrease was not statistically significant. P values comparing
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the level of CCR5 expression on untreated MDDCs and 0.1% or 1% seminal 
plasma-pulsed MDDCs were >0.05. CCR5 expression was decreased on both 
0.1% and 1% seminal plasma-pulsed MDDCs (fig.V.2b and fig.V.2d). The 
difference in the MFI of CCR5 expression between control MDDCs and 0.1% 
seminal plasma-pulsed MDDCs was 5.9+2.1 which is 35.3%(±6.7) decrease, 
and that between control MDDCs and 1% seminal plasma-pulsed MDDCs was 
8.9±2.9 which is 50.3%(±8.0) decrease. Similar results were obtained when 
MDDCs were exposed to both TNF-a and seminal plasma. The level of CCR5 
expression was decreased by seminal plasma but not statistieally signifieantly 
(fig.V.2f and fig.V.2h). TNF-a alone also decreased the level o f CCR5 
expression on MDDCs when compared with that seen on untreated MDDCs 
by MFI of 7.4+6.0 (fig.V.2j and fig.V.2i).
Expression of CXCR4 was influenced by seminal plasma or TNF-a to a 
greater extent than CCR5. Both 0.1% and 1% seminal plasma increased the 
level of CXCR4 expression on MDDCs by MFI of 11.3+4.5 which is 
107.0%(+55.9) increase (P=0.2) and by MFI o f 8.0+4.1 which is 73.7%(+50.2) 
increase (P=0.4) compared with that seen on untreated MDDCs (fig.V.2d). 
CXCR4 expression appears to be decreased on MDDCs pulsed with 1% 
seminal plasma compared with that seen on 0.1% seminal plasma-pulsed 
MDDCs but not significantly (P=0.6; fig.V.2d). Fig.V.2g and fig.V.2h show 
that MDDCs exposed to both TNF-a and seminal plasma display significantly 
increased expression of CXCR4. The differences in MFI of CXCR4 between 
MDDCs exposed to TNF-a and MDDCs exposed to both TNF-a and 0.1% or 
1% seminal plasma were 61.0+11.2 [166.6%(±37.0) increase; P=0.006] and
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55.7+21.51 [82.9%(±84.5) increase; P=0.02], respectively. TNF-a alone also 
increased the level of CXCR4 expression on MDDCs by MFI of 16.3+2.2, 
142.2%(±46.8) increase, although such an increase was not statistically 
significant (fig.V.2k and fig.V.21; P=0.2).
V.2.2. Assessment of MDDC infection with HIV-1
HIV-negative seminal plasma pulsed-MDDCs and control MDDCs (i.e. 
untreated MDDCs) were exposed to different strains of HIV (table II.2) as 
described in II.6.3. Infection of MDDCs with HIV-1 was assessed using two 
different methods: i) a viral DNA assay using HIV-1 specific env primers and 
(3-globin primers as a positive control, and ii) a p24 protein ELISA for 
measurement of p24 antigen levels in culture supernatants (frozen and 
thawed).
Fig.V.3 shows that MDDCs could be infected with virus in vitro. Prior to 
adding to MDDC culture the virus was treated with DNase and this removed 
DNA from the viral stock as demonstrated by viral DNA assay (fig.V.3d). 
Amplification of HIV env DNA demonstrated that without seminal plasma 
(Lane B) MDDCs were infected with JRCSF virus [R5 strain (fig.V.3a] and 
with evidence of a much lower level of infection with PEI 06 virus [R5/X4 
strain (fig.V.3b)]. Infection with JW5 virus [X4 strain (fig.V.3c)] was not 
observed. Infection with JRCSF virus was also detected in MDDCs pulsed 
with 0.1% seminal plasma (fig.V.3a, Lane C) but not in MDDCs pulsed with 
1% seminal plasma (fig.V.3a, Lane D). When MDDCs were pulsed with 1% 
seminal plasma the level of CCR5 expression decreased, as previously
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described (fîg.V.2d). The viral DNA assay demonstrated that JRCSF virus was 
unable to infect 1% seminal plasma-pulsed MDDCs and this may be due to 
reduced levels o f CCR5 expression on MDDCs. Infection with P E I06 virus 
was greatly enhanced when 0.1% seminal plasma was added (fig.V.Sb, Lane 
C) and was decreased when 1% seminal plasma was added (fig.V.Sb, Lane D) 
to the culture. Detectable levels of infection with JW5 virus were observed 
only when 0.1% seminal plasma was present in the culture (fig.V.Sc; Lane C). 
Although MDDCs expressed CXCR4 (fig.V.2d) the level of CXCR4 
expression on these untreated MDDCs may not be sufficient for entry o f X4 
strain of virus. However, 0.1% seminal plasma pulsed MDDCs displayed 
increased levels of CXCR4 expression, which may have enhanced entry o f X4 
strain of virus. Infections with PE 106 virus and JW5 virus were not detected in 
MDDCs pulsed with 1% seminal plasma (fig.V.Sb and fig.V.Sc). Although 
statistical analyses on the level of CXCR4 expression on 1% seminal plasma- 
pulsed MDDCs showed no significant difference from 0.1% seminal plasma- 
pulsed MDDCs, failure in infecting 1% seminal plasma-pulsed MDDCs 
suggests that the level of CXCR4 expression on these cells may not be 
sufficient for entry of X4 strains of virus as seen in control MDDCs (the level 
o f CXCR4 expression on 1% seminal plasma-pulsed MDDCs was not 
significantly different from control MDDCs).
p24 levels in supernatants of HIV-1 infected MDDC cultures which were 
collected at different time points during the cultivation, were measured by 
ELISA. p24 protein in the supernatants was present at a very low 
concentration or below the detection limit (table V .l). For MDDC sample 1 it
(4-1O ( N
vd
I
I
1
I
S
A
'O
G
u
1
do
%
2 A
2A
rf
>
-g
H
r2
0
g
1
I
S
I
I
1
C /D
<
C /D
g
nd
I
I
1
I
O
A
( U
I
« 3
I
0  ü
1
i
s
t
t
(4H
O
i
I
U
Q
I
I
1
Q
I
I
in oo 
( N  C N oQ Q
m m m
^  ^
Q Q Q
co
Ph
< o
O
co
& o O
C N m
139
appears that a lower concentration of seminal plasma (0.1%) enhanced 
infection of MDDCs with R5 strains of HIV-1 (day 5 and day 6), however it 
was not the case for MDDC sample 2 and 3. This data suggests that productive 
infection o f these cells with HIV-1 in this system was not efficient enough to 
release measurable amount of p24 by ELISA or our ELISA system is not 
sensitive enough. Therefore, supernatants from the allogeneic MLR using 
HIV-1 infected MDDCs were collected and p24 levels in the supernatants 
were measured by ELISA. Amounts of p24 protein in the allogeneic MLR 
supernatants were still lower than detection limit, 0.0316ng/ml (table V.2).
Virus in seminal plasma from HIV*" individuals was capable of infecting 
MDDCs since viral DNA was detected in cells which were incubated with 
seminal plasma from HIV^ patients (fig.V.4). Fig.V.4a shows viral DNA 
detection in MDDCs pulsed overnight with seminal plasma from a HIV^ 
patient whose viral load in seminal plasma was 2,000 copies/ml (patient 9; 
refer table III. 1 in chapter III for patient details). Fig.V.4b shows viral DNA 
detection in MDDCs pulsed with seminal plasma from a HIV^ patient whose 
viral load in seminal plasma was 68,000 copies/ml (patient 10; refer table III.l 
in chapter III for patient details). When MDDCs were pulsed with seminal 
plasma with a viral load of 2,000 copies/ml, viral DNA was detected in cells 
pulsed with 1% seminal plasma (equivalent to 20 copies o f virus), but not in 
cells pulsed with 0.1% seminal plasma (equivalent to 2 copies o f virus) 
(fig.V.4a). In contrast, when seminal plasma which has a higher viral load 
(68,000 copies/ml) was used to pulse MDDCs viral DNA was detected in 
MDDC populations pulsed with both 0.1% (equivalent to 68 copies o f virus)
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and 1% (equivalent to 680 copies of vims) seminal plasma (fig.V.4b). This 
data suggests that viral strains present in seminal plasma can infect DCs 
efficiently. Final viral concentrations of as little as 20 copies/ml was sufficient 
to infect these cells and the infection could be detected by a nested PGR. An 
allogeneic MLR was set up using MDDCs that were pulsed with seminal 
plasma from patient 10. Despite the fact that viral DNA was detected in 
MDDCs which were in vzYro-infected with vims present in seminal plasma, 
levels o f p24 in supernatants of allogeneic MLR were lower than detection 
limit (0.0316ng/ml; table V.3). This data suggests that HIV enters MDDCs, 
with reverse transcription o f viral RNA to DNA (as demonstrated by PCR; 
fig.Y.4) but with little or no productive replication of vims and hence may not 
have transmitted vims to allogeneic T cells.
V.2.3. Assessment of antigen presenting function of HIV-1 infected 
CD14^-monocyte-derived DCs (MDDCs)
Antigen presenting function of MDDCs which were infected with vims was 
assessed by allogeneic MLRs. After 5 days of culture MDDCs were pulsed 
with vims exhibiting different cellular tropism (JRCSF: CCR5-utilising strain; 
PE 106: CCR5 and CXCR4-utilising strain; JW5: CXCR4-utilising strain) 
overnight. Cells were washed and were used to stimulate allogeneic T cells. 
Cells were cultured for further 4 days. The data showed that infection with 
vims, as confirmed by PCR (fig.V.3) enhanced allostimulatory potentials o f 
MDDCs but not significantly (fig.V.5). It appears that JW5 vims has the least 
effect on the allostimulatory potentials of MDDCs (fig.V.5). This may be 
associated with the level of infection of MDDCs. Viral DNA assay
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Fig. V.5. Allogeneic MLR with MDDCs pulsed with virus with different cellular 
tropism.
MDDCs were pulsed with virus exhibiting different cellular tropism (JRCSF: CCR5- 
utilising strain; PE106:CCR5 and CXCR4-utilising strain; JW5:CXCR4-utilising 
strain) overnight. Cells were washed and an allogeneic MLR was set up next day 
using 10  ^ responder cells per well. Cells were cultured for further 4 days. Cells were 
pulsed with 0.5pCi of pH]-thymidine per well at day 4 and harvested at day 5. 
Graphs (a), (b), and (c) show mean count per minute (CPM) with standard errors of 
each experiment. Graph (d) shows mean stimulation index (SI) of 3 experiments with 
standard errors. Each experiment was set up in triplicate. The table below the graphs 
shows P values comparing ability of MDDCs which were exposed to virus to 
stimulate allogeneic T cells with that of control MDDCs. P values comparing 
allostimulatory ability of DCs exposed to different strains of virus are also shown. P 
values were evaluated from mean SI of 3 experiments and standard errors. Statistical 
analysis method employed was ‘independent sample T test’ and performed uing a 
SPSS 10.0 software. SI was calculated by dividing mean CPM of background (ie. no 
DC) from mean CPM of each DC number (equation 1 in II.7).
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demonstrated undetectable level of JW5 virus DNA by PCR (fig.V.Sc, lane B). 
It was expected that antigen-carrying DCs would undergo maturation and 
hence their allostimulatory function would be enhanced. Therefore, it is not 
surprising that JW5 virus exposed-MDDCs which did not have detectable 
levels o f viral DNA, displayed allostimulatory potentials similar to those of 
control MDDCs (i.e. unexposed to virus; fig.V.5).
Antigen presenting function o f MDDCs exposed to both virus and seminal 
plasma was assessed to determine whether presence of virus abolished the 
suppressed allostimulatory capacity of seminal plasma-pulsed MDDCs 
(chapter IV) or whether seminal plasma altered the allostimulatory potentials 
o f antigen-carrying DCs. First o f all, two experiments demonstrated a 
significantly increased allostimulatory ability of JRCSF virus-infected 
MDDCs when compared with that of uninfected control MDDCs (fig. V.6a and 
fig.V.6c, P=0.000 and P=0.001, respectively). These two experiments also 
demonstrated a decreased allostimulatory ability of MDDCs when exposed to 
JRCSF virus in the presence of 1% seminal plasma compared with that o f 
MDDCs exposed to virus only (P=0.007 for fig.V.6a and P=0.001 for 
fig.V.bc). When the allostimulatory potential of MDDCs exposed to both 
JRCSF virus and 1% seminal plasma was compared with that o f control 
MDDCs (i.e. not exposed to either seminal plasma or virus) the suppressive 
effect of seminal plasma was not observed (fig.V.6a and fig.V.6c, P=0.8 and 
P=0.06, respectively). The summary of all experiments showed a tendency o f 
increased allostimulatory potentials when MDDCs were exposed to virus 
(without seminal plasma and with 0 .1% seminal plasma) although it was not
Fig. V.6. Allogeneic MLR with MDDCs infeeted with JRCSF virus and/or pulsed 
with different concentrations of HIV-negative seminal plasma
MDDCs were pulsed with JRCSF virus (CCR5-utilising strain) alone or together with 
0.1% or 1% HIV-negative seminal plasma overnight. Cells were washed and 
allogeneic MLRs were set up next day using 10  ^ responder cells per well. Cells were 
cultured for further 4 days. Cells were pulsed with 0.5pCi of pH]-thymidine per well 
at day 4 and harvested at day 5. Graphs (a), (b), and (c) show mean counts per minute 
(CPM) with standard errors. Graphs (d) shows mean stimulation index (SI) of 3 
experiments with standard errors. Each experiment was set up in triplicate. The table 
below graph (d) shows P values comparing ability of HIV-1 infected MDDCs which 
were exposed to 0.1% or 1% seminal plasma to stimulate allogeneic T cells with that 
of HIV-1 infected MDDCs which were not exposed to seminal plasma or with that of 
uninfected MDDCs. Also, P values comparing allostimulatory ability o f MDDCs 
exposed to different concentrations of seminal plasma were shown. Statistical 
analyses method employed was ‘Independent sample T test’ and were performed 
using a SPSS 10.0 software. SI was calculated by dividing mean CPM of background 
(ie. no MDDC) from mean CPM of each MDDC number (equation 1 described in
II.7). Refer the text for statistical analyses on individual experiment presented in 
fig.V.6 a-fig.V.6c.
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statistically significant (fig.V.6 d). Neither such increases nor signifieant 
suppression in the allostimulatory eapacity o f MDDCs were not seen when 
eells were exposed to both 1% seminal plasma and virus when compared with 
control MDDCs (fig.V.6d). These data were correlated with the data obtained 
from viral DNA assay (fig.V.3a) which showed detectable level of viral DNA 
in both MDDCs exposed to virus only and MDDCs exposed to virus together 
with 0.1% seminal plasma, but not in MDDCs exposed to virus and 1% 
seminal plasma. Taken together the data suggests that allostimulatory 
potentials of MDDCs which are infected with HIV were related to the level o f 
infection with HIV. Although MDDCs exposed to JRCSF virus in the presence 
of 1% seminal plasma did not have detectable level of viral DNA these cells 
did not show the seminal plasma-induced suppressed allostimulatory capacity 
which was previously seen in chapter IV. This may be due to infeetion o f 
allogeneic T cells with HIV which were captured by or attaehed to MDDCs. 
This can be possible as MDDCs has ‘dendritic’ morphology and also 1% 
seminal plasma-pulsed MDDCs express CD4 (fig.IV.4 in ehapter IV).
Similar results were obtained when P E I06 virus infected MDDCs or JW5 
virus infected MDDCs were used (fig.V.7 and fig.V.8). Two experiments 
showed a significant increase in allostimulatory capacity of MDDCs infected 
with P E I06 virus compared with that o f control MDDCs (fig.V.Ta and 
fig.V.Tb, P=0.01 and P=0.000, respectively). All three experiments 
demonstrated highest allostimulatory potential of MDDCs which were infeeted 
with P E I06 in the presence of 0.1% seminal plasma. This was, again, 
correlated with data obtained from viral DNA assay showing high level o f
Fig. V.7. Allogeneic MLR with MDDCs infected with PE106 virus and/or pulsed 
with different concentrations of HIV-negative seminal plasma
MDDCs were pulsed with PE 106 virus (both CCR5 and CXCR4-utilising strain) alone 
or together with 0.1% or 1% HIV-negative seminal plasma overnight. Cells were 
washed and allogeneic MLRs were set up next day using 10  ^ responder eells per well. 
Cells were cultured for further 4 days. Cells were pulsed with O.SpCi of pH]- 
thymidine per well at day 4 and harvested at day 5. Graphs (a), (b), and (e) show mean 
counts per minute (CPM) with standard errors. Graphs (d) shows mean stimulation 
index (SI) of 3 experiments with standard errors. Each experiment was set up in 
triplieate. The table below graph (d) shows P values comparing ability of HIV-1 
infected MDDCs which were exposed to 0.1% or 1% seminal plasma to stimulate 
allogeneie T cells with that of HIV-1 infected MDDCs which were not exposed to 
seminal plasma or with that of uninfeeted MDDCs. Also, P values comparing 
allostimulatory ability of MDDCs exposed to different coneentrations of seminal 
plasma were shown. Statistical analyses method employed was ‘Independent sample T 
test’ and were performed using a SPSS 10.0 software. SI was calculated by dividing 
mean CPM of background (ie. no MDDC) from mean CPM of each MDDC number 
(equation 1 described in II.7). Refer the text for statistieal analyses on individual 
experiment presented in fig.V.7a-fig.V.7c.
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Fig. V.8. Allogeneic MLR with MDDCs infected with JW5 virus and/or pulsed 
with different concentrations of HIV-negative seminal plasma
MDDCs were pulsed with JW5 vims (CXCR4-utilising strain) alone or together with 
0.1% or 1% HIV-negative seminal plasma overnight. Cells were washed and 
allogeneic MLRs were set up next day using 10  ^ responder cells per well. Cells were 
cultured for further 4 days. Cells were pulsed with 0.5pCi of [^H]-thymidine per well 
at day 4 and harvested at day 5. Graphs (a), (b), and (c) show mean counts per minute 
(CPM) with standard errors. Graphs (d) shows mean stimulation index (SI) of 3 
experiments with standard errors. Each experiment was set up in triplicate. The table 
below graph (d) shows P values comparing ability of HIV-1 infected MDDCs which 
were exposed to 0.1% or 1% seminal plasma to stimulate allogeneic T cells with that 
of HIV-1 infected MDDCs which were not exposed to seminal plasma or with that of 
uninfected MDDCs. Also, P values comparing allostimulatory ability of MDDCs 
exposed to different concentrations of seminal plasma were shown. Statistical 
analyses method employed was ‘Independent sample T test’ and were performed 
using a SPSS 10.0 software. SI was calculated by dividing mean CPM of background 
(ie. no MDDC) from mean CPM of each MDDC number (equation 1 described in
II.7). Refer the text for statistical analyses on individual experiment presented in 
fig.V.8a-fig.V.8c.
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infection with PE I06 as determined by PCR. The summary of all three 
experiments using MDDCs infected with PE 106 virus (fig.V.Td) or using 
MDDCs infected with JW5 virus (fig.V.Sd) showed the enhanced 
allostimulatory potentials of virus infected MDDCs and further enhanced with 
0.1% seminal plasma. Furthermore, MDDCs exposed to both 1% seminal 
plasma and virus exhibited higher allostimulatory capacity compared with 
control MDDCs. Such enhancement was associated with infection o f the cells 
with HIV although viral DNA level was considerably low as demonstrated by 
PCR (fig.V.3). A decreased allostimulatory capacity of MDDCs was 
demonstrated when cells were pulsed with 1% seminal plasma from a HIV^ 
patient with viral load of 2,000 copies/ml (fig.V.9a; P=0.03). Seminal plasma 
from a patient with viral load of 68 ,000  copies/ml also decreased the 
allostimulatory function of MDDCs but not significantly (fig.V.9b, P=0.07).
These data together with data obtained from viral DNA assay suggest that 
allostimulatory capacity of MDDCs are associated with level o f infection with 
HIV. The suppressive effect of seminal plasma was not observed when the 
cells were exposed to virus at the same time although viral DNA assay could 
not detect viral DNA in these cells suggesting that virus may be captured by 
MDDCs or may attach to the cells which can infect and hence activate 
allogeneic T cells. Alternatively a very low infection level of MDDCs by HIV 
may be sufficient to activate and mature MDDCs and hence induces an 
enhanced allostimulatory capacity of these cells.
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V.3. D is c u ss io n
In this chapter the effects of seminal plasma on HIV-1 co-receptor expression 
on CD 14^ monocyte-derived dendritic cells, on HIV-1 infection o f these cells, 
and on the antigen presentation function of HIV-1-infected MDDCs were 
investigated.
MDDCs expressed both primary HIV-1 co-receptors. Seminal plasma induced 
changes in surface expression of CCR5 and CXCR4. The level of CXCR4 
expression on MDDCs was increased by seminal plasma whereas the level of 
CCR5 expression decreased (fig.V.2a-2d). This data suggests that seminal 
plasma may favour the infection of DCs with X4 strains o f HIV-1. This was 
confirmed by in vzYro-infection studies. Infection with X4 strain (JW5 virus; 
fig.V.3c) was only observed in 0.1% seminal plasma-pulsed MDDCs and 
infection with the R5/X4 strain [PE 106 virus (fig.V.Sb)] was enhanced when
0.1% seminal plasma was present. On the other hand infection with R5 strain 
(JRCSF) was detected in both untreated and 0.1% seminal plasma-pulsed 
MDDCs (fig.V.Sb), but not in MDDCs pulsed with 1% seminal plasma. 
Although the level of CXCR4 expression on 1% seminal plasma-pulsed 
MDDCs, which was higher than on untreated MDDCs, was not significantly 
decreased compared with that on 0 .1% seminal plasma no detectable level o f 
infection of MDDCs by JW5 virus was observed. This suggests that seminal 
plasma may also inhibit entry of virus without decreasing CXCR4 expression. 
Alternatively such a small decrease may be sufficient to stop the X4 strains o f 
virus entry. Our data, however, does not support the observation that R5
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strains of vims are transmitted preferentially via sexual contact. It is possible 
that LC in the mucosa may not be the first target of viral infection as reported 
by others previously (Zhang et al, 1999).
Despite the fact that the same amount of vims (Ing/ml of p24 protein, 10  ^
MDDCs/ml) was used to infect MDDCs, JRCSF vims infected MDDCs more 
efficiently than PE I06 as was demonstrated by viral DNA assays [fig.V.Sa and 
fig.V.Sb, Lane B (vims only)]. This may be because ‘dual’ tropic strains like 
PE I06 vims are actually mixed populations of both R5 and X4 quasispecies 
and P E I06 may contain less of the R5 strain. Seminal plasma samples from 
two HIV^ patients were also used to infect MDDCs and the viral DNA assay 
showed that these cells were readily infected with vims present in seminal 
plasma (fig.V.4). Furthermore, as little as 20 copies of vims were sufficient to 
infect DCs.
To determine whether DCs were productively infected with vims, p24 protein 
production by MDDCs infected with HIV-1 in vitro (table V.3) was measured 
by ELISA. Levels of p24 antigen in culture supernatants from allogeneic 
MLRs which were set up using HIV-1 infected MDDCs [infected with JRCSF, 
P E I06 and JW5 vimses with or without seminal plasma (table V.2), and 
infected with vims present in seminal plasma from patient 10 (table V.3)] were 
also measured by ELISA to investigate whether productive infection occurred 
within CD4^ T cells to which MDDCs transmitted vims. Antigen presenting 
function of HIV -1 -infected MDDCs was assessed by allogeneic MLRs.
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Little or no p24 protein release was detected by HIV-1 infected MDDCs, 
demonstrating that DCs may not be productively infected or the assay 
employed was not sensitive enough. Taken together with data from viral DNA 
assay it suggests that virus may be present in MDDCs in the latent form and 
consequently not available for infection of CD4^ T cells. Whether DCs are 
productively infected with HIV is controversial. Several groups have shown 
that DCs are productively infected as has been demonstrated by electron 
microscopy showing budding of viral particles (Patterson et al, 1987; Blauvelt 
et al, 1997) and by detection of p24 protein (Chougnet et al, 1999; Kacani et 
al, 1998; Blauvelt et al, 1997). Indirect evidence has also been provided by the 
fact that DCs have been shown to transmit virus to monocytes (Kacani et al,
1998), and to T cells (Frank et al, 1999; Frankel et al, 1998; Ludewig et al,
1996). In contrast, others have detected entry of HIV but little evidence for 
productive infection in DCs without T cells (Granelli-Pipemo et al, 1998; 
Weissman et al, 1995^; Weissman et al, 1995^; Ayehunie et al, 1995; 
Ramazzotti et al, 1995; Cameron et al, 1994; Pinchuk et al, 1994; Pope et al, 
1994; Cameron et al, 1992). These latter results support our findings presented 
in this chapter where p24 antigen in MDDC supernatants was undetectable by 
ELISA. However, the DC-T cell association does provide a site of HIV 
replication, and the degree of infection appears to be related to the degree o f T 
cell activation (Blauvelt et al, 1997; Cameron et al, 1994; Pinchuk et al, 1994; 
Tsunetsugu-Yokota et al, 1997). The exact mechanisms involved in the 
transmission of HIV from DCs to T cells are not fully understood. It has been 
suggested that CD40-CD40L [CD 154] and CD28-CD80 interactions are 
important in this process (Pinchuk et al, 1994; Caux et al, 1994) suggesting
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the importance of T cell activation. It has also been shown that direct contact 
of HIV-1-infected DCs with T cells through adhesion molecules, is crucial for 
efficient virus transmission from DCs to T cells and subsequent virus 
production (T sunetsugu-Y okota et al, 1997). Whether MDDCs transmitted the 
virus to T cells was not determined by viral DNA PCR in this study. 
Supernatants from allogeneic MLR did not contain detectable levels o f p24 
antigens. There are several possible explanations as to why we were unable to 
detect p24 antigen released in DC supernatants or in allogeneic MLR 
supernatants in this study and they include:
i) The p24 protein ELISA used in this study may not be sensitive enough 
to detect p24 protein released. The detection limit o f our assay ranged 
between 0.0316ng/ml and Ing/ml. Others have shown that p24 
production by DCs infected with HIV-1 without T cells or those co­
cultured with T cells could be as little as 0.0Ing/ml (Kacani et al, 1998; 
Blauvelt et al, 1997).
ii) The culture conditions/periods o f cultivation employed in this study 
may not be optimum. Productive infection of DCs depends on the 
culture conditions as has been shown by the fact that when DCs were 
infected and cultivated without cytokine supplementation p24 antigen 
production was rarely observed whereas when cultivated in the 
presence of GM-CSF and IL-4 large amounts of p24 protein were 
produced after 7 days of cultivation (Kacani et al, 1998; Blauvelt et al,
1997). We have supplemented the cultures with GM-CSF and IL-4 
every other day and have cultivated the cells for up to 5 or 6 days after 
incubation with virus overnight. Detectable levels of p24 were obtained
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towards end of cultivation period [after 5 or 6 days of cultivation (table
V .l)]. Therefore, cultivation time may not have been long enough to 
release larger amount of p24 and the system may have required a 
longer cultivation time,
iii) Ing/ml (p24 protein concentration) of virus may not be sufficient to 
infect 10  ^ DCs/ml productively. We did not evaluate the infectious 
dose [50% tissue culture infective dose (TCID50)] of virus used to 
infect DCs. It is difficult to assess TCID50 o f JRCSF virus since 
TCID50 are evaluated based on syncytium formation. JRCSF virus is 
R5 strain o f virus and does not cause formation o f syncitia (Dr. P. 
Hayes, personal communication). Thus it is difficult to conclude that 
the amount of virus used in this study was sufficient for detectable 
level of p24 proteins to be produced.
MDDCs which were infected with virus showed increased allostimulatory 
capacity. MDDCs infected with JRCSF virus or PE 106 virus displayed higher 
allostimulatory capacity than MDDCs infected with JW5 (fig.V.5) and this 
observation was associated with levels of infection with the virus as 
demonstrated by PCR (fig.V.3). The suppressive effect of seminal plasma on 
MDDC function (chapter IV) was largely overcome if  virus was present in the 
culture (fig.V.6 -fig.V.8) although there was a decrease when MDDCs were 
exposed to 1% seminal plasma from HIV^ patients (fig.V.9), compared with 
control MDDCs which were not exposed to seminal plasma. It has been shown 
that HIV-1 infected DCs may have increased pro-inflammatory activity as has 
been demonstrated by elevated production of TNF-a and IL-1(3 (Lore et al.
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1999) as a result of activation o f NF-kB (Kobayash et al, 1989; Okamoto et al, 
1989). Therefore, it is possible that MDDCs infected with HIV in our study, 
may have produced TNF-a which abrogated the suppressive effect o f seminal 
plasma on the allostimulatory function of MDDCs which was demonstrated in 
chapter IV. This Taken together, HIV exposure clearly overcame the 
suppressive effect of seminal plasma. However, productive infection o f T cells 
was not demonstrated by p24 release, despite demonstration of virus entry and 
reverse transcription of viral RNA to DNA by PCR.
Future work
All the further work listed below could be performed with five populations of 
DCs described below:
i) DCs infected with HIV-1 alone.
ii) DCs infected with HIV-1 in the presence of TNF-a.
iii) DCs infected with HIV-1 in the presence o f seminal plasma from HIV-
1 negative individuals.
iv) DCs infected with HIV-1 in the presence of seminal plasma from HIV- 
1 negative individuals plus TNF-a.
v) DCs infected with virus present in seminal plasma from HIV^ 
individuals.
1. Do DCs become productivelv infected with HIV-1?
Whether DCs are productively infected with virus should be measured using a 
more sensitive ELISA system (i.e. commercially available ELISA kits) for p24
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antigen. Cultivation time with virus could be extended to allow release of 
more p24 proteins.
2. Can infected DCs activate T cells?
It has been shown that the degree of T cell infection parallels the degree of T 
cell activation (Cameron et al, 1994; Pinchuk et al, 1994; Tsunetsugu-yokota 
et al, 1997; Blauvelt et al, 1997). It has been suggested that infection with HIV 
results in a defect in antigen presenting function of DCs (Knight et al, 1993; 
Macatonia et al, 1989). Our data from allogeneic MLRs using HIV-infected 
MDDCs demonstrated that HIV infection of MDDCs did not result in a 
suppressed allostimulatory function. This could be confirmed by performing 
the following experiments: DCs could be co-cultured with CD4^ T cells [both 
autologous and allogeneic] or recall antigen stimulated autologous CD4^ T 
cells. The function of DCs could then be assessed by [^H]-tymidine uptake.
3. Can infected DCs transmit virus to CD4^ T cells?
After pulsing of DCs with virus, DCs could be co-cultured with autologous 
CD4^ T cells for a longer period (up to 14 days). p24 antigen levels could be 
measured in culture supernatants collected at different time points and viral 
DNA could be assessed in cells which are harvested at different time points. 
To do this experiment sorting of the cells (CD3^ cell sorting to eliminate DCs) 
prior to viral DNA assay would be required to differentiate infection o f DCs 
from infection of T cells. This would allow investigation o f whether DCs 
transmit virus to CD4^ cell and also to monitor productive infection o f these 
cells.
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4. Quantitation of viral DNA in DCs.
Whether seminal plasma induces preferential infection with certain types o f 
virus [R5, X4 or R5/X4 strains] could be determined by quantitating viral 
DNA copies of each virus in DCs after in vitro infection. Virus DNA could be 
quantitated using a LightCycler™ (Roche, Lewes, East Sussex, U.K.) which 
allows measurement o f copy numbers.
5. Does viral load in semen have an influence on the suppressive effect of 
seminal plasma?
Our preliminary data showed that the viral load in seminal plasma appears to 
be correlated with a reduced suppressive effect of seminal plasma on the 
allostimulatory capacity of DCs. To confirm this phenomenon, the same 
experiment could be performed using larger numbers o f HIV^ seminal plasma 
samples with wide ranges o f viral load. Also, in vzYro-infection studies with 
different viral concentrations can be performed.
There are other factors which may have effect on the allostimulatory function 
of DCs. They include levels of TNF-a production which is probably elevated 
upon infection with HIV. The results from the study using HIV^ seminal 
plasma did not correlate with the in vitro-studies and this may be due to 
different levels of and types of cytokines present in HIV*" seminal plasma from 
HIV-negative seminal plasma and consequently results in a different outcome.
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Since the development of a vaccine to prevent sexual transmission o f HIV 
which is the most frequent mode of transmission, is the ultimate goal, the 
mechanisms of sexual transmission of HIV must be understood. Several 
different approaches have been used to elucidate mechanisms o f sexual 
transmission of HIV such as SIV-macaque model (Hu et al, 2000; Miller and 
Hu, 1999; Joag et al, 1997; Blauvelt et al, 1997; Spira et al, 1996; Zambruno 
et al, 1995), skin expiants (Blauvelt et al, 2000; Reece et al, 1998), and 
mucosa biopsies (Greenhead et al, 2000; Collins et al, 2000; Hu et al, 2000). 
Studies using mucosal tissues include the use of gastrointestinal biopsies 
(Olsson et al, 2000; Poles et al, 2000), rectosigmoidal biopsies (Olsson et al, 
2000; Poles et al, 2000) and female reproductive tract biopsies (Collins et al, 
2000; Greenhead et al, 2000). However, the histologic anatomy o f these 
different mucosal tissues is very diverse. The nature and localisation o f APCs 
which are suggested to be the first targets of HIV infection or association and 
overall structural cellular organisation differ in these tissues. Therefore, the 
most appropriate model to investigate the mechanisms of heterosexual 
transmission of HIV would be use of female genital tract tissues. Ex vivo 
studies together with in vitro studies described in this chapter would allow 
better understanding of the mechanisms of heterosexual transmission o f HIV.
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VI
D is c u s s io n :
R o le  o f  Se m in a l  flu id  in  Se x u a l  T r a n sm issio n  o f  H IV -I
HIV-1 is transmitted vertically from mother to child, by sexual contact or by 
contact with infected blood. Sexual transmission is responsible for more than 
90% of HIV-1 infections in Africa and in developing countries. The UNAIDS 
figures estimate that 5.3 million people were newly infected with HIV with 3 
million deaths from AIDS occurred during the year 2000. This thesis focuses 
on factors influencing HIV-1 transmission via sexual contact. Semen is the 
vehicle for the virus during the sexual transmission of HIV from a male. 
Mucosal DCs are considered to play an important role in establishing infection 
and mediating the systemic spread of HIV due to their following 
characteristics: i) location within the mucosal epithelium, ii) expression of 
CD4 and CCR5 (Zhang et al, 1998; Zoeteweij et al, 1998; Zaitseva et al, 
1997; Granelli-Pipemo et al, 1996), iii) the ability to migrate to T cell-rich 
areas o f lymph nodes (Hu et al, 2000; Banchereau et al, 1998) and iv) the 
ability to induce clustering, activation and transmission o f HIV to T cells 
(Zoeteweij et al, 1998; Blauvelt et al, 1997). Therefore, this thesis examined, 
in particular, the main reservoir of HIV-1 in semen and the effect o f seminal 
plasma on DC function, phenotype and susceptibility to HIV-1 infection.
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VI. 1. S u m m a r y  OF T h e sis
The HIV-1 reservoir in semen was defined in order to evaluate ‘sperm- 
washing’ as a method of reducing the risk o f HIV-1 transmission in HIV- 
discordant couples who wish to have children (chapter III). There is still 
controversy surrounding whether spermatozoa express CD4 and are infected or 
infectable with HIV-1. The study described in chapter III demonstrated that 
spermatozoa are not infected with HIV-1 in vivo as was demonstrated by the 
fact that neither viral RNA nor DNA was detected in these cells (Kim et al,
1999). The lack o f potential for these cells to become infected was confirmed 
by phenotypic analysis of sperm cells. Spermatozoa did not express CD4 or 
CCR5 on the cell surface. Although there was a low level o f CXCR4 
expressed on spermatozoa, these cells lacked CD4 expression both at the 
protein and mRNA levels, suggesting that spermatozoa are not likely to be 
infectable with HIV.
Galactosylceramide (or a derivative) which has shown to be an essential 
component of the neural receptor for HIV-1 (Bath et al, 1991; Harouse et al, 
1991), has been shown to be present on the surface membrane of the mid-piece 
and equatorial segments of human spermatozoa (Baccetti et al, 1994; Brogi et 
al, 1995). Although there is one report showing that sperm glycolipids are 
capable of binding to gpl20 (Brogi et al, 1995), whether these glycolipids 
fimction as an alternative receptor for HIV infection of spermatozoa has not 
yet been confirmed. Since the mid-piece of sperm contains mitochondria that
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generate energy for motility of sperm, it is possible that, if  glycolipids on the 
surface o f the mid-piece of sperm function as an alternative receptor for HIV, 
HIV infection may result in disrupted mitochondrial function and sperm 
immotility. This may explain an observation of Scofield et al in 1994 that HIV 
was detected in immotile but not in motile spermatozoa. ‘Sperm-washing’ 
involves isolation of motile sperm cells by a ‘swim-up’ procedure which 
would reduce or possibly even eliminate contamination with ‘infected’ non- 
motile sperm cells if  these exist. Therefore, even with the assumption that 
sperm cells may be infected with HIV via glycolipids on the cell surface which 
may impair the motility of sperm cells, ‘sperm washing’ would still reduce the 
risk of transmission in HIV-discordant couples. It should be noted that in this 
study, virus was not detected in the less motile or dead sperm cell fraction. 
Recently, it has been shown that hepatitis C virus transmission can be reduced 
or eliminated by the ‘sperm-washing’ procedure (Pasquier et al, 2000). 
However, it has been suggested that hepatitis C virus is a blood-born infection 
and is not transmitted sexually (Dr. J. Gilmour, personal communication). 
Technical differences in HIV-1 detection and sperm preparation methods, or 
contamination of spermatozoal preparations with NSCs, may have resulted in 
discrepancies in results obtained by different groups.
HIV-1 was present in semen both as ffee-virus and NSC-associated virus (Kim 
et al, 1999) and these data have been supported by others (Pasquier et al, 2000; 
Coombs et al, 1998; Gupta et al, 1997; Dyer et al, 1996; Vemazza et al, 1996; 
Liuzzi et al, 1996; Rasheed et al, 1995). The present study also provided
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indirect evidence that semen may be a distinct reservoir of HIV-1 as was 
demonstrated by the finding that levels of HIV-1 viraemia in semen did not 
always correspond with that in blood plasma or with blood CD4 counts. Other 
groups have reported similar findings (Coombs et al, 1998; Gupta et al, 1997; 
Liuzzi et al, 1996; Rasheed et al, 1995).
NSCs consist of immature germ cells, epithelial cells and leukocytes including 
macrophages, CD3^CD4^ and CD3^CD8^ T lymphocytes and CD 103^ T cells 
(Quayle et al, 1997). It has been shown that among NSCs, T lymphocytes and 
macrophages are infected with HIV-1 in vivo (Quyale et al, 1997). The study 
described in chapter III showed that up to 45% of the NSC population express 
CD4, suggesting that these cells may be susceptible to HIV-1 infection. The 
mechanisms for preferential transmission of R5 strains and the initial events in 
infection after mucosal exposure to virus are not yet well understood. Mucosal 
integrity obviously plays an important role in sexual transmission of diseases. 
Due to their anatomical location, the vagina and ectocervix are the female 
genital tissues facing the potentially highest exposure to pathogens. These 
tissues are covered by layers of epithelial cells and antimicrobial secretions 
which provide a protective barrier. T cells (both CD4^ T cells and CD8  ^ T 
cells), B cells, Langerhans’ cells and plasma cells are present in the female 
genital mucosa, located predominantly in the epithelium, parabasal and basal 
layers of the vagina and ectocervix (Johansson et al, 1999; Pope et al, 1998; 
Morris et al, 1983). It has been suggested that mucosal DCs may be the first 
cells to become infected following exposure to HIV (Miller and Hu, 1999;
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Spira et al, 1996; Joag et al, 1997; Reece et al, 1998). Freshly isolated LCs 
(from skin) express functional CCR5 but not CXCR4 (Zaitseva et al, 1997) 
suggesting that selection of R5 strains could take place in the mucosa. 
Conversely, it has been shown that DCs isolated from human cervicovagina 
mucosa express CXCR4 but not CCR5 (Hladik et al, 1999). T cells derived 
from the human cervicovagina, form stable conjugates with DCs in vitro and 
result in productive infection by viruses of both co-receptor specificities 
(Hladik et al, 1999), suggesting that selection of virus variants does not occur 
by differential expression of co-receptors on genital cells. It has also been 
suggested that T cells in the endocervix may be the first cells to become 
infected (Zhang et al, 1999). Infection of T cells in the macaque endocervix 
with SIV was detected 3 days post inoculation. However, the possible 
infection of endocervical DCs or macrophages with SIV at day 3 was not 
assessed and therefore, it can not be concluded that T cells rather than DCs are 
the first cells to become infected. SIV infection was not detected in any cell 
type studied (i.e. T cells, CD4^ cells, macrophages and DCs) 1 day after 
inoculation, but by day 7 infection of endocervical DCs and macrophages, in 
addition to T cells was detected (Zhang et al, 1999). Genotypic and phenotypic 
analyses o f viral isolates from blood and semen (Zhu et al, 1996; Kroodsma et 
al, 1994) provided evidence that the semen may be a reservoir for R5 strains of 
virus thus allowing preferential transmission of R5 strains. The present study 
supports this hypothesis. It has been demonstrated that NSCs express CCR5, 
but negligible amounts of CXCR4, suggesting that this may contribute to the 
selection of R5 strains of virus within semen (chapter III). However whether
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such low levels of CXCR4 expression on NSCs is sufficient to allow entry of 
X4 strains remains to be determined. Therefore, it is possible that R5 strain 
selection may take place in semen as well as in LCs at the mucosal surface.
In chapter IV the effects of seminal plasma on the phenotype and function o f 
DCs were investigated. Immature DCs derived from peripheral blood CD 14^ 
monocytes using GM-CSF and IL-4 were generated as previously described 
(Sallusto et al, 1995; Sallusto and Lanzavecchia, 1994). Seminal plasma had 
suppressive effects on the allostimulatory capacity of DCs and reduced 
expression of co-stimulatory molecules on these cells (chapter IV). Whether 
such suppressive effects on allostimulatory capacity were the result o f 
prostaglandin activity was investigated, since PGE2 has been shown to have 
immunomodulatory effects and is also known to be present in human semen at 
a concentration 10  ^ times that seen in peripheral blood (Kelly, 1997^). PGE2 
has both pro-inflammatory (Rieser et al, 1998; Reiser et al, 1997; Portanova et 
al, 1996; Kalinski et al, 1998) and suppressive effects (Strassman et al, 1994) 
on APCs. PGE2 inhibits IL-12 production in DCs (Kelly et al, 1997^; Kraan et 
al, 1995; Van Parijs et al, 1997) resulting in induction of type-2 polarised 
effector DCs (Kalinski et al, 1998; Kalinski et al, 1997) which induce Th-2 
type responses (Kalinski et al, 1998). PGE2 has also been shown to stimulate 
IL-10 production in DCs (Groux et al, 1996; Kelly et al, 1997^) resulting in 
tolerogenic DCs, also known as type-3 polarised effector DCs (Steinbrink et 
al, 1997). These tolerogenic DCs express low levels of co-stimulatory 
molecules (Kalinski et al, 1998; Steinbrink et al, 1997) and hence may induce
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anergy. The present data did not demonstrate a suppressive effect of 
prostaglandins on DC function. However, this study demonstrated that the 
suppressive effect induced by seminal plasma was abrogated by removal of 
lipids (chapter IV), suggesting that glycolipids in seminal plasma do have 
suppressive effects on DC function. It is possible that other components o f 
seminal plasma may also play a role in induction of the suppressive effects, 
such as prostasome, polyamine, TGF-P and IL-10 although IL-10 is present in 
semen at very low concentrations (Kelly, 1995; Alexander and Ansderson, 
1985). Although prostaglandin by itself did not induce suppressive effects in 
vitro, it is possible that prostaglandins may have DC suppressive effects in 
combination with other seminal components. It is also possible that spermine 
oxidation products resulting from an interaction with bovine serum may have 
resulted in the suppressed allogeneic MLRs as was seen in the murine MLRs 
(Labib and Tomasi, 1981). A further study using spermine oxidase inhibitors 
or pulsing DCs with seminal plasma in the absence of bovine serum in the DC 
medium would determine whether spermine oxidation products are responsible 
for the suppressed allogeneic T cell proliferation described in chapter IV. The 
possibility that the suppressive effect of seminal plasma might be due to 
induction of T cell anergy was investigated, but no such phenomenon was 
demonstrated (chapter IV).
The suppressive effect of seminal plasma on the allostimulatory function o f 
DCs was overcome by addition of TNF-a (chapter IV). The decrease in 
expression of co-stimulatory molecules on DCs exposed to seminal plasma
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was no longer observed when DCs were exposed to both TNF-a and to 
seminal plasma in combination. Previously published data have demonstrated 
that pro-inflammatory cytokines induce maturation of DCs (Sallusto and 
Lanzavecchia, 1997; Jonuleit et al, 1997; Celia et al, 1997; Roake et al, 1995; 
Sallusto et al, 1995). HIV was shown to infect DCs in vitro and this infection 
also abrogated the suppressive effect of seminal plasma on DCs (chapter V). 
This may result from maturation of DCs on antigen-uptake and/or increased 
production of pro-inflammatory cytokines (e.g. TNF-a and IL -ip) by HIV-1 
infected DCs (Lore et al, 1999).
The expression of HIV-1 co-receptors on DCs was influenced by seminal 
plasma, by TNF-a and by both in combination (chapter V). TNF-a alone, 
seminal plasma alone or in combination induced a decrease in CCR5 
expression and an increase in CXCR4 (chapter V) which may favour infection 
by X4 strains of HIV-1. These data were supported by those of others (Canque 
et al, 1999; Sallusto et al, 1998; Zaitseva et al, 1997). Expression of CXCR4 is 
also up-regulated by type-2 cytokines such as IL-4 and down-regulated by 
type-1 cytokines such as IFN-y (Zoeteweij et al, 1998). Therefore, an increase 
in type 2 cytokine production, which can occur during HIV infection 
(Stylianou et al, 1999; Meroni et al, 1996) and elevated levels o f pro- 
inflammatory cytokines such as TNF-a, IL- 8  and IL-6 , which can also occur 
in STDs, (Ramsey et al, 1995) may promote infection of DCs with X4 strains. 
The infection of seminal plasma-pulsed DCs, but not of control DCs, with an 
X4 strain of virus was observed (chapter V). Increased expression o f CXCR4
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on seminal plasma-pulsed DCs may result from TGF-P present in semen. 
TGF-P has been shown to up-regulate CXCR4 expression on DCs (Zoeteweji 
et al, 1998).
There are limitations in our study. CD 14  ^monocyte-derived DCs were used as 
a mucosal LC model which has been found recently to be not an ideal model in 
terms o f phenotype (fig.1.6). LCs derived from CD14'CDla^ LC precursors, 
LCs isolated from female mucosa, or mucosal biopsis obtained from the 
female genital tract would be a better model. A summary of the thesis is 
outlined in fig.VI.l. It also describes proposed mechanisms which may be 
important in the suppressive effects of seminal plasma on DCs which would 
provide ‘protection’ to the ‘male cells’ in a ‘female environment’, and 
mechanisms where ‘danger’ which would be apparent if  a pathogen was 
present, may be tackled by functioning DCs.
VI.2. S i g n i f i c a n c e  o f  t h e  i n  v i t r o  f i n d i n g s  t o  t h e  i n  v i v o  s i t u a t i o n
VI.2.1. The effect of seminal plasma and TNF-a on DC function in the 
female reproductive tract
The function of the DC in mucosal tissues, including the female reproductive 
tract, is to take up and process antigen of potential pathogens and present 
peptides of the antigen in association with MHC molecules. The presented 
antigen may then be recognised by both naive and memory T cells, resulting in
/
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T cell activation via co-stimulatory molecules expressed on the DC surface 
(including CD40, CD80 and CD86) and ultimately leading to the generation of 
an immune response to the pathogen. This sequence of events involves both 
maturation and migration o f the DC from that o f an antigen uptake phenotype 
at the mucosal epithelium to that of an immunostimulatory phenotype in the 
local lymph node, where the vastly higher T cell density facilitates interaction 
o f the DC with the T cell.
The mucosa o f female reproductive tract, like other mucosa, encounters many 
potential infectious agents and consequently an effective barrier must be 
presented. The vagina and ectocervix, which are potentially the tissues facing 
the greatest exposure to pathogens, including HIV-1 in semen, are covered 
with layers of epithelial cells (fig.1.4) and antimicrobial secretions such as 
lactoferrin, lysozyme and transmembrane mucins (e.g. Mucin 1 or episialin) 
and secretory mucins (DeSouza et al, 1999; Gendler and Spicer, 1995). Such 
anatomy provides a primary protective barrier. Although potential pathogens 
must be eliminated, the main function of the female reproductive tract is to 
facilitate insemination, fertilisation and development of the embryo. To the 
female, cells in semen are allogeneic, however to promote fertilisation o f the 
embryo an immune response to spermatozoa should be avoided. The results of 
this and other studies demonstrate some of the mechanisms that humans have 
evolved to both promote fertilisation by minimising immune responses to 
seminal components but also discriminate and respond to potential pathogens 
if  present within the semen. The significance of the present findings on these
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two opposing functions (fertilisation versus response to pathogens) can best be 
explained by describing the possible in vivo situations. In this study, TNF-a 
was employed as an inflammatory stimulus, which would be one inflammatory 
component present in semen when a male is infected with a pathogen (STDs) 
in vivo.
i) Exposure o f the female reproductive tract to semen in the absence of 
inflammation
Exposure o f MDDCs to seminal plasma would mimic the in vivo situation 
where the female reproductive tract would be exposed to semen in the absence 
o f an inflammatory stimulus or STD. In this situation mucosal epithelial DC 
(i.e. LC) function would be suppressed by seminal plasma as demonstrated by 
decreased expression of co-stimulatory molecules, along with a decreased 
ability to stimulate T cells. Therefore, an immune response to spermatozoa 
would be discouraged, promoting fertilisation. This inhibition of an immune 
response to semen may be more important in the long term, with the female 
potentially exposed frequently to semen over her entire reproductive life-span 
and beyond. Seminal plasma appears to discourage an immune response by 
affecting DC rather than T cell function directly as seminal plasma pulsed 
MDDCs did not appear to induce anergy in T cells. T cells were not exposed 
directly to seminal plasma as the accepted model o f DC function is that DC-T 
cell interaction occurs in the lymph node away from contact with seminal 
plasma. T cells exposed to seminal plasma pulsed MDDCs proliferated in 
response to IL-2 and to freshly added seminal plasma unpulsed MDDCs. The
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present study demonstrated that lipids might be the major suppressive 
component of seminal plasma. However, individual lipid molecules may 
activate DC function demonstrating that the suppressive effects are induced by 
a complex interaction between seminal components.
ii) Exposure of the female reproductive tract to an inflammatorv stimulus 
fwithout semen)
Exposure of MDDCs to TNF-a alone would mimic the in vivo situation where 
the female reproductive tract would be exposed to an inflammatory stimulus or 
STD in the absence o f semen. This situation may occur either as a result o f a 
non-sexually transmitted vaginal infection (e.g. thrush) or due to a STD that 
may establish itself at a time point subsequent to insemination. The results o f 
the present study demonstrated that under these conditions mucosal DC 
function would be induced, with maximal increases in expression o f co­
stimulatory molecules and T cell stimulatory abilities. Such factors would 
promote an immune response to the pathogen.
iii) Exposure of the female reproductive tract to semen in the presence o f 
inflammation
Exposure o f MDDCs to seminal plasma and TNF-a would mimic the in vivo 
situation where the female reproductive tract would be exposed to semen in the 
presence of an inflammatory stimulus or STD. Some suppressive effect of 
seminal plasma was evident in this study as the increases in expression of 
CD86 and allostimulatory abilities were not as great as in MDDCs exposed to
165
TNF-a alone. However, the present data would suggest that in this 
circumstance mucosal DC function would be retained, with increased ability to 
stimulate T cells, compared with unexposed mucosal DCs. Therefore, an 
immune response to a possible pathogen would be promoted.
VI.2.2. The relationship between DCs in the female reproductive trac t and 
HIV-1
The interaction between seminal plasma, TNFa, DCs and HIV-1 was 
investigated in order to elucidate factors that may influence sexual 
transmission of HIV-1 to the female with the focus being the potential for the 
DC to be infected with HIV-1.
i) Influence of seminal plasma and TNF-a on CCR5 and CXCR4 
expression bv MDDCs 
HIV co-receptor expression was assessed as described in chapter IV Exposure 
o f MDDCs to seminal plasma, TNF-a or both together resulted in decreased 
expression of CCR5 but increased expression of CXCR4. Therefore, if  DCs 
are infected with HIV-1, exposure to seminal plasma and/or TNF-a may 
promote infection with X4 rather than R5 strains. However, CCR5 and 
CXCR4 expression would have evolved not to allow infection with HIV-1, but 
rather to mediate cellular responses to the chemokines RANTES, M IP -la , 
M IP-ip and SDF-1. One of the main functional attributes of a DC is that of 
migration from the mucosal tissue to the lymph node, with chemokines
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controlling this process. Therefore, decreased CCR5 but increased CXCR4 
expression may represent a migratory DC phenotype, reducing the ability to 
respond to RANTES, M IP-la  and M IP-ip produced in the mucosal tissue, 
especially in inflammation, but increasing the ability to migrate towards SDF- 
1 present in the lymph node at higher concentrations (Delgado et al, 1998; 
Sallusto et al, 1998).
The finding that either seminal plasma or TNF-a alone induced a migratory 
phenotype in the DC is in contrast to the effect o f these two agents on DC co­
stimulatory abilities, with seminal plasma suppressing and TNF-a enhancing 
such activities. Therefore, exposure of DCs to seminal plasma components 
promotes maturation o f DCs in terms of migratory abilities but without 
increased T cell stimulatory abilities.
ii) HIV-1 infection of DCs and the influence of seminal plasma 
The present study assessed the susceptibility of MDDCs to infection with R5 
(JRCSF), X4 (JW5) and dual tropic (PE 106) strains of HIV-1. In addition the 
effect of seminal plasma on MDDC susceptibility to infection was assessed, 
thereby mimicking the in v/vo-situation were the mucosal epithelium of the 
female reproductive tract would be exposed to HIV-1 in the presence of 
seminal plasma.
Detection of viral DNA in HIV-1 exposed MDDCs demonstrated infection of 
these cells with all three strains of virus. However, no evidence of productive
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infection could be demonstrated by release of p24 protein into MDDC culture 
supernatants. Together, these findings suggest that HIV-1 viral particles may 
attach to DCs via CD4 and either CCR5 or CXCR4 co-receptors and fuse with 
the cellular membrane. Viral RNA is then reverse transcribed into viral DNA, 
which was detected by PCR. Whether viral DNA may then integrate into the 
DC genome, forming stable proviral DNA, was not assessed. The lack o f 
productive infection and evidence from other studies would argue against this 
(Granelli-Pipemo et al, 1998; Weissman et al, 1995^; Weissman et al, 1995'’; 
Ayehunie et al, 1995; Ramazzotti et al, 1995; Cameron et al, 1994; Pinchuk et 
al, 1994; Pope et al, 1994; Cameron et al, 1992). Studies o f HIV-1 replication 
in T cells have demonstrated that an activated host cell is required for 
productive infection (Blauvelt et al, 1997; Cameron et al, 1994; Pinchuk et al, 
1994; Tsunetsugu-Yokota et al, 1995). HIV-1 may enter resting T cells, with 
reverse transcription of viral RNA, however, in resting T cells viral DNA 
remains in an unstable unintegrated form without productive infection. Stable 
integration of proviral DNA in to the T cell chromosome requires T cell 
activation. However, integration of proviral HIV DNA does occur in 
terminally differentiated macrophages (Wienberg et al, 1991; Lewis et al, 
1992) and therefore, HIV-1 may well integrate into terminally differentiated 
DCs.
Seminal plasma exposure resulted in prominent alterations in the susceptibility 
of MDDCs to the three different strains of HIV-1, as demonstrated by PCR, 
which appeared to reflect the seminal plasma induced alterations in co-receptor
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expression by MDDCs. The absence o f seminal plasma favoured infection of 
MDDCs with the R5 strain JRCSF, with these cells displaying a CCR5'”®'’ / 
CXCR4'°'^ phenotype. Seminal plasma pulsed MDDCs were susceptible to the 
X4 strain JW5, with these cells displaying a CCR5'°'^ / CXCR4'”®'’ phenotype. 
Both unpulsed and seminal plasma-pulsed MDDCs were susceptible to 
infection with the dual tropic strain FBI06.
Therefore, seminal plasma favoured infection of DCs with X4 strains of HIV-1 
apparently due to increased expression of CXCR4 and decreased expression of 
CCR5. In addition, seminal plasma exposure may also affect the function of 
these co-receptors on the DC as well as their level of expression, however this 
was not assessed in the present study. Semen would be present at the point o f 
insemination and therefore, the results of this study suggest that infection of 
DCs in the epithelium of the female reproductive tract with X4 strains o f HIV- 
1 would be favoured if this strain of virus is present in semen. This is contrary 
to the compelling epidemiological evidence the R5 strain is the predominant 
HIV strain transmitted. This evidence would argue against direct infection of 
the DC, with viral fusion and reverse transcription of RNA, being the key 
event in transmission of HIV-1. However it is possible that semen may be a 
reservoir for R5 strains of virus due to the high level of CCR5 expression (but 
only low levels of CXCR4 expression) on NSCs (Kim et al, 1999) with the R5 
strains predominating in semen (Zhu et al, 1996; Kroodsma et al, 1994).
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HIV-1 exposed MDDCs displayed increased T cell stimulatory abilities as 
shown by their increased allostimulatory capacities. As was the case for TNF- 
a , HIV-1 infection overcame the suppressive effects of seminal plasma, with 
MDDCs exposed to both virus and seminal plasma displaying greater T cell 
stimulatory capacity than untreated MDDCs. This increased T cell stimulatory 
ability was greatest with each viral strain with the corresponding seminal 
plasma concentration favouring DC infection.
VI.3. T h e  r o l e  o f  m u c o s a l  e p i t h e l i a l  DCs i n  s e x u a l  t r a n s m i s s i o n  o f  
HIV
Using the MDDC as a model for immature DCs, the present study investigated 
the possible interactions between mucosal DCs in the female reproductive 
tract, seminal plasma, inflammatory stimuli and HIV-1. The ultimate aim was 
to elucidate the possible mechanisms of and factors influencing sexual 
transmission of HIV-1. In relation to HIV transmission the present study has 
demonstrated that:
ii) Seminal plasma favoured infection of DCs with X4 strains o f HIV -1.
iii) Seminal plasma had suppressive effects on DC co-stimulatory cell
surface phenotype and T cell stimulatory ability.
iv) This suppressive effect was overcome either by exposure to an
inflammatory stimulus (TNF-a) or to HIV-1 itself.
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v) Seminal plasma or TNF-a induced a CCR5‘°'^/CXCR4'”®'’ migratory 
phenotype.
The direct involvement of the DC being a key event in transmission of HIV-1 
remains unproven. However, data from this and other studies demonstrates that 
the biology of the DCs may result in this cell playing a crucial role in HIV-1 
transmission. Using the data of this study as the focus, but with data from 
other studies included, the following sequence of events and a possible role of 
epithelial mucosal DCs in HIV-1 transmission to the female is proposed:
Step 1) Sexual exposure of the female to semen from a HIV^ man.
DCs in the mucosal epithelium may be exposed to both seminal plasma and to 
HIV-1, either as free virus in the seminal plasma or as infected NSCs. 
Epidemiological data suggests that impaired mucosal integrity due to the 
presence of ulcerative STDs increases the chance o f sexual transmission of 
HIV-1. Such impaired mucosal integrity would increase the exposure of 
mucosal leukocytes, including the DC, to HIV and semen. STDs also increase 
numbers and / or activation status of DCs, macrophages and T cells which are 
susceptible to viral infection.
Step 2) Association o f HIV-1 with the DC
HIV-1 may then associate with the DCs in vivo in two ways and both may 
feasibly occur simultaneously. HIV may bind to the DCs via CD4 and either 
CCR5 or CXCR4 co-receptors, resulting in viral fusion and reverse
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transcription of viral RNA but without productive infection. The presence of 
semen may favour infection of DCs by X4 strains of HIV-1. HIV-1 may also 
associate with the DC at the cell surface without fusion of the viral particle. A 
role for the adhesion molecule DC-SIGN in binding HIV at the DC surface has 
been suggested (Geitenbeek et al, 2000'’). There is no evidence that semen 
affects the strain o f HIV that may bind via DC-SIGN and presumably both R5 
and X4 strains may bind in this manner, if  present. However, other studies 
have shown that R5 strains predominate in semen (Zhu et al, 1996; Kroodsma 
et al, 1994) and the present study demonstrates CCR5 rather than CXCR4 
expression by NSCs.
Step 3) Dissemination of HIV-1 via the DC
DCs exposed to semen would mature to a CCR5'°'^ / CXCR4'”®'’ migratory 
phenotype and migrate towards the lymph node in response to a concentration 
gradient of SDF-1. TNF-a may also be present in semen, which may enhance 
the alteration to a migratory phenotype. The CCR5'°'^ phenotype may assist 
migration away from RANTES, M IP-la  and M IP-ip, should the mucosal 
epithelial region be inflamed. Therefore, HIV associated with the DC would be 
carried from the mucosal tissue to the lymph node where DCs would cluster 
with T cells, facilitating infection o f T cells in the lymph node. It would be 
expected that virions associated with the DC surface via DC-SIGN would be 
the HIV particles transferred to the T cell. However, a low and undetectable 
level of productive HIV infection in DCs could conceivably result in T cell 
infection.
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In the present study DCs exposed to and apparently infected with HIV-1, 
displayed increased T cell stimulatory abilities, even in the presence of 
suppressive seminal plasma. Exposure to seminal TNF-a would further 
enhance DC-T cell stimulatory abilities. Therefore, the DCs in contact with 
HIV-1 and responsible for HIV transmission to the T cells, would also be the 
DC with a greater ability to stimulate T cells. This enhanced T cell stimulation 
would further promote productive viral replication in the DC-T cell cluster 
with establishment of the infection in the lymph node and ultimate 
dissemination of HIV.
The mucosal tissue exposed to HIV and semen would contain leukocytes other 
than DCs that would be targets for more productive HIV replication. However, 
the marked ability of the DC, rather than other mucosal leukocytes, to migrate 
from the mucosal epithelium directly to the T cell rich lymph node, followed 
by DC-mediated T cell activation with productive viral replication, implicates 
the DC as an important factor in the sexual transmission of HIV-1 and 
subsequent systemic dissemination.
One of the desirable outcomes of an efficient treatment or vaccine for HIV, in 
addition to lowering blood plasma viral load, would be a lowering of the viral 
load in semen as semen serves as the primary vector for sexual transmission of 
HIV since it contains both cell-associated and cell-free viruses. In order to stop 
systemic spread of virus infection after genital exposure, a vaccine which can
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induce potent immunologic memory cell populations that rapidly expand in 
response to the presence of HIV recall antigens within the genital tract or 
draining lymph nodes is desirable. Another important fact to be considered in 
order to reduce the incidence of sexual transmission of HIV is treatment of 
other STDs. This can both reduce viral shedding in semen and in vaginal fluid 
and can restore mucosal integrity, providing a more effective barrier to, and 
protection from HIV and other STDs.
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